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ABSTRACT 
Product toxicity is a common problem in microbial production of biorenewable fuels and 
chemicals. Historically, the field of metabolic engineering has relied on enrichment of expression 
libraries and strain evolution for improving tolerance. Reverse engineering of these strains can 
aid in the identification and development of rational design strategies for strain improvement, 
according to Orgel’s Second Rule that “evolution is cleverer than you are”.    
Here, we investigated the evolved strain with increased short-chain fatty acid tolerance 
and 5-fold higher fatty acid titer relative to its parent strain to discover and understand the 
mechanisms of the phenotypic changes. Four mutations were identified in the evolved strains, as 
well as the chronological order of mutations during adaptive evolution. Then we studied each 
mutation and their synergistic interaction by characterizing the reconstructed strains, which had 
single mutation, double mutation or triple mutations replaced into the genome of the parent 
strain. The waaG mutation contributed to increased C8 tolerance, fatty acid titer, and membrane 
integrity. The increased fatty acid titer was mainly affected by the mutant rpoC gene. The 
decreased membrane fluidity and increased cell surface hydrophobicity of evolved strain were 
caused by the synergistic interaction of waaG, rpoC, and basR mutations. We also noticed each 
mutation was able to alter the membrane lipid composition differently. The association between 
mutations and phenotypic changes we identified could be used as rational engineering strategies 
for improving tolerance and production of microbial biocatalyst. 
However, the rpoC and basR encode transcriptional regulators, and we were not able to 
fully understand the mechanisms of these two mutations by only genome-level reverse 
engineering. Thus, we further investigated these two mutations by transcriptome analysis. 
Compared evolved strain LAR1 to parent strain ML115 during fatty acid producing, twenty-nine 
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genes made statistically significant changes in transcript abundance, which could be influenced 
by rpoC mutation. Also, nine genes were identified had differential transcript abundance, which 
could be impacted by the basR mutation. Characterization of these interesting genes is in 
progress to discover the mechanisms of increased short-chain fatty acids tolerance and 
production of evolved strain LAR1.         
In order to deepen our understanding the association between fatty acid production and 
cell membrane properties, we characterized a small group of environmental E. coli isolates with 
significantly higher short-chain fatty acids production in minimal medium relative to lab strain 
MG1655. Consistent with previous studies, decreased membrane fluidity was associated with 
increased fatty acid production. The C16:1/C16:0 ratio (mol/mol) was suggested to be one of the 
important metrics, when rationally engineering membrane lipid composition for improving short-
chain fatty acids production in E. coli. We also discovered the direct association between cell 
surface hydrophobicity and short-chain-fatty acids titer. In short, the findings of our work could 
provide new insights into the mechanisms of short-chain fatty acid tolerance and production, and 
rational engineering strategies for improving performance of biocatalyst.      
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CHAPTER 1. INTRODUCTION 
Background 
Increasing attention has been paid to engineering microorganisms to produce biofuels and 
biorenewable chemicals using sustainable carbon-based sources in order to mitigate 
environmental pollution of producing petroleum-based fuels and chemicals and to meet the 
increasing global demand for energy (1–4). In this work, we focus on one of the attractive 
biorenewable chemicals, fatty acids, which have a large and increasing market due to their wide 
range of applications as a multifunctional precursors (5–12).  However, it is a common problem 
that the desired products are toxic to the engineered microbial biocatalyst, which appears to 
impair cell growth and limit fermentation performance (13–18). Extensive work has been done to 
characterize the inhibition of ethanol and butanol in Escherichia coli and yeast (19–22). 
However, more efforts were needed in order to understand the mechanisms of the fatty acid 
toxicity in microbial biocatalysts.   
Biorenewable processes such as the production of ethanol, glycerol, 1,3-propanediol, and 
lactic acid have already been industrialized (3). Many reports have been published on increasing 
fatty acid production in engineered E. coli strains or yeast (23–27) while the inhibition of short-
chain fatty acids has also been observed (23, 27). Thus, it is possible to industrialize the 
production of short-chain fatty acids, if the titer, production, and yield of engineered biocatalyst 
could achieve the commercial level.  In order to meet this objective, we need to eliminate or at 
least largely alleviate the inhibition of short-chain fatty acids. The first important step is to 
characterize and understand the mechanisms of the inhibition. Transcriptome analysis and cell 
characterization study both proved that short-chain fatty acids damage the cell membrane during 
fatty acid production in E. coli, which seems to be the major mechanism of toxicity (27, 28). In 
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addition, it has also been reported that the membrane damage and intracellular acidification are 
caused by exogenous challenge with octanoic acid (C8) at pH 7.0 in E. coli (14, 29). In the past 
few years, many efforts have been made to address the membrane damage issue in order to 
increase the short-chain fatty acid tolerance and production in E. coli. Altering membrane lipid 
composition successfully increased the membrane integrity and fatty acid tolerance, while it did 
not increase fatty acid productivity (28). Preventing medium-chain fatty acid incorporation into 
the cell membrane successfully increased the fatty acid tolerance and production (30). 
Synthesizing trans unsaturated fatty acids and incorporating them into the cell membrane 
improved E. coli  robustness and fatty acids production (31).  
In our previous work, we applied adaptive laboratory evolution to E. coli to improve 
exogenous octanoic acid tolerance. The evolved strain had a 5-fold increase in fatty acid 
production, increased membrane integrity, and increased tolerance to not only short-chain fatty 
acids but also butanol isomers (23). It is important to discover and understand the mechanisms of 
the phenotypic changes of the evolved strain by reverse engineering, which can be used as design 
strategies of rational engineering for biocatalyst improvement. Reverse engineering is a powerful 
tool, which contributed to improving succinate production in E. coli (32), increasing yeast 
membrane thermotolerance (33), and identification of the major furfural reductase in E. coli (34).  
In this work, we investigated the evolved strains by whole-genome sequencing, 
transcriptome analysis and strains characterization, in order to discover the mechanisms of 
increased short-chain fatty acid tolerance and production, and altered cell membrane properties. 
Four mutations were identified in the evolved strains, and the association between mutations and 
phenotypic changes were discovered by us. Two mutations encode transcriptional regulators, 
thus we did further investigation by transcriptome analysis. Characterization of the genes with 
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differential transcript abundance is in progress to have a better understanding of the evolved 
strain. At the same time, cell membrane properties of a small group of environmental E. coli 
isolates with high short-chain fatty acids production were investigated. We determined that cell 
membrane fluidity and cell surface hydrophobicity were associated with short-chain fatty acid 
titer in E. coli. Overall, our work focuses on discovering and understanding the mechanisms of 
increased short-chain fatty acids tolerance, high fatty acid production, and altered cell membrane 
characterizations. These mechanisms could be used as rational engineering strategies for 
improving performance of engineered microbial biocatalyst.       
Thesis Organization 
The thesis is composed of seven chapters. They are organized as follows: Chapter 1 is a 
general introduction of background and the organization of this thesis. Chapter 2 is a book 
chapter that reviewed the evolutionary methods for improving production of biorenewable fuels 
and chemicals. Chapter 3-6 are papers either published, under review or intended for submission 
for publication regarding the topic of increasing short-chain fatty acids tolerance and production 
in E. coli. Chapter 7 is a summary of the all work as well as insights into future work. 
Chapter 2: Evolutionary Methods for Improving the Production of Biorenewable Fuels and 
Chemicals 
Chapter 2 is a book chapter about how evolution works, the use of evolution to improve 
the tolerance and production of biorenewable fuels and chemicals, and the application of reverse 
engineering to identify the inhibition mechanisms of inhibition compounds. 
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Chapter 3: Evolution for Exogenous Octanoic Acid Tolerance Improves Carboxylic Acid 
Production and Membrane Integrity 
Chapter 3 is a research paper overall introducing the evolved strains which are the 
important research subjects of my studies, including how we obtained the evolved strains, and 
phenotypic changes of evolved strains. My contributions to this work include assessing cell 
membrane integrity, isobutanol and n-butanol tolerance, and preparing the manuscript.    
Chapter 4: Genome-level Reverse Engineering of Escherichia coli Evolved for Increased 
Short-chain Fatty Acid Tolerance and Production 
Chapter 4 is a research draft about investigating the evolved strain to discover and 
understand the mechanisms of the phenotypic changes by genome-level reverse engineering. We 
identified four mutations in evolved strains, and explored how each mutation and their 
synergistic interaction contributed on increased short-chain fatty acid tolerance, improved fatty 
acid titer, and altered cell membrane characterizations.  
Chapter 5: Transcriptome analysis of Escherichia coli evolved for Short-chain Fatty Acid 
This chapter is a research draft about further studying the evolved strain by transcriptome 
analysis to discover the mechanisms of the two mutations which encode transcriptional 
regulators. Characterization of the genes with differential transcript abundance between evolved 
strain and parent strain is in progress.    
Chapter 6: Lessons in Membrane Engineering for Octanoic Acid Production from 
Environmental Escherichia coli Isolates 
Chapter 6 is a submitted manuscript about characterizing the cell membrane of a small 
group of environmental E. coli isolates with high short-chain fatty acid production, in order to 
learn design strategies of membrane engineering to improve short-chain fatty acid production. 
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Chapter 7: Summary and Future Work 
The final chapter summarizes the important findings in this work, proposes future work 
that can lead to deepen understanding of this research topic.  
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CHAPTER 2. EVOLUTIONARY METHODS FOR IMPROVING PRODUCTION OF 
BIORENEWABLE FUELS AND CHEMICALS 
Accepted for book chapter in Biotechnology for Biofuel and Optimization 
Tao Jin, Yingxi Chen, Laura R. Jarboe* 
Department of Chemical and Biological Engineering, Iowa State University, Ames, IA 
*Corresponding author, ljarboe@iastate.edu, 515-294-2319 
Abstract 
Evolutionary methods to improve strain performance are a powerful complement to 
rational, predictive strain engineering. These evolutionary methods can consist of serial transfers 
or engineered methods, such as global transcription machinery engineering (gTME) and the 
SCALEs expression libraries. The types of improvements achieved in strain performance include 
increasing the tolerance to inhibitory products, such as alcohols and carboxylic acids, and 
increasing the tolerance and utilization of biomass-derived sugars, such as pentose sugars and 
biomass hydrolysate. In some cases, the selective pressure applied during the evolutionary 
process has enabled co-selection of growth and strain performance. This approach has proven 
successful for the production of ethanol, lactic acid, succinate and alanine. In other cases, strains 
are evolved for tolerance to exogenously-supplied inhibitors, with the intention of increasing 
production by increasing tolerance. This has been successful in some cases, particularly in 
regards to ethanol production. Identification of the mutations that enable the evolved phenotype 
and understanding the molecular basis of their contribution to strain fitness and performance can 
reveal novel strategies for increasing tolerance. In this manner, our knowledge of possible design 
schemes and our understanding of our workhorse biocatalysts are increased. Reverse engineering 
has provided rational design strategies for increasing tolerance to isobutanol, furfural and ethanol 
as well as increasing the production of succinate. 
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Introduction  
Metabolic engineering is, by definition, a rational and predictive field [1,2]. This type of 
deliberate, planned approach has enabled the production of a wide variety of biorenewable fuels 
and chemicals, including but not limited to ethanol, butanol, styrene and carboxylic acids [3-6]. 
Similarly, an engineering approach has proven useful in enabling the utilization of renewable 
biomass-derived carbon sources, such as pentose sugars [7-9], anhydrosugars [10], and syngas 
[11,12]. However, our incomplete and imperfect knowledge of microbial metabolism, 
physiology and regulatory networks hinders our ability to consistently and efficiently obtain 
strains with sufficiently high titer, yield and/or productivity through rational engineering alone.  
One of the challenges frequently associated with production of biorenewable compounds 
at a high yield and titer from biomass-derived substrates is biocatalyst inhibition [13-19]. This 
inhibition can either be from the desired product or from non-sugar components of the “dirty” 
feedstock. This inhibition can sometimes be mitigated via in situ product removal [20-25] or 
treatment of the feedstock [26-35], though this may incur an unacceptable increase in cost.  
Another option for dealing with this inhibition is to modify the biocatalyst for increased 
tolerance of the inhibitory compounds. Metabolic engineering for increased tolerance has 
included strategies such as provision of the appropriate exporter [36,37] and engineering of 
stronger membranes [38,39]. However, this rational approach to increasing tolerance can be 
limited when either the mechanism of toxicity is not known and/or there is not a clear 
engineering strategy to mitigate the identified inhibition mechanism. Omics analysis can prove 
quite useful in identifying the mechanism of inhibition [40-43], though interpretation of omics 
data is dependent upon the quality and thoroughness of enzyme annotation and regulatory 
network characterization. 
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Evolutionary strategies for improving biocatalyst performance provide an excellent 
counterpoint to the rational design strategy. Evolution can be used to improve tolerance to 
exogenous inhibitors, improve utilization of a target substrate or improve production of the target 
compound. Such strategies are not hindered by erroneous or incomplete enzyme annotation or 
lack of regulatory network characterization. When the appropriate selective pressure is applied 
and the key mutations supporting the evolved phenotype are identified, novel design strategies 
can be distilled and our understanding of the biocatalyst can increase. As we increase the pool of 
available design strategies and our understanding of the organism, our ability to apply rational, 
predictive engineering strategies also increases.  
The goal of this chapter is to describe the use of evolution to improve production of 
biorenewable fuels and chemicals. Other similar works have been published recently on this 
topic [44-53]. Here we given an overview of how evolution works, the development of 
evolution-based strain design tools, evolution to increase tolerance to exogenously supplied 
inhibitors, evolution to improve strain performance, and reverse engineering to identify design 
principles. Note that evolutionary efforts that target specific enzymes have recently been 
reviewed elsewhere [54-56] and are not discussed here. 
Mechanisms of Evolution 
The power of natural selection is promising and very useful for the modification of 
microorganisms for a variety of properties. Put more succinctly as Orgel’s 2nd rule, “evolution is 
cleverer than you are” [57,58]. In this work, we are interested in the use of adaptive evolution to 
improve microbial production of biorenewable fuels and chemicals, such as biocatalyst tolerance 
to toxic compounds or operating conditions, or to otherwise improve strain performance.  
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How does evolution work? 
The essence of evolution is perturbation of the DNA sequence. These changes can occur 
within coding regions (genes) or non-coding regions. Changes within coding regions can either 
impact the resulting amino acid sequence, or be “silent” mutations that change the codon identity 
but not the resulting amino acid. Changes to the genome sequence can occur through a variety of 
events, as described elsewhere [59-61]. These events can involve changes of single nucleotides 
or insertion or deletion of various-sized segments. 
Single base-pair (point) mutations can arise either through damage to the DNA or during 
DNA replication. The physical structure of the nucleotides can be impacted by mutagens, such as 
radiation or ethidium bromide [62,63]. Mutations can also arise via incorporation of the wrong 
nucleotide during DNA replication though proofreading systems exist to detect and repair these 
types of errors, they are not infallible [64,65].  
As opposed to the single base-pair changes described above, many observed mutations 
involve the insertion or deletion of more than just one base pair. These types of insertions and 
deletions can possibly arise via transposons and retrotransposons. Transposons are a class of 
genetic elements which can duplicate themselves and move to different position within a 
genome. Retrotransposons are a subclass of transposons, which need RNA to be intermediates. 
Transposons can have dual impacts on their host, in that they can confer mutations that are either 
beneficial or harmful. However, in adaptive evolution, transposons are considered to be an 
accelerator of the evolutionary process [66]. Large-scale genomic rearrangements have also been 
observed [67]. Another possible mutation type is the insertion or deletion of a small number of 
nucleotides, i.e. in-frame deletion of a single amino acid [68].  
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Most microorganisms have a relatively low and stable mutation rate. For example, E. coli 
averages 0.0025 mutations per genome per replication and S. cerevisiae maintains 0.0027 
mutations per generation [69]. Mutations to the proofreading systems, general stress response or 
DNA repair systems can increase this mutation rate [60,61,70]. For example, RpoS is a well-
characterized regulator of the general stress response and two mechanisms of the RpoS-mediated 
response can increase the mutation rate of stressed cells. One mechanism is the increased 
expression of the error-prone DNA polymerase, Pol IV; the other is the decreased expression of 
the mismatch repair enzymes [60,61,71].   
Thus, there are a variety of natural mechanisms for generating diversity in microbial 
genomes (Table 1). These mechanisms include single base pair changes, either within a coding 
or non-coding region; short insertions or deletions that can possibly truncate a gene or change the 
number of amino acids; gene silencing or increased expression via transposon insertion; or large-
scale rearrangements in genome organization. One can envision that these changes can influence 
the strain behavior in a variety of ways, including but not limited to perturbation of transcript 
abundance, transcript stability, translation initiation, translation efficiency and enzyme amino 
acid sequence. This change in amino acid sequence could impact protein function, protein 
stability and interaction with other cellular components. In this manner, directed evolution 
enables screening of these variants and selection of those that confer the desired behavior. 
Directed evolution 
Directed evolution performed in the laboratory seeks to exploit the natural evolution 
process in order to obtain strains with desired properties. There are a variety of techniques for 
guided laboratory evolution. Each of these essentially aims to obtain evolved strain(s) by 
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propagating the parent strain in a controlled environment. The specifics of the propagation 
methods and the controlled environment depend on the experimental purpose.  
A traditional example of this propagation is the sequential transfer method [72-74]. 
Essentially, cells are grown in a condition which is stressful enough to slow growth, but not 
stressful enough to halt DNA replication. As the cells grow in this stressful condition, some will 
acquire mutations, as described above. Those that have acquired a mutation that enhances growth 
in the condition of interest will grow faster than their cohorts. As additional beneficial mutations 
are acquired, one strain will eventually become the dominant strain within the population. 
During this time, the selective pressure can be increased. Since mutations are largely acquired 
during the growth phase and since growth is the selective marker, it is desirable to maintain the 
cells in a state of near-continual growth. Ideally, such growth would involve the use of a 
carefully-maintained chemostat culture. However, in practice this is often approximated through 
the use of serial batch cultures. Since the culture at the end of the serial transfer process 
presumably contains a variety of strains, it is very important to isolate and characterize single 
colonies before proceeding. Briefly, the culture is diluted into new growth medium on a regular 
basis, i.e. every 24 hours, and the magnitude of the selective pressure is gradually increased. 
Finally the evolved strain is obtained when the cells display the desired behavior. Here we 
briefly describe several cases where this type of approach was used. 
In order to increase thermal tolerance, E. coli cells were sequentially transferred in 
minimal medium for 523 days. During the course of this evolution, the temperature was 
increased from 36.9˚C to 44.8˚C. The final evolved strain was able to grow at 45.9˚C, while the 
original parent strain cannot grow at 43.2 ˚C [72].  
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A variety of studies have aimed to increase ethanol tolerance. For example, ethanologenic 
E. coli KC01 was sequentially transferred in rich medium with 50 g L-1 xylose for 6 weeks while 
the concentration of ethanol was increased from 10 g L-1 to 40 g L-1. The evolved strain SZ470 
could successfully grow anaerobically in the presence of 40 g L-1 ethanol. This represents a two-
fold increase in ethanol tolerance relative to the parent strain [73]. Yomano et al took a slightly 
different approach to selecting for ethanol tolerance. Ethanologenic E. coli strain KO11 was 
subjected to alternating rounds of growth in liquid and on solid media. The liquid media 
contained selective concentrations of ethanol. At the end of the growth period on liquid media, 
cells were plated onto solid media and colonies with high ethanol production capability were 
identified based on size and morphology [75]. This alternation between liquid and solid media 
represents a useful deviation from the standard liquid-to-liquid serial transfer method. 
Recently, a new sequential transfer method was created and demonstrated by increasing 
n-butanol tolerance in E. coli. This new method is named “visualizing evolution in real time” 
(VERT) [76,77] and is based on traditional evolution, but can track distinct improvements in 
fitness by fluorescence-based techniques [76,77]. In the VERT scheme, subpopulations of the 
parental strain are generated. These subpopulations are isogenic except for the recombinant 
expression of distinct fluorescence proteins. These fluorescence reporters enable rapid 
determination of the population distribution. When the various subpopulations are growing at 
similar rates, the population distribution is roughly equal between the various groups. When a 
cell in one subpopulation acquires a useful mutation that enables faster growth, this 
subpopulation will become dominant. This alerts researchers that a useful mutation has occurred.  
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Engineered Methods of Evolution 
Modification of microbial biocatalysts for some complex functionalities, such as 
increased tolerance or production of desired compounds, can require perturbation of multiple 
genes. However, our ability to rationally plan and then introduce these modifications can be 
limited by our knowledge of microbial physiology and metabolism and resource availability. 
These combinations can also require unacceptably lengthy directed evolution schemes.  
Global transcription machinery engineering (gTME) 
Global transcription machinery engineering (gTME) aims to introduce these multiple 
perturbations to the transcriptome by altering the transcription machinery. This method has 
proven to be an appealing and efficient tool to improve the performance of biocatalysts [78].  
One of the first examples of gTME was the improvement of ethanol tolerance and 
production by S. cerevisiae [79]. A library of mutated versions of the SPT15 gene, which 
encodes the TATA-binding protein, was generated by error-prone PCR. This led to increased 
ethanol tolerance and yield, as described below. SPT15 was also selected for mutation in a 
gTME project that aimed to improve xylose tolerance and consumption by S. cerevisiae [80]. 
The mutant library was screened in xylose defined medium; the resulting strain showed a 
conversion efficiency of 93.5% for 50 g L-1 xylose. This conversion efficiency is comparable to 
the 98.3% observed for 50 g L-1 glucose. Even when glucose and xylose were supplied as a ratio 
of 1:1, the utilization was 97.3% and 90.8% respectively. 
The power of gTME has also been demonstrated in E. coli [78]. The rpoD gene, which 
encodes the main sigma factor σ70, was subjected to random mutagenesis, along with its 
promoter region, for three rounds of error-prone PCR. After screening and selection from the 
library in the presence of 50 g L-1 ethanol, the best mutant showed better growth in the presence 
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of 20 – 70 g L-1 ethanol relative to the strain harboring only the wild-type rpoD. gTME was also 
demonstrated to increase the production of lycopene by 50% and increase tolerance to multiple 
inhibitors, such as sodium dodecyl sulfate. 
Global transcription factor cyclic AMP receptor protein (CRP) of E. coli was subjected to 
gTME for increasing the tolerance to 1-butanol [81]. Four mutants with improved performance 
were selected from the library. DNA shuffling was then used to combine these beneficial 
mutations. The final mutant MT5 showed a growth rate of 0.18 h-1 in the presence of 9.7 g L-1 1-
butanol, which was twice as high as that observed for the parent strain. 
Thus, gTME has proven to be an effective method for enabling complex phenotypes in a 
variety of organisms. These complex phenotypes include tolerance of inhibitory compounds and 
production of target compounds. 
SCALEs  
 gTME aims to perturb the expression of a large number of genes by changing the 
sequence, and therefore behavior, of proteins involved in controlling gene expression. SCALEs 
aims to perturb the expression of multiple genes by increasing the copy number of genomic 
DNA fragments of various sizes. Libraries of cells containing these fragments are then enriched 
for their ability to confer a phenotype of interest. The cells isolated by this enrichment procedure 
are typically then subjected to a genome-wide, microarray-type multiscale analysis [82].  
For example, E. coli K12 was used to construct five genomic libraries for the 
demonstration and validation of SCALEs [82]. Transformants carrying the plasmid -based DNA 
fragments of different sizes were cultured in a continuous fermentation system for selection and 
sampled periodically. Microarray and multiscale analysis was then conducted on the enriched 
plasmids to identify the position and size of the inserts contributing to the increased fitness.  
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This approach was used to identify E. coli K12 genes responsible for the increased 
tolerance of E. coli to acetate. This interest in acetate tolerance was motivated by the fact that 
acetate is a common inhibitor found in biomass hydrolysate [83]. The populations surviving in 
the presence of 1.75 g L-1 acetate were selected and subjected to microarray and multiscale 
analysis. In this manner, a list of genes whose overexpression contributed to high acetate 
tolerance was obtained. This list includes such genes as murC for peptidoglycan biosynthesis and 
yjdL for dipeptide transporter. 
 The SCALEs method was also employed to improve the growth of E. coli NZN111 [84]. 
Previous metabolic engineering of NZN111 had resulted in a growth deficiency due to a high 
NADH/NAD+ ratio. The SCALEs analysis led to the identification of 9 E. coli K12 genes that 
can increase the growth of NZN111 approximately 5-fold when their expression was increased. 
The enriched population also showed a 20% increase in succinate production. 
 Other methods for improving the relative fitness of biocatalysts include COMPACTER 
[85] and TRMR [86]. 
Evolution for Increased Tolerance  
As described in many recent reviews [17,87-89], the metabolic engineering of 
biocatalysts for economically-viable production of desired compounds is often restricted by 
product-mediated inhibition, such as that imposed by organic solvents [90,91] and carboxylic 
acids [18]. Additionally, low-cost, renewable feedstocks, such as those derived from biomass or 
industrial byproducts, often contain compounds that can inhibit biocatalyst growth and 
metabolism [92]. One approach for dealing with this inhibition is selective removal of the 
inhibitory compound as it is formed [93-95]. Another approach is to evolve the microbes for 
improved tolerance of the inhibitory compounds [19,96] (Table 2). Performing reverse 
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engineering to reproduce the phenotype or trait of interest can aid in the identification of design 
principles and increased characterization of the host microbe, as described below. 
Organic solvents, including next-generation biofuels such as butanol [19], are highly 
toxic to microorganisms. This toxicity is largely attributed to their hydrophobicity and the 
resulting damage to the cell membrane [97,98]. A variety of rational engineering strategies have 
been applied to increase the tolerance of biocatalysts to these inhibitory products. Here we 
briefly summarize two of these. As mentioned above, provision of biocatalysts with appropriate 
efflux pumps has been shown to increase tolerance to inhibitory products [19]. For example, 
marA, which is responsible for activation of the AcrAB-TolC efflux pump, was overexpressed in 
E. coli leading to the increased tolerance to geraniol [99]. On solid media with 1.0% (v/v) 
geraniol, the strain harboring overexpressed marA gene showed 104-fold colony forming 
efficiency compared to that of the parent strain. Additionally, the intracellular accumulation of 
geraniol was only half of the parent strain. Organic solvents can interfere with appropriate 
protein folding, and thus the GroESL chaperone system, which facilitates protein folding, was 
overexpressed in E. coli. The resulting strain had increased tolerance to organic solvents such as 
ethanol, n-, 2-, i-butanol and 1, 2, 4-butanetriol [100].  
The standard sequential transfer method has been used in a variety of cases to adapt 
microbes to inhibitory environments (Table 2) [101]. Here we summarize a few of these 
instances. Uses of modified evolution techniques are described at the end of this section. 
Directed evolution was conducted in batch fermentors to acquire a strain of E. coli with 
increased isobutanol tolerance. After 45 sequential transfers, tolerance increased from 4 g L-1 to 
8 g L-1 [102]. This demonstrates the ability of the sequential transfer method to obtain significant 
gains in tolerance in a relatively short time. In another isobutanol-focused project, parallel 
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directed evolution was applied to multiple populations of E. coli simultaneously in minimal 
medium containing isobutanol with either glucose or xylose as carbon source [103]. After 
approximately 500 generations in glucose medium and 430 generations in xylose medium, the 
tolerance of the mutants was improved from 0.75% (w/v) to 2% (w/v) and 1.75% (w/v), 
respectively. However, the strain evolved on glucose also showed increased isobutanol tolerance 
in xylose minimal media and the strain evolved on xylose showed increased isobutanol tolerance 
in glucose minimal media. Thus, the specificity of the adaptation in the two carbon sources was 
relatively low. When these evolved strains were further characterized in rich media with 
isobutanol, there was no significant gain in fitness relative to the parent. These results highlight 
the fact that selected mutations can be specific to the experimental conditions (media type) while 
other aspects of the experimental condition can be less impactful (carbon source). 
Another evolutionary approach to improve isobutanol production by E. coli focused on 
tolerance of the valine analog norvaline [104]. It should be noted that the isobutanol production 
pathway in this case is this same pathway that is used to produce valine. Through a combination 
of mutagenic treatment, selection for growth in the presence of norvaline, and repair of a 
mutation within rpoS, the final strain NV3r1 was obtained. This strain produced 21.2 g L-1 
isobutanol at a yield of 0.31 g g-1, relative to the 12.0 g L-1 and 0.24 g g-1 observed for the parent 
strain.     
Directed evolution has also been applied to microorganisms other than E. coli. A butanol-
tolerant S. cerevisiae strain was obtained after 30 serial transfers in the presence of 2-butanol 
[105]. The resulting mutant was able to maintain growth in 3% (v/v) 2-butanol, a concentration 
which completely inhibited growth of the parent strain. The evolved strain also showed increased 
tolerance to other butanol isomers. Specifically, the evolved strain was able to grow in the 
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presence of 1.9% (v/v) 1-butanol and 1.9% (v/v) iso-butanol, while no growth was observed for 
the parent strain in these concentrations. Similarly, when Pseudomonas putida was evolved for 
cyclohexane tolerance, it also acquired enhanced tolerance to the organic solvents decalin, 
methyl cyclohexane and toluene [106]. This evolved strain was acquired by only 12 sequential 
transfers with cyclohexane content increased from an original value of 5% (v/v) to a final 
concentration of 60% (v/v). Note that evolved strain was evaluated in 60% (v/v) of each of the 
solvents listed. These two studies demonstrate that adaptive mutations that confer tolerance one 
inhibitor can also be beneficial in conferring tolerance to other, chemically similar, inhibitors. 
Carboxylic acids are very appealing biorenewable chemicals for synthesizing a variety of 
commodity chemicals [107,108]. However, as with organic solvents, the fact that they hinder the 
performance of the biocatalyst is still an issue that needs to be addressed for economically viable 
production [109,110]. Many rational engineering efforts have been taken to improve the 
resistance of microbes to the free fatty acids. For example, the Aas pathway for incorporating 
medium-chain fatty acids into membrane phospholipids was deleted in E. coli with the 
expression of the gene encoding cytosolic acyl-ACP thioesterase from Umbellularia californica 
to alleviate the toxicity and restore the strength of cell membrane [111]. The CFUs (colony-
forming unit) of the engineered strain were twice as high as those of the parent strain in the 
presence of 1 g L-1 of 12:0 and 14:0 fatty acids. By employing an alternative thioesterase from 
Geobacillus sp.Y412MC10, the membrane content of unsaturated fatty acids was decreased, thus 
increasing the tolerance to the free fatty acids [38]. An evolutionary approach has also been used 
to improve tolerance to octanoic acid in E. coli [112]. Specifically, 17 transfers were performed 
in glucose minimal media over the course of approximately 700 hours. Initially, 10 mM octanoic 
acid was used, though the concentration was gradually increased to 30 mM. The resulting 
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evolved strain showed increased tolerance not only to octanoic acid, but also to hexanoic acid, 
decanoic acid, and somewhat surprisingly, isobutanol and n-butanol.  
In addition to dealing with inhibitory products, biocatalysts can also be limited by the 
inhibitory compounds contained in the substrates. Biomass-derived sugars have been utilized as 
substrate for the production of biorenewable chemicals and fuels [113,114]. However, inhibitory 
compounds are often formed during the pretreatment process [16,115]. Some of these 
compounds, including furan derivatives, aldehydes and organic acids, have been under 
investigation regarding their impact on microbes [16,43,116-118]. Furfural is the most 
thoroughly characterized of these biomass-associated inhibitors [119-125]. 
A furfural-resistant E. coli strain EMFR9 was derived from ethanologenic LY180 based 
on growth in batch fermentors with gradually increased furfural concentration from 0.5 g L-1 to 
1.3 g L-1 during 54 serial transfers [122]. In minimal medium with 100g L-1 xylose, this resulting 
strain could produce approximately 40 g L-1 ethanol in the presence of 1.0 g L-1 furfural; the 
parent LY180 could not even maintain growth in such conditions. The increased tolerance of 
EMFR9 to furfural also resulted in increased tolerance to 5-hydroxymethyl furfural (5-HMF) 
[126]. Specifically, EMFR9 produced more than 40 g L-1 ethanol after 96 hr in minimal medium 
with 100 g L-1 xylose and 2.5 g L-1 5-HMF. Note that 1.0 g L-1 5-HMF completely inhibited 
growth of the parent strain.  
Directed evolution has also been applied to directly improve the tolerance of biocatalysts 
to lignocellulosic biomass hydrolysate. S. cerevisiae strain TMB3400 was evolved in batch 
cultures with 20 g L-1 glucose and xylose respectively and 12 inhibitory compounds. 
Specifically, these cultures included HMF, furfural, acetic acid, formic acid, levulinic acid, 
vanillin, syringaldehyde, coniferyl aldehyde, hydroquinone, cinnamic acid, 4-hydroxybenzoic 
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acid and guaiacyl acetone, each of which have been detected in spruce hydrolysate [127]. When 
characterized in the presence of 20 wt% of this simulated spruce hydrolysate “cocktail”, the 
evolved strain’s maximum specific growth rate (0.33 h-1) was double that of the parent and the 
length of the lag phase was similarly reduced 2-fold. The original parent strain was also evolved 
in a chemostat for 97 generations using actual spruce hydrolysate, as opposed to the simulated 
cocktail. Initially, 20% (v/v) hydrolysate was used and the concentration was gradually increased 
to 50% (v/v). Mutants were selected from both evolutionary procedures and further 
characterized. Strains from both groups demonstrated a 25 – 38% increase in specific sugar 
consumption rates and a 32 – 50% increase of specific ethanol productivity compared to the 
parent strain using actual spruce hydrolysate. 
Modified evolutionary strategies have also been used to increase tolerance to organic 
solvents. gTME was used on the global transcription factor cAMP receptor protein (CRP) for 
improving the tolerance of E. coli to isobutanol [128]. One of the resulting mutants showed 
growth of 0.18 h-1, compared to 0.05 h-1 of the parent strain, in 9.6 g L-1 of isobutanol.  
VERT was applied to E. coli BW25113 for improving its tolerance to n-butanol in 
chemostat with M9 minimal medium and 5 g L-1 glucose [129]. After 144 generations, the 
resistance of the evolved strain was increased from 0.5% (v/v) to 1.3% (v/v).VERT was also 
used to identify the adaptive events of S. cerevisiae derived from FY2 during corn stover 
hydrolysate utilization [130]. The growth rate of the best mutant was increased by 57% in 25% 
(v/v) hydrolysate relative to the parent strain.  
Here we have described the use of serial transfer-based evolution, gTME and VERT to 
increase the tolerance of a microbial biocatalyst to specific inhibitory compounds. It can be seen 
that these are effective tools and sometimes the acquired tolerance also applies to other 
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compounds. However, as described in the next section, acquiring tolerance with the goal of 
increasing production of the focal compound, has proven challenging. 
Evolution for Increased Production 
Besides enhancing biocatalyst tolerance to both substrates and products, metabolic 
engineering of biocatalysts for improving their performance of production is also of great 
importance. In some cases, evolution-based strategies can be designed so that selecting for cells 
with faster growth co-selects for strains with improved production abilities (Table 3). 
E. coli W was engineered for ethanol production by chromosomal insertion of the pdc 
and adhB genes from Zymomonas mobilis [131]. Successive dilutions were transferred to solid 
media for selecting large colonies with higher expression of these two genes, enabling higher 
ethanol production. Serial transfers in rich media with 10% glucose were then used to stabilize 
both the alcohol dehydrogenase activity and the high resistance to Cm, where Cm resistance is 
indicative of pdc/adhB expression. These serial transfers were performed for more than 60 
generations. The resulting strains were able to produce more than 50 g L-1 ethanol from 100 g L-1 
glucose and more than 40 g L-1 ethanol from 80 g L-1 xylose. 
E. coli strain TCS009, a derivative of MG1655 engineered for production of ethanol from 
glycerol, was also improved through co-selection of growth and ethanol production [132]. After 
500 serial dilutions in minimal media with glycerol as sole carbon source, the specific growth 
rate had increased 1.8-fold. Ethanol production by this evolved strain was also improved both in 
terms of yield and rate. Specifically, the evolved strain produced ethanol from glycerol at a yield 
of 0.45+0.01 g/g-1 over 48 hours, while its parent had a yield of 0.34+0.00 g/g-1 over 72 hours.  
This growth-based strain improvement was also used as part of the engineering of E. coli 
W3110 for D-lactic acid production. Alternating periods of rational pathway engineering and 
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serial transfer-based metabolic evolution were used to fine-tune strain performance. In this case, 
the engineered central metabolic pathway enabled co-selection for growth and lactic acid 
production because the engineered strain was only able to regenerate NAD+ through the 
production of lactic acid. The final strain was able to produce more than 500 mM D-lactic acid 
with 98% purity from mineral salts medium containing 5% glucose [133].  
E. coli KO11 was modified for D-lactate production by alternating rounds of rationally-
selected genetic manipulations and directed evolution. This re-engineering included elimination 
of the ethanol pathway, along with other competing pathways. This pathway elimination left the 
lactate-producing pathway as the sole route for regenerating NAD+. Then, the engineered strain 
was subjected to sequential transfer-based evolution. By co-selecting growth and lactate 
production, the resulting strain SZ132 was able to produce 1000±20 mmol D-lactate in rich 
medium with 10% (w/v) glucose and 700±11 mmol D-lactate from defined NBS medium, also 
with 10% (w/v) glucose [134]. SZ132 was further modified to eliminate loss of carbon due to co-
product formation. The poor performance of the resulting strain SZ186 in mineral salts medium 
motivated further rounds of serial transfer-based metabolic evolution to improve the ability to 
completely utilize glucose [135]. 1.23±0.03 M D-lactate could be produced by the final strain 
SZ194 from NBS medium with 12% (w/v) glucose.  
A similar strategy was used for succinate production. E. coli ATCC 8739 was rationally 
engineered for succinate production by the traditional elimination of competing pathways. In this 
case, cell growth was coupled with succinate production since the succinate-synthesizing 
pathway was the sole route for regeneration of NAD+. With the alternating use of metabolic 
engineering and evolution for more than 1,000 generations, the resulting strain HX024 was able 
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to produce 813±28 mM succinate from NBS mineral salts medium with 12% (w/v) glucose, 
which was 4.5 fold more than the parent strain [136].  
Similarly, deleting the alternative NAD+-generating pathways resulted in succinate 
production as the only route for oxidizing NADH. After conducting 2,000 generations of 
metabolic evolution, the selected mutants produced 622–733 mM succinate from AM1 medium 
with 100 g L-1 glucose and 516 mM malate from NBS medium with 100 g L-1 glucose [137].  
The examples described above were all able to redesign the central metabolic pathways 
so that the biocatalyst could only maintain redox balance by producing the target compound. In 
this manner, cells that acquired mutations that enabled increased production of the target 
compound would also have increased ability to turn over NADH, resulting in increased biomass 
production and growth. There are also examples of metabolic pathway redesigns so that 
production of the target compound is the only way to produce the ATP needed for growth. 
For example, the L-lactic acid producer SZ194 described above was re-engineered for 
alanine production by replacing the ldhA gene with the gene encoding an alanine dehydrogenase 
from Geobacillus stearothermophilus [138]. In the redesigned metabolic pathways, cells could 
produce ATP by producing alanine. Through a similar alternating strategy of rational 
engineering and serial transfer-based evolution, the resulting strain could convert 120 g L-1 of 
glucose to 1279 mmol L-alanine within 48 h.  
A similar strategy was used to engineer E. coli for production of optically pure L-lactic 
acid. E. coli SZ63 [133], initially engineered for D-lactate production, was modified for L-lactate 
production by replacing the native ldhA gene with the ldhL gene from Pediococcus acidilactici 
[139]. Metabolic evolution was then required to improve the expression of the foreign gene, as 
determined by comparison of growth and lactate dehydrogenase activity to the L-lactic acid 
27 
 
producing parent strain. After a period of evolutionary selection, the selected strain SZ85 was 
able to produce 505±12 mM L-lactate from M9 medium with 5% (w/v) glucose within 24h. 
Computational strain design via the OptKnock optimization algorithm was used to 
predict manipulations needed for lactic acid production by E. coli strain MG1655 [140]. Growth 
of this engineered strain was coupled to lactate production and thus approximately 1,000 
generations of adaptive evolution in minimal media followed the strain engineering. Eleven 
different strains were characterized by this method. The best lactate producer attained a titer of 
19 mM lactate from 0.2% glucose. 
Directed evolution was also applied to biocatalysts in conjunction with targeted genetic 
manipulations to enhance strain performance. An industrial S. cerevisiae strain was modified for 
production of ethanol from pentose sugars by introducing the D-xylose-utilization cassette from 
Clostridium phytofermentans. This engineered strain was then subjected to both treatment with 
the chemical mutagen ethyl methanesulfonate (EMS) and genome shuffling. The EMS treatment 
aimed to increase the mutation rate and the genome shuffling provided large-scale 
rearrangements that were unlikely to occur naturally. The resulting strain was then subjected to 
directed evolution in the form of 11 sequential batch cultures in the presence of increasing 
concentrations of xylose. The initial xylose concentration was 40 g L-1, the final concentration 
was 100 g L-1. The final strain produced ethanol at a yield of 0.46 g g-1 in YP medium from a 
mixture of xylose and glucose. This yield was double that observed for the parent strain [141].  
Another example of evolutionary improvement of yeast behavior is the improvement of 
lactose utilization by S. cerevisiae T1 [142]. After serial transfers in batch fermenters, the 
ethanol production from lactose was increased from 7.1±0.8 g L-1 to 10.52±0.04 g L-1. 
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Enabling Increased Production by Increasing Tolerance  
As described above, it is sometimes possible to co-select for increased production of a 
target compound and growth. This enables evolution-based selection of strains with the ability to 
produce the target compound at increased yield, titer and/or productivity. But such selection 
schemes are not always feasible. In such cases, strains are often evolved for increased tolerance 
of an exogenously supplied target compound, with the goal of increasing the strain’s ability to 
produce the target compound. This has met with mixed results (Table 4).  
Various projects have aimed to increase the ethanol tolerance of ethanologenic E. coli 
strains through directed evolution. Recombinant KO11 grew poorly in the presence of 35 g L-1 
ethanol and had a maximum observed ethanol titer of more than 50 g L-1. Its evolved derivative 
LY01 could tolerate up to 50 g L-1 of ethanol and was able to produce 60 g L-1 ethanol from 140 
g L-1 of either glucose or xylose within 72 hrs [75]. Note that the evolution of strain LY01 
included selection for high ethanol-producing strains, as evaluated by colony size and 
morphology on solid media. Strain SZ470, the evolved derivative of nontransgenic E. coli KC01 
[73], not only had increased ethanol tolerance but also had improved ethanol production. 
Specifically, within 72 hours SZ470 produced 23.5 g L-1 ethanol from 50 g L-1 xylose; KC01 
only produced 16 g L-1.  
A non-carboxylic acid producing derivative of E. coli strain MG1655 was evolved for 
tolerance to exogenously supplied octanoic acid. When the evolved strain LAR was provided 
with the thioesterase for octanoic acid production, the observed octanoic acid titer was 
approximately twice as high as that observed for the parent strain, also encoding the thioesterase 
[112]. 
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In one of the first demonstrations of gTME, TATA-binding protein Spt15 of S. cerevisiae 
was targeted, with the goal of improving tolerance to 20% (v/v) ethanol and up to 120 g L-1 
glucose [79]. The selected mutant strain had an ethanol yield of 0.40 g/g, an increase of 15% 
relative to the parent.  
However, increased tolerance does not always contribute to improved production. This 
disconnect between tolerance of exogenously supplied inhibitor and increased ability to produce 
the inhibitor has also been observed in some rational engineering-based design schemes [38]. E. 
coli strain SA481 was obtained by evolution of an isobutanol-producing strain for tolerance to 
exogenously supplied isobutanol [102]. However, the isobutanol titer of 20 g L-1 achieved by this 
evolved strain in standard fermentation conditions was similar to the parent. 
Reverse Engineering of Evolved Strains  
As is evident from the cases described above, evolution-based strain improvement is a 
valuable partner for rational engineering strategies. Our reliance on evolutionary techniques is 
partially due to incomplete understanding of our biocatalysts. Investing the time and effort to 
fully characterize the evolved strains and identify and understand the mutations that confer 
evolved strain behavior can increase our understanding of these organisms (Table 5). This 
increased understanding can in turn lead to decreased dependence on evolutionary methods. We 
refer to this characterization of evolved strains as reverse engineering.  
Recently, characterization tools such as genome sequencing, transcriptome analysis and 
metabolic flux analysis, have become faster and cheaper, all of which support reverse 
engineering efforts. Reverse engineering aims not to identify all mutations that occurred during 
evolution, but to instead identify the crucial mutations which enable the evolved phenotype, and 
to understand how these mutations are beneficial. Reverse engineering is a tool to expose the 
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story behind the evolution experiments, which can in turn accelerate the pace of future 
biorenewable fuels and chemicals design processes.  
Identifying and understanding the key mutations that support the evolved phenotype 
requires knowledge of what mutations occurred during the evolutionary engineering. Whole-
genome sequencing is invaluable to this goal [143]. As described above, isobutanol-producing E. 
coli was subjected to directed evolution to increase both isobutanol tolerance and isobutanol 
production [102]. The evolved strain, SA481, was found to have acquired one single nucleotide 
change, 25 insertion sequences and a genomic deletion involving 62 genes. 28 of these mutations 
were individually reconstructed in the parent strain and tested for their contribution to the 
evolved phenotype. Five of these mutations were found to contribute to the evolved phenotype. 
These five mutations, essentially deletion of acrA, gatY, tnaA, yhbJ and marCRAB, were then 
combined into a single strain TW306 and the resulting phenotype was assessed. The engineered 
strain TW306 reproduced the evolved strain phenotype [102]. 
After finding the important mutations, the next step is to explore which mutations 
promote fitness, the mechanisms of how the tolerance to inhibitors has increased, and the 
functions of poorly-characterized enzymes and pathways involved in the evolved phenotype. In 
addition to the use of genome sequence as described above, transcriptome analysis and metabolic 
flux analysis have proven quite useful in such efforts [43,122].  
For the ethanologenic E. coli strain evolved for furfural tolerance, transcriptome analysis 
led to the discovery that YqhD is the primary NADPH-dependent furfural reductase in E. coli 
[122,144]. Sequence analysis of the region surrounding yqhD identified an insertion mutation 
within yqhC in the evolved strain. This mutation was found to be responsible for the decreased 
expression of YqhD because YqhC is a regulator of yqhD [145]. 
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E. coli strain MG1655 was subjected to evolution for increased ethanol tolerance and 
then characterized via a variety of techniques, including genome sequencing, transcriptome 
analysis and ribosome profiling. Six mutated genes (metJ, rho, rpsQ, ispB, lptF, topA) were 
identified in evolved strain MTA156. Only one of these mutations, H122L within topA, was 
found to have no impact on ethanol tolerance. The main goal of this study was to understand the 
impact of ethanol on gene expression machinery, and thus these researchers focused the rest of 
their characterization on the MetJ transcriptional repressor, Rho transcription termination factor, 
and RpsQ ribosomal subunit protein. The H31P mutation in RpsQ was found to decrease the 
effect of ethanol on miscoding errors during translation. This decrease in translational 
misreading was due to enhanced ribosome accuracy. The rho [L270M] mutation led to decreased 
activity of Rho-dependent terminators, where these terminators can cause abnormal transcription 
termination under ethanol stress. The ∆E91mutation within MetJ results in increased expression 
of methionine biosynthesis genes; this presumably leads to increased methionine availability, 
preventing some ribosomal stalling [68]. The thorough reverse engineering efforts employed 
here have provided multiple new mechanisms of ethanol toxicity, as well as design strategies for 
mitigating this toxicity.  
As described above, a metabolic pathway was designed in E. coli C so that production of 
succinate was linked to growth. It was found that in this evolved strain, the glucose uptake 
system had switched from the traditional PEP-based phosphotransferase system to the GalP 
permease. This change occurred via a mutation in ptsI and allowed more PEP to be directed 
towards succinate, instead of being converted to pyruvate via glucose import. A second change 
in the evolved strain was the increased usage of the PEP carboxykinase (Pck) pathway to convert 
PEP to OAA instead of the PEP carboxylase (Ppc) pathway. The Pck pathway produces a 
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molecule of ATP for every conversion of PEP to OAA while the PPC pathway does not. This 
results in the production of more ATP in the evolved strain. This change in pathway usage was 
evidenced by both increased activity of the Ppc pathway and increased expression of the genes 
encoding this pathway. This increased expression was attributed to at least three distinct 
mutations. These results demonstrate the ability to identify important mutations and pathway 
changes even in the absence of whole-genome sequence data [146]. 
A distinct strain of E. coli engineered for succinate production, NZ-037, was also 
subjected to metabolic evolution to improve its succinate production. The evolved strain, 
HX024, was found to have three distinct single base pair changes within the lpdA gene. Each of 
these nucleotide changes resulted in a change in the corresponding amino acid. This alteration to 
the LpdA protein sequence eliminated the NADH sensitivity of the pyruvate dehydrogenase 
enzyme complex, of which LpdA is a component. This decreased NADH sensitivity enabled 
increased succinate production [136]. 
Eleven E. coli strains subjected to computationally-designed engineering strategies and 
then evolved by co-selecting for growth and lactate production were subjected to whole-genome 
sequencing and characterization [147]. Seven of these sequenced strains were found to contain 
an 82-bp deletion mutation in the rph-pyrE region. rph encodes an RNase and pyrE encodes an 
enzyme involved in biosynthesis of pyrimidine nucleotides. Introduction of this mutation into the 
parent strain was shown to increase growth by approximately 15%. 
These examples demonstrate how reverse engineering efforts can reveal novel design 
strategies and increase our understanding of microbial physiology and metabolism.  
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Modeling of Evolution 
There has been much work performed recently in modeling the evolutionary process in 
silico. This work is discussed here only briefly. A thermodynamic perspective has also been 
applied to these models and, as supported by experimental data of Thermoanaerobacterium 
saccharolyticum evolution, shown that the rate of entropy production increases as a strain is 
allowed to evolve [148]. This entropy increase was shown to be asymptotically approaching a 
maximum rate of entropy production predicted according to the Boltzmann distribution. Further 
consideration of this evolved organism in terms of metabolic control analysis successfully 
predicted the enzyme likely to be altered during the evolution of T. saccharolyticum in serial 
cultures [149]. Specifically, the metabolic reaction performed by phosphoglucose isomerase had 
the large flux control coefficient of the various metabolic reactions and when sequenced in 10 
evolved clones, the gene encoding phosphoglucose isomerase was found to contain a variety of 
mutations. These results demonstrate the ability of a predictive model to prioritize targets for 
engineering, targeted enzyme evolution, or analysis when characterizing evolved isolates. 
Concluding Statement 
We have summarized the use of serial dilution and engineering evolutionary methods to 
improve the production of biorenewable fuels and chemicals. These evolutionary tools have 
proven quite effective and as reverse engineering tools become more accessible, additional 
design strategies can be distilled from these evolved strains. 
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Table 1. Representative mutations within the E. coli genome. 
 
Location Type Possible Impacts Example Ref. 
coding 
“Silent” single 
nucleotide change 
where the amino 
acid sequence is not 
changed 
Transcription and translation rate, 
protein folding 
Silent mutations in ompA impacted transcription and 
translation.  
Silent mutations in recombinant EgFABP1 gene affected 
translation and protein folding. 
[150, 
151] 
coding 
Non-synonymous; 
single nucleotide 
change where amino 
acid sequence is 
altered 
Transcription and translation rate, 
enzyme activity 
Single point mutation in rho decreased the activity of Rho-
dependent terminators.  
Three single point mutations in lpdA eliminated NADH 
sensitivity. 
[68, 
136] 
noncoding Single nucleotide changes 
Transcription and translation of 
nearby genes 
Four different single point mutations in the mgl operator 
(mglO) increased the glucose transport rate.  [152] 
coding Insertion 
Silencing or increased expression 
of the affected gene and possible 
downstream genes 
An insertion mutation in hfq led to significant pleiotropic 
phenotypes, such as increased cell size and decreased 
growth rates.  
An IS10 insertion mutation in yqhC affected the 
transcription of downstream genes yqhD and dkgA. 
[145, 
153] 
noncoding Insertion or Deletion 
Perturbed expression of nearby 
genes 
Insertion mutations upstream of the bgl promoter activated 
the silent bgl operon. 
Deletion mutation in the mgl operator (mglO) increased the 
glucose transport rate. 
[152, 
154] 
coding Deletion 
In-frame deletions can alter 
enzyme activity. 
Out-of-frame deletions can result 
in translation termination and 
altered or absent enzyme activity. 
The single-amino acid deletion in metJ altered MetJ 
activity, resulting in increased expression of the methionine 
biosynthesis pathway. 
[68] 
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Table 2. The use of directed evolution to increase tolerance to inhibitory products or inhibitors in 
biomass-derived sugars. 
 
Strain Inhibitory compound Tolerance 
Duration of 
evolution 
% increase 
compared to 
parent strain 
Ref. 
E. coli SA481 Isobutanol 0.8% (w/v) 45 transfers 100 [102] 
E. coli G3.2 Isobutanol 2% (w/v) 
(glucose) 
500 generations 60 [103] 
E. coli X3.5 Isobutanol 1.75% (w/v) 
(xylose) 
430 generations 40 [103] 
S. cerevisiae JBA-mut 
Isobutanol 1.9% (v/v) 30 transfers  [105] 
2-butanol 3% (v/v) 30 transfers 58 [105] 
1-butanol 1.9% (v/v) 30 transfers  [105] 
P. putida JUCT1 
Cyclohexane 60% (v/v) 12 transfers 1100 [106] 
Decalin 60% (v/v) 12 transfers  [106] 
Methyl cyclohexane 60% (v/v) 12 transfers  [106] 
Toluene 60% (v/v) 12 transfers  [106] 
E. coli EMFR9 Furfural 0.13% (w/v) 54 transfers 160 [122] 5-HMF 0.25% (w/v) 54 transfers  [126] 
S. cerevisiae RK60-5 Simulated spruce hydrolysate 60% (w/v) 429 generations 200 [127] 
S. cerevisiae KE1-17 Spruce hydrolysate 50% (v/v) 97 generations 150 [127] 
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Table 3. The use of directed evolution to increase production of biorenewable fuels and 
chemicals. 
 
Strain Product Medium Production by Evolved Strain Ref. 
E. coli KO12 Ethanol Luria Broth + 100 g L-1 glucose 1.2 M [131] 
E. coli KO11 Ethanol Luria Broth + 80 g L-1 xylose 0.90 M [131] 
E. coli TCS009 
e50rep1/pLOI297 
Ethanol Defined minimal medium + 40 g 
L-1 glycerol 
0.39 M [132] 
S. cerevisiae GS1.11-26 Ethanol YP + 35 g L-1 xylose 0.46 g g-1 [141] 
S. cerevisiae T1-E Ethanol Defined minimal medium + 25 g L-1 lactose 0.22 M [142] 
E. coli SZ63 D-lactic acid M9 + 50 g L-1 glucose 0.54 M [133] 
E. coli SZ132 D-lactic acid Luria Broth + 100 g L-1 glucose 1.0 M [134] 
E. coli SZ132 D-lactic acid NBS + 100 g L-1 glucose 0.70 M [134] 
E. coli SZ194 D-lactic acid NBS + 120 g L-1 glucose 1.2 M [135] 
E. coli SZ85 L-lactic acid M9 + 50 g L-1 glucose 0.51 M [139] 
E. coli HX024 Succinate NBS + 120 g L-1 glucose 0.81 M [136] 
E. coli KJ060 Succinate AM1 + 100 g L-1 glucose ~0.70 M [137] 
E. coli KJ071 Malate AM1 + 100 g L-1 glucose 0.52 M [137] 
E. coli XZ132  L-alanine AM1 + 120 g L-1 glucose 1.3 M [138] 
 
 
Table 4. Increased tolerance leading to increased production. 
 
Strain Medium Production 
% increase 
relative to 
parent strain 
Ref. 
E. coli LY01 Luria Broth + 140 g L-1 glucose 61±3 g L-1 ethanol 42.8 [75] 
E. coli LY01 Luria Broth + 140 g L-1 xylose 63±1 g L-1 ethanol 42.8 [75] 
E. coli SZ470 Luria Broth + 50 g L-1 xylose 23.5 g L-1 ethanol 100 [73] 
E. coli LAR1 +  
pJMY-EEI82564 Luria Broth + 15 g L
-1 glucose 540+50 mg L
-1 
carboxylic acid 400 [112] 
S. cerevisiae 
spt15-300  
Minimal medium + 100 g L-1 
glucose 
0.40 g ethanol g-1 
glucose 
n/a [79] 
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Table 5. Examples of reverse engineering projects involving E. coli. 
 
Motivation Characterization Method Results Ref. 
Increasing isobutanol 
tolerance and 
production 
Whole-Genome Sequencing Silencing of acrA, gatY, tnaA, yhbJ and marCRAB enables increased isobutanol tolerance. [102] 
Increasing furfural 
tolerance 
Transcriptome Analysis, 
Targeted Sequencing 
YqhD is the primary NADPH-dependent furfural reductase; YqhC is a 
regulator of yqhD 
[122, 
145] 
Understand the impact 
of ethanol on gene 
expression machinery 
Genome Sequencing, 
Transcriptome Analysis, 
Ribosome Profiling 
RpsQ [H31P]: decreased the effect of ethanol on miscoding errors 
during translation; 
Rho [L270M]: decreased activity of Rho-dependent terminators; 
MetJ [∆E91]: increased expression of methionine biosynthesis gene 
[68] 
Increasing succinate 
production 
Genome Sequencing, 
Targeted Enzyme Assay, 
Real-Time Reverse 
Transcription-PCR 
A point mutation in ptsI allows more PEP to be directed towards 
succinate; 
Increased usage of Pck pathway instead of Ppc pathway enables 
increased ATP production. 
[146] 
Increasing succinate 
production 
Genome Sequencing; 
Transcriptome Sequencing; 
Targeted Enzyme Assay; 
Mutations in lpdA eliminated the NADH sensitivity of the pyruvate 
dehydrogenase enzyme complex, which enabled increased succinate 
production. 
[136] 
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Figures 
 
 
Figure 1. Evolutionary strain improvement can play an important role in the strain design cycle.  
Characterization of the evolved strain and its sequence and expression changes can yield novel 
design strategies for future improvement.  
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Abstract 
Carboxylic acids are an attractive biorenewable chemical, but as with many 
biorenewables, their toxicity to microbial biocatalysts limits their fermentative production. While 
it is generally accepted that membrane damage is the main mechanism of fatty acid toxicity, 
previous metabolic engineering efforts that increased membrane integrity did not enable 
increased carboxylic acid production. Here we used an evolutionary approach to improve 
tolerance to exogenous octanoic acid, with the goal of learning design strategies from this 
evolved strain. This evolution of an Escherichia coli MG1655 derivative at neutral pH in 
minimal media produced a strain with increased tolerance not only to octanoic acid, but also to 
hexanoic acid, decanoic acid, n-butanol and isobutanol. This evolved strain also produced 
carboxylic acids at a 5-fold higher titer than its parent strain when expressing the Anaerococcus 
tetradius thioesterase. While it has been previously suggested that intracellular acidification may 
contribute to carboxylic acid toxicity, we saw no evidence that the evolved strain has increased 
resistance to this acidification. Characterization of the evolved strain membrane showed that it 
had significantly altered membrane polarization (fluidity), integrity (leakage) and composition 
relative to its parent. The changes in membrane composition included a significant increase in 
average lipid length in a variety of growth conditions, including 30 °C, 42 °C, carboxylic acid 
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challenge and ethanol challenge. The evolved strain has a more dynamic membrane composition, 
showing both a larger number of significant changes and larger fold changes in the relative 
abundance of membrane lipids. These results highlight the importance of the cell membrane in 
increasing microbial tolerance and production of biorenewable fuels and chemicals. 
Introduction 
Carboxylic acids are an attractive biorenewable chemical, due in part to their ability to be 
catalytically converted to a variety of industrial chemicals, such as alkanes (Lennen et al., 2010) 
and olefins (Lopez-Ruiz and Davis, 2014). Significant strides have been made in engineering 
Escherichia coli and Saccharomyces cerevisiae for production of these compounds (Lennen and 
Pfleger, 2012, Choi and Da Silva, 2014, Leber and Da Silva, 2014 and Tee et al., 2014). 
Unfortunately, the toxicity of these carboxylic acids to the microbial biocatalyst appears to be 
limiting biocatalyst performance. There is strong evidence that membrane damage is the main 
mechanism of toxicity ( Lennen et al., 2011, Jarboe et al., 2013 and Liu et al., 2013), including 
the observation that membrane leakage sharply increases near the end of the production phase 
(Royce et al., 2013). Previous metabolic engineering efforts that were successful in increasing 
the membrane integrity were not successful in increasing carboxylic acid titers (Lennen and 
Pfleger, 2013), though other efforts that increased tolerance by preventing medium-chain fatty 
acid incorporation into the cell membrane did enable increased production (Sherkhanov et al., 
2014). 
Product toxicity is frequently encountered in metabolic engineering projects (Nicolaou et 
al., 2010 and Jarboe et al., 2011). There are a variety of strategies for mitigating this toxicity, 
including in situ removal of the product during the course of the fermentation (Dafoe and 
Daugulis, 2014, Lopez-Garzon and Straathof, 2014 and McKenna et al., 2014) and increasing the 
56 
 
robustness of the microbial biocatalyst. Biocatalyst tolerance can be increased either through an 
evolutionary approach ( Portnoy et al., 2011 and Abatemarco et al., 2013) or through rational 
engineering that addresses known mechanisms of toxicity ( Luo et al., 2009 and Jarboe et al., 
2011). The evolutionary approach has been quite successful in improving strain performance 
when production of the target compound can be linked to growth (Jarboe et al., 2010). This 
linkage between growth and production generally requires redox balance and a net ATP 
production by the pathway. Evolution for tolerance to an exogenously-supplied inhibitor with the 
goal of increasing production of that same inhibitory compound has met with mixed results 
(Yamane et al., 1998, Atsumi et al., 2010 and Wang et al., 2011). 
The use of evolutionary-based strain improvement relies on Orgel׳s Second Rule that 
“evolution is cleverer than you are” (Dennett, 1996). In order to learn from this cleverness and 
increase our arsenal of rational strategies for strain improvement, it is important to reverse 
engineer these evolved strains. The outcome of such reverse engineering efforts have included 
the identification of improved succinate production pathways (Zhang et al., 2009), the 
identification of the major E. coli furfural reductase ( Miller et al., 2009), methods of enabling 
ethanol resistance in E. coli ( Haft et al., 2014) and methods for improving the yeast membrane 
for thermotolerance (Caspeta et al., 2014). 
Here we describe the evolution of E. coli for tolerance to exogenously supplied octanoic 
acid, with a resulting 5-fold increase in carboxylic acid production and increased tolerance not 
just of carboxylic acids, but also of butanol isomers. This work describes the phenotypic 
characterization of this strain, with a particular focus on the membrane. 
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Methods 
Strains and growth conditions 
E. coli strains used in this study are listed in Table 1. Carboxylic acid stock solutions 
were prepared in 100% ethanol. The concentration of ethanol used in these stock solutions had 
no significant impact on growth (data not shown). Media were adjusted to pH 7.0 with 2.0 M 
potassium hydroxide. 
Directed evolution and strain selection 
Strain ML115 was subjected to 17 serial transfers in 350 mL MOPS medium (Wanner, 
1994) with 2.0% dextrose and 350 mg/L chloramphenicol in 500 mL fleakers. The temperature 
was controlled at 37 °C and mixing was maintained at 150 rpm with magnetic stir bars. The pH 
was maintained at 7.0 using gravity-fed 2.0 M potassium hydroxide. The octanoic acid 
concentration was periodically increased in 10 mM increments. The final culture was plated onto 
solid media and individual colonies were selected and characterized by measuring the specific 
growth rate in closed fermentation vessels containing MOPS 2.0 wt% dextrose with 10 mM C8, 
pH 7.0, 150 rpm, 37° C. Colonies were first analyzed as mixed cultures of 5–6 strains. The 
strains populating the mixed population showing the highest specific growth rate were then 
characterized in pure culture. This work describes the characterization of the strain with the 
highest growth rate, LAR1. 
Strain characterization 
Tolerance to hexanoic, octanoic and decanoic acid was performed in 500 mL fleakers 
automatically controlled at 37 °C, 150 rpm and pH 7.0 in 350 mL MOPS 2.0% dextrose. 
Tolerance to n-butanol and isobutanol was assessed in 250 mL baffled flasks with 25 mL MOPS 
2.0 wt% dextrose, 37 °C, 200 rpm, with an initial media pH of 7.0. 
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Plasmid construction 
The acyl–acyl carrier protein thioesterase (acyl-ACP TE) from Anaerococcus tetradius 
(GenBank: EEI82564) which primarily produces octanoic acid (Jing et al., 2011) was provided 
by Dr. Nikolau at Iowa State University. The acyl-ACP TE originally cloned in pUC57 was 
digested with BamHI and EcoRI at 5′ and 3′ ends and cloned into pTrcHisB plasmid (Life 
Technologies) to produce plasmid pJMY-EEI82564. 
Characterization of carboxylic acid production 
Strains transformed with pJMY-EEI82564 were spread onto Luria Broth (LB) plates with 
100 mg/L ampicillin and incubated at 30 °C overnight. Individual colonies were precultured in 5 
mL LB media with 100 mg/L of ampicillin in 50 mL centrifuge tubes overnight, and then were 
inoculated into 250 mL shake flasks containing fresh 50 mL of LB media with 1.5% dextrose, 
100 mg/L ampicillin, and 1.0 mM of isopropyl-β-d-thiogalactopyranoside (IPTG). Cultures were 
grown at 30 °C on a rotary shaker at 200 rpm. The initial ODs were approximately 0.07 and the 
cells were harvested after 72 h. 
Determination of carboxylic acid titers 
Carboxylic acid production was quantified by an Agilent 7890 gas chromatograph 
equipped with an Agilent 5975 mass spectroscope using flame ionization detector and mass 
spectrometer (GC-FID/MS) after carboxylic acid extraction as described in (Zhang et al. 2012). 
Briefly, 1 mL of whole liquid media was taken and extracted by 9 mL of a mixture of 
chloroform/methanol/water (1.5:1.0:1.0 vol) with 100 μl acetic acid and 20 μL of a mixture of 
internal standards (1.0 mg/mL for each). The organic phase (bottom) was filtered through a glass 
column filled with 1.0 g of magnesium sulfate, and then dried under nitrogen flow. After 
methylation with 4.0 mL of 5.0% sulfuric acid in methanol at 90 °C for 2 h, 2.0 mL of 
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hexane/chloroform (4.0:1.0 vol) and 2.0 mL of 0.90% sodium chloride solution were added and 
vortexed. The top organic layer was filtered through a glass column filled with 0.20 g sodium 
bicarbonate and 1.0 g of magnesium sulfate, dried again with nitrogen gas, and then resuspended 
in 500 μL of hexane before injection to GC-FID/MS. The temperature for GC-FID/MS analysis 
was held at 50 °C for 1 min, ramped to 140 °C at 20 °C/min, and then to 220 °C at 4 °C/min 
before it was raised to 280 °C at 15 °C/min. Helium was used as a carrier gas and the flow rate 
was 1 mL/min through a DB-5MS separation column (30 m, 0.25 mm ID, 0.25 μm, Agilent). 
Nonanoic (C9), tridecanoic (C13), pentadecanoic (C15), and heptadecanoic (C17) acids were 
added as internal standards for carboxylic acid quantification. 
Membrane characterization 
Membrane permeability was assessed by SYTOX Green staining. Strains were grown to 
OD550 of ~1 in MOPS 2.0 wt% dextrose at 37 °C and 200 rpm, pelleted, washed twice, and then 
resuspended in PBS pH 7.0 to OD550 1. The washed cells were treated either with 10 mM 
octanoic acid at pH 7.0 or a similar volume of PBS pH 7.0. Cells were incubated at 37 °C and 
200 rpm for 90 min and then diluted 10-fold into PBS pH 7.0. SYTOX Green Nucleic Acid Stain 
(Invitrogen) was added from a 5.0 mM stock in DMSO to a final concentration of 5.0 μM. After 
15 min of staining, cells were subjected to analysis using a BD Biosciences FACSCanto II flow 
cytometer with simultaneous measurements of forward and side laser scatter at 488 nm 
excitation and 530 nm emission. 15,000 cells were collected per sample. 
Membrane fluidity characterization was performed using 1, 6-diphenyl-1, 3, 5-hexatriene 
(DPH) accordingly to previously-described methods (Royce et al., 2013). Briefly, cells were 
grown to mid-log in MOPS 2.0% dextrose at 37° C, harvested, washed and resuspended in PBS 
pH 7.0 at a final concentration of 1×108 cells/mL with 0.2 μM DPH. Fluorescence polarization 
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was determined based on vertical and horizontal fluorescence readings obtained using a Synergy 
2 Multi-Mode plate reader. The impact of temperature was assessed by changing the temperature 
at which the assay was performed. 
The membrane lipid composition was analyzed using a modified Bligh and Dyer method, 
as previously described (Royce et al., 2013). This protocol differs from the carboxylic acid 
production analysis in that it uses cells collected from the pelleting of 25 mL of culture media, 
while the carboxylic acid titer analysis featured 1 mL of sample containing both media and cells. 
Cells for the composition analysis were grown in MOPS 2.0 wt% dextrose with an initial pH of 
7.0 in baffled flasks and shaking at 200 rpm from an initial OD550 of 0.1 to mid-log (OD550 
~0.8) prior to harvesting. 
Intracellular pH measurements 
The intracellular pH was measured using a pH-dependent green fluorescent protein 
encoded by pJTD1 as previously described (Thomas et al., 2001 and Royce et al., 2014). Briefly, 
cells were grown in LB media at an initial pH of 7.0 with 100 mg/L ampicillin and 200 μM l-
arabinose from an initial OD550 of 0.1 to mid-log (OD550 ~0.8), harvested by centrifugation 
and resuspended in PBS pH 7.0. Samples for the standard curve were treated with sodium 
benzoate. Experimental samples were treated with octanoic acid at pH 7.0. The fluorescence 
intensity was measured at 30 °C using excitation filter=485/20 nm and emission filter=528/20 
nm. 
Results 
Though metabolic engineering efforts for carboxylic acid production have been able to 
effectively increase titers and yields, it appears that product toxicity limits further gains in titer 
(Lennen et al., 2011, Lennen and Pfleger, 2012, Jarboe et al., 2013 and Tee et al., 2014). Here we 
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used directed evolution to improve E. coli tolerance to octanoic acid. This evolution provides a 
system for study and characterization, so that we can identify design strategies for further 
increasing tolerance in production strains. 
Development and isolation of evolved strains 
An evolved strain exhibiting an octanoic acid tolerance phenotype was obtained by 
sequentially transferring parent strain ML115 in MOPS minimal media containing octanoic acid 
while maintaining the media pH at 7.0 (Fig. 1A). Strain ML115 lacks the fatty acid β-oxidation 
pathway via deletion of fadD; this prevents degradation of carboxylic acids. The selective 
pressure of octanoic acid was increased in 10 mM (1.44 g/L) increments to a final concentration 
of 30 mM over the course of 714 total hours. 
Twenty-six distinct strains were isolated as single colonies from this final mixed 
population. These 26 strains were grouped into five sets of mixed cultures that each contained 
five or six distinct strains. These mixed cultures were characterized in the presence of 10 mM 
C8, with the assumption that mixed cultures containing strains with increased tolerance will 
show increased growth. These mixed cultures showed specific growth rates ranging from 0.54 to 
0.65 h−1 (Table 2), relative to the 0.28 h−1 shown by the parent. The five strains that composed 
the mixed culture with the highest specific growth rate were then tested individually and found to 
have specific growth rates ranging from 0.60 to 0.69 h−1. This work focuses on phenotypic 
characterization of the evolved strain with the highest growth rate, which we have named LAR1. 
Genomic sequence analysis of this strain is in progress and will be discussed in a forthcoming 
publication. 
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Evolution for octanoic acid tolerance extends to other carboxylic acids and butanol 
As expected from the directed evolution process, the evolved strain shows increased C8 
tolerance relative to its parent (Fig. 1B). Specifically, when characterized in pure cultures in 
closed fermentation vessels maintained at pH 7.0, the evolved strain shows only slight growth 
inhibition during exponential phase from 10 mM C8, though the final OD550 reached during 
stationary phase (1.4±0.1) is lower than its growth under the control condition (3.2±0.4). Under 
this same condition, the parent strain grown in the presence of 10 mM C8 shows a growth lag of 
approximately 10 h and after 24 h has only reached a final OD550 of 0.20±0.03. The evolved 
strain also shows increased tolerance to 20 mM C8 in shake flasks. Specifically, the parent strain 
had a specific growth rate of 0.137±0.003 h−1 and the evolved strain had 2.2-fold higher rate of 
0.30±0.03 h−1. 
We have previously observed between 25% and 30% inhibition of MG1655 growth by 10 
mM hexanoic acid (C6), C8 and decanoic acid (C10) under this growth condition (Royce et al., 
2013), where our parent strain ML115 is an engineered derivative of MG1655 (Table 1). 
However, our evolved strain showed only very slight inhibition in the presence of 10 mM of 
each of these three compounds (Fig. 1C). The evolved strain’s specific growth rate in the control 
condition was 0.60 h−1, while the specific growth rate was 0.57, 0.58 and 0.57 h−1 in the presence 
of 10 mM C6, C8 and C10, respectively. This indicates that the useful mutations acquired during 
evolution for C8 tolerance also apply to C6 and C10. This is consistent with the expectation that 
saturated, straight-chain carboxylic acids of various lengths have generally similar mechanisms 
of inhibition. 
The evolved strain shows increased tolerance not just of carboxylic acids, but also to two 
of the most popular butanol isomers. Specifically, the evolved strain showed significantly 
63 
 
increased growth relative to the parent strain in the presence of 0.60% (v/v) (65 mM) isobutanol 
and n-butanol. The parent strain had a 37% reduction in specific growth rate in the presence of 
isobutanol while the evolved strain had a growth rate reduction of only 27%. The increased 
growth rate shown by the evolved strain was significantly (P=0.0018) higher than the parent 
strain. The parent strain had a 53% decrease in the specific growth rate in presence of n-butanol, 
while the evolved strain had a reduction of 46% (P=0.054). 
The fact that this evolved strain shows increased resistance to membrane-damaging 
compounds other than carboxylic acids expands the impact of this work and highlights the 
importance of understanding the physical changes that enable this increased tolerance. 
Evolution for octanoic acid tolerance enabled increased octanoic acid production 
When metabolic pathway design enables co-selection for increased growth and increased 
production of the target compound, evolutionary schemes have proven quite effective in 
improving strain performance, as seen for E. coli in regards to production of, for example, 
ethanol, lactic acid and succinate (Zhang et al., 2009 and Jarboe et al., 2010). However, 
engineering or evolving for increased tolerance of exogenously-supplied compounds with the 
aim of improving production has been met with mixed results. Such an approach was effective 
for ethanol (Yamane et al., 1998 and Wang et al., 2011), but not for isobutanol (Atsumi et al., 
2010). Additionally, rational membrane engineering efforts that were able to mitigate carboxylic 
acid toxicity did not result in increased carboxylic acid production (Lennen and Pfleger, 2013). 
However, in the work presented here, the strain evolved for increased octanoic acid 
tolerance produced significantly higher titers of octanoic acid and nearly all other carboxylic 
acids when provided with the A. tetradius thioesterase (Fig. 2A). Specifically, the evolved strain 
produced 180±30 mg/L (1.3±0.2 mM) octanoic acid and 540±50 mg/L (3.0±0.4 mM) total 
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carboxylic acids, relative to the 32±7 (0.22±0.05 mM) and 100±20 (0.5±0.1 mM) produced by 
the parent strain. The only carboxylic acid that was not produced at significantly higher amounts 
by the evolved strain is C18:0, with titers of 8±2 in the evolved strain and 5±2 mg/L in the parent 
strain. The OD500 value for the evolved strain was an average of 3-fold higher than the parent 
strain over the 76-hour fermentation (Fig. 2C). Thus, the 5-fold increase in carboxylic acid 
production cannot solely be attributed to increased biocatalyst abundance. 
In addition to producing a significantly higher amount of most carboxylic acids, the 
evolved strain also shows a significantly altered fatty acid distribution (Fig. 2B). The evolved 
strain has significantly less C16:0, C18:1 and C18:0 and significantly more C10–OH, C12:1, 
C12:0 and C14:0 than the parent strain. Surprisingly, the relative abundance of C8:0 is similar 
for both strains, even though the C8 titers differ by more than two-fold. 
The evolved strain has altered membrane properties 
It is generally accepted that membrane damage is the key mechanism of microbial 
inhibition during both carboxylic acid challenge and carboxylic acid production (Lennen et al., 
2011, Jarboe et al., 2013, Royce et al., 2013 and Royce et al., 2014). Therefore, we compared the 
membrane characteristics of the evolved strain to the parent strain. 
Carboxylic acid-induced membrane leakage has previously been quantified using both 
Mg2+ leakage (Liu et al., 2013 and Royce et al., 2013) and permeability to SYTOX (Lennen and 
Pfleger, 2013). Here we used the SYTOX method, where permeability to this compound 
indicates a damaged membrane. Flow cytometry was used to separate and quantify SYTOX-
permeable and SYTOX-impermeable cells. This analysis showed that the evolved strain showed 
increased resistance to the membrane-damaging effect of 10 mM C8 during exogenous challenge 
(Fig. 3A). Specifically, 83% of the parent strain population became SYTOX-permeable while 
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only 49% of the evolved strain population became permeable. This increased resistance is 
consistent with the increased tolerance and increased carboxylic acid production. 
We previously demonstrated that while transient challenge with exogenous C8 can result 
in altered membrane fluidity, as indicated by the membrane polarization value, cells given a few 
hours to adapt to this challenge were able to compensate for this perturbation (Royce et al., 
2013). Consistent with this adaptability was the fact that there was no significant change in 
membrane fluidity during carboxylic acid production (Royce et al., 2013). However, it was 
observed here that the evolved strain has a significantly higher membrane polarization than the 
parent strain in the temperature range of 30–45 °C (Fig. 3A). This increased polarization 
corresponds to an increase in membrane rigidity and decreased fluidity. 
The evolved strain has altered membrane composition 
This altered membrane integrity and rigidity could be due to altered lipid composition of 
the membrane. Therefore we grew both strains in a variety of conditions known to impact the 
membrane composition and measured the various membrane lipid components (Table 3). Note 
that our concentration of 430 mM ethanol (2.0%) was motivated by published studies of ethanol 
toxicity (Luo et al., 2009). 
Previous membrane engineering efforts have aimed to decrease the saturated:unsaturated 
(S:U) ratio ( Luo et al., 2009 and Lennen and Pfleger, 2013). Consistent with increased tolerance 
being associated with a decreased S:U ratio, we observed that the evolved strain had a 
significantly lower S:U ratio than the parent strain when grown in the presence of 30 mM C8 
(Fig. 3C). We also observed that the evolved strain had a significantly higher S:U ratio than the 
parent strain when grown at 42 °C (Fig. 3C, Table 3). Our observed decrease of the S:U ratio in 
the parent strain in the presence of ethanol is consistent with previous reports ( Luo et al., 2009), 
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as is our observation of a positive relationship between the S:U ratio and growth temperature for 
the parent strain ( Okuyama et al., 1977). 
Other membrane engineering efforts have prevented incorporation of medium-chain fatty 
acids into the membrane via deletion of aas (Sherkhanov et al., 2014). In this case, the 
engineered strain showed decreased C12/C16 and C14/C16 ratios, increased viability during 
fatty acid production and a 20% increase in fatty acid production when the fermentation was 
performed with a dodecane overlay for in situ product extraction. Our parent strain and evolved 
strains had C12/C16 ratios (mol) of 0.05±0.03 and 0.0040±0.0004 and C14/C16 ratios of 
0.10±0.03 and 0.051±0.002, respectively. This decrease in both of these ratios during the 
evolutionary process is consistent with the previously-described engineering efforts, though the 
ratios obtained by our evolved strain are lower than those obtained via aas deletion (Sherkhanov 
et al., 2014). 
In addition to the altered S:U, C12/C14 and C14/C16 ratios, we observed that our 
evolved strain has a significantly increased average membrane length relative to its parent ( Fig. 
3D). This increase is consistent with the dose-dependent increase in average length that we 
previously observed during short-term adaptation to C8 (Royce et al., 2013). In these previous 
short-term adaptation experiments, E. coli MG1655 was able to attain average lipid lengths of up 
to 16.26. However, the evolved strain is able to attain average lengths of 16.39, while the largest 
value observed for the parent strain was 16.18. This significant increase in average lipid length 
for the evolved strain was observed under a variety of conditions, including exogenous ethanol 
challenge and growth at 42 °C (Fig. 3D). 
This increase in average lipid length is an intriguing strategy for potentially increasing 
membrane integrity. If one desires to mimic this change as a rational metabolic engineering 
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strategy, a more detailed comparison of the lipid composition of the two strains is useful (Table 
3). This comparison shows that for at least four of the five conditions tested, the C16:1 content is 
significantly lower in the evolved strain and the C16:0, C18:1, C19cyc and total C18 pool are all 
significantly higher in the evolved strain. Note that the total C18 pool includes C18:1, C18:0 and 
C19cyc. Thus, the evolved strain seems to have (a) changed the distribution of lipids within the 
C16 pool and (b) increased the relative size of the C18 pool. 
The evolved strain has increased variability in membrane content 
The data discussed above involved a direct comparison of the relative membrane 
composition between the evolved and parent strain. We also considered changes in the 
membrane composition in response to changes in the growth environment (Table 3). Our 
observed increase in relative abundance of C18:1 in the parent strain in the presence of ethanol 
and at 30 °C relative to 37 °C is consistent with previous reports (Ingram, 1982), as is our 
observed decrease in C18:1 and C19cyc content at 42 °C (Yuk and Marshall, 2003). 
The most striking difference between our two focal strains is the observation that the 
evolved strain has an increased dynamic range of membrane composition. First, the evolved 
strain has a larger number of significant perturbations to membrane content than the parent 
strain: 27 relative to 16. Second, the number of lipids whose relative amount significantly 
changed by at least two-fold is larger in the evolved strain than in the parent. The only significant 
and greater than two-fold change in the parent strain was a 2.0±0.3-fold increase in C18:0 in the 
presence of C8. Contrastingly, the evolved strain had four perturbations of at least two-fold: 
2.15±0.04 for C16:1 in the presence of C8, −2.2±0.2 for C17cyc in the presence of C8, 8±2 for 
C12:0 at 30° C and 3.0±0.3 for C18:0 at 30° C. Finally, it should be noted that for two of the four 
experimental conditions, 2.0% ethanol and 42 °C, at least seven of the eight lipids had a 
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significantly altered relative abundance in the evolved strain. The highest number of significantly 
perturbed lipids in the parent strain in any one condition was five, observed in response to 
octanoic acid challenge. 
Thus, the evolved strain appears to be able to implement more, and larger, perturbations 
to the relative distribution of membrane lipids than the parent strain. 
Similar sensitivity to intracellular acidification 
Our group has previously demonstrated that exogenous challenge with octanoic acid 
results in intracellular acidification, even when the bulk media pH is maintained at 7.0 (Royce et 
al., 2014). Intracellular pH was subsequently monitored during carboxylic acid production and 
no acidification was observed, though it was not clear if this was due to metabolic differences 
between exogenous challenge and production or insufficient carboxylic acid titers to achieve the 
dose necessary for acidification (Royce et al., 2014). 
Here we measured the intracellular pH of our parent and evolved strains during 
exogenous challenge with C8 and no significant difference was observed (Fig. 4). This suggests 
that it is possible for cells to improve C8 tolerance and production without mitigating the 
intracellular acidification problem. 
Discussion and Conclusions 
Here we have described the evolution of E. coli for tolerance to the straight-chain, 
saturated carboxylic acid octanoic acid at neutral pH. This evolution was motivated by our 
desires to not only enable increased production of these compounds but also to understand the 
physical changes in the biocatalyst that enable the increased tolerance and production. By 
understanding the physical changes that occurred, we can understand the “clever” tricks 
described by Orgel׳s Rule and become cleverer in our metabolic engineering strategies. 
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Our identification and analysis of the mutations acquired by this evolved strain will be 
discussed in forthcoming publications. It has been confirmed that a single amino acid change at 
position 419 within the RNA polymerase β′ subunit (rpoC) contributes to some, but not all, of 
the gain in fitness of the evolved strain. This mutation is consistent with the global transcription 
machinery engineering method (Alper et al., 2006) and with outcomes for other evolutionary 
studies (Harden et al., 2015). We have also confirmed a single amino acid change as position 82 
within BasR, the transcriptional regulator component of BasS/BasR system, which has been 
implicated in the metal response (Ogasawara et al., 2012). Though the contribution of this 
mutation to the evolved strain phenotype has not yet been determined, this mutation is consistent 
with the results of other evolutionary studies related to n-butanol tolerance (Reyes et al., 2012). 
Other mutations, including the possible duplication of a 10-kb genomic region, are currently 
being verified and investigated. 
Our strain evolved at neutral pH for tolerance to exogenously supplied octanoic acid also 
showed increased tolerance to other compounds (Fig. 1). The increased tolerance to hexanoic 
and decanoic acids was not surprising, given the chemical similarity of these compounds to 
octanoic acid. The increased tolerance to n-butanol and isobutanol was surprising, as these 
compounds are alcohols, not carboxylic acids. However, when one considers that the toxicity of 
both of these compounds is largely attributed to membrane damage (Lennen et al., 2011, Jarboe 
et al., 2013, Reyes et al., 2013, Royce et al., 2013, Royce et al., 2014 and Zu et al., 2014), this 
result is consistent with our conclusion that the evolved strain has acquired a membrane with 
increased resistance to the damage caused by these compounds. 
We were pleased to see that this evolved strain had increased production ability relative 
to the parent strain (Fig. 2). Though the titers achieved by this strain were lower than values 
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reported for other strains (Tee et al., 2014), it should be noted that only the most basic metabolic 
engineering strategies have been applied to this strain to enable carboxylic acid production, 
including abrogation of fatty acid uptake and acetate production and provision of an appropriate 
thioesterase. Other proven strategies, such as increased expression of fabZ (Ranganathan et al., 
2012), and characterization in pH-controlled fermenters have not been applied. 
We quantified the membrane of the evolved strain in regards to its fluidity, integrity 
(leakage) and composition (Fig. 3). Each of these metrics showed a significant difference from 
the parent strain. Most intriguingly, the evolved strain seems to have a more dynamic membrane 
(Table 3). This suggests that a change has occurred in the regulation of membrane composition. 
It should be noted that we have not proven that these changes in the membrane are the cause of 
the increased tolerance and increased carboxylic acid production. Other changes to the 
membrane, or other changes not explored here, may be of comparable or increased importance 
than the results described here. Other recent publications have highlighted the importance of the 
membrane when evolving strains for increased tolerance (Reyes et al., 2013 and Caspeta et al., 
2014). Thus, it is increasingly apparent that metabolic engineering strategies for rationally 
strengthening the microbial membrane are needed. 
Our production experiments were performed at 30 °C, and at this temperature the evolved 
strain has a higher S:U ratio than the parent strain ( Fig. 3C). However, this trend is reversed at 
42 °C, raising the interesting question of whether or not the evolved strain would still produce 
more carboxylic acids than the parent strain if evaluated at 42 °C. We have previously observed 
an antagonistic relationship between C8 adaptation and heat shock at 42 °C. MG1655 adapted to 
30 mM C8 for 3 h has significantly more membrane leakage than heat shocked cells that were 
not adapted to C8 (Royce and Jarboe, unpublished data). Ongoing analysis being performed by 
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our group aims to identify the mutations that enable the evolved phenotype and, more 
importantly, understanding of how they support the evolved phenotype. The work described here 
demonstrates that (a) it is possible to increase carboxylic acid production via an increase in 
tolerance, (b) the strain with increased tolerance has altered membrane properties and (c) 
acquisition of tolerance to octanoic acid enables increased tolerance to the membrane-damaging 
biofuels of n-butanol and isobutanol. 
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Tables 
Table 1. Strains and plasmids. 
 
Strain Genotype References 
ML115 “parent” MG1655 fadD poxB ackA-pta: cmR (Zhang et al., 2012) 
LAR1 “evolved” ML115 evolved for C8 tolerance This work 
Plasmid   
pJMY-EEI82564 pTrc-EEI82564 thioesterase from Anaerococcus tetradius (Jing et al., 2011) This work 
pJTD1 pBad24-TorA-GFPmut3* (Thomas et al., 2001) 
 
Table 2. Characterization of evolved isolates in closed fermentation vessels with MOPS 2.0 wt% 
dextrose and 10 mM C8 at 37° C, 150 rpm, pH of 7.0. The parent strain had a specific growth 
rate of 0.28 h−1. 
 
Strain number (s) Specific growth rate (h-1) 
Mixed cultures 
1–5 0.65 
6–10 0.64 
11–15 0.54 
16–20 0.64 
21–26 0.63 
Pure cultures 
1 0.6 
2 0.67 
3 0.67 
4 n.d. 
5 (LAR1) 0.69 
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Table 3. Mol% of various lipids and lipid groups in the cell membrane for parent strain ML115 and evolved strain LAR1 grown to 
mid-log in MOPS 2.0% dextrose at 37° C and an initial pH of 7.0 and then adapted to the indicated stressor for 3 h. Each value is an 
average and standard deviation of three biological replicates, except the evolved strain at 30° C, where n=2. Total C16 includes C16:1, 
C16:0 and C17cyc. Total C18 includes C18:1, C18:0 and C19cyc. 
Bolded values indicate lipids whose relative content was significantly (P<0.05) different between the two strains in the same 
condition.  
*Indicates lipids whose relative content significantly (P<0.05) differed in the same strain relative to the control condition.  
Values in parentheses indicate the fold change relative to the same strain in the control condition. This is only shown for lipids whose 
relative abundance was significantly different from the control condition. 
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Figures 
Figure 1. Development and characterization of the evolved strain. All experiments were 
performed at 37 °C in MOPS 2.0 wt% dextrose.  
(A) Development of evolved strain LAR1 by serial dilution of parent strain ML115 in closed 
fermentation vessels at pH 7.0, 150 rpm. Arrows indicate the first transfer corresponding to each 
increase in octanoic acid concentration. (B) Evolved strain LAR1 has increased tolerance to 
exogenously supplied C8 relative to its parent ML115. (C) Evolved strain LAR1 shows similar 
growth in the presence of 10 mM C6, C8 or C10. (B and C) Strains were characterized in closed 
fermentation vessels at pH 7.0, 150 rpm. Data is the average of three biological replicates, with 
error bars indicating one standard deviation. (D) Evolved strain LAR1 has increased tolerance of 
0.6% (v/v) isobutanol and n-butanol. Strains were grown in shake flasks at 200 rpm with an 
initial pH of 7.0. Values are the average of three biological replicates with error bars indicating 
one standard deviation. P values for parent strain vs evolved strain: control, 0.0032; isobutanol, 
0.0018; n-butanol, 0.054 (t-test). 
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Figure 2. Evolved strain LAR1 shows increased carboxylic acid production relative to parent 
strain ML115. Both strains contain plasmid pJMY-EEI82564 encoding the A. 
tetradius thioesterase.  
Strains were grown for 72 h in LB with 1.5% glucose at 30 °C, 200 rpm with 100 mg/L 
ampicillin and 1.0 mM IPTG. Values are the average of four biological replicates, with error bars 
indicating one standard deviation. (A) Carboxylic acid concentrations, all except C18:0 have a P-
value of <0.05 using two-tailed t-test. (B) Relative distribution, by weight. C10–OH, C12:1, 
C12:0, C14:0, C16:0, C18:1, C18:0 have P<0.05. (C) Growth. 
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Figure 3. Evolved strain LAR1 has altered membrane characteristics relative to parent strain 
ML115.  
(A) LAR1 has a more polarized membrane than ML115. Cells were grown in MOPS 2.0% 
dextrose at 37 °C and concentrated in PBS pH 7.0 with DPH. P=2×10−4 by paired two-tailed t-
test. (B) LAR1 has increased membrane resistance to exogenously supplied C8 relative to 
ML115. Cells were grown in MOPS with 2.0% dextrose to OD550 ~1, challenged with C8 at pH 
7.0 and then treated with SYTOX and analyzed by flow cytometry. Values are the average of 
three biological replicates with error bars indicating one standard deviation. P values for parent 
strain vs evolved strain: control, 0.056; +C8, 0.0052. (C, D) Membrane saturated:unsaturated 
ratio and average lipid length. Cells were grown to mid-log in MOPS 2.0% dextrose at 37 °C, 
harvested, resuspended in fresh media and then incubated in the indicated condition for 3 h. The 
S:U ratios are significantly different (P<0.05) between strains for 30 mM C8 and 42 °C. The 
average lipid length was significantly different (P<0.05) between strains for all conditions. Each 
value is an average and standard deviation of three biological replicates, except the evolved 
strain at 30 °C, where n=2. 
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Figure 4. Evolved strain LAR1 has comparable intracellular pH to parent strain ML115 in 
response to exogenous challenge with C8.  
Strains encoding pH-sensitive GFP via pJTD1 were grown in LB at 37 °C with 100 mg/L 
ampicillin and 200 μM l-arabinose, concentrated and then challenged with C8 at pH 7.0. Paired 
t-test showed no significant difference between the two strains. 
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Introduction 
Fatty acids are of great importance in the industrial field due to their wide applications as 
multifunctional precursors to produce various fuels, chemicals, and textile fibers (1–4). So far, 
the production of industrial fatty acids relies heavily on a nonrenewable and unsustainable 
resource, petroleum (2, 4), which can lead to severe environmental, political, and economic 
consequences (5). Therefore, it is necessary to develop new pathways to produce fatty acids 
using renewable and sustainable carbon feedstocks. In this respect, biocatalysts are attractive and 
promising. They have already been broadly applied to biorenewable industries for the production 
of various chemicals, such as ethanol, glycerol, 1, 3-propanediol, and lactic acid (6). Moreover, it 
is potentially feasible for researchers to engineer organisms to obtain the biocatalysts with 
significant ability to produce fatty acids since organisms can naturally synthesize fatty acids with 
12-18 carbons, the primary components of the microbial cell membrane (6). Although, big 
progress has been made for increasing the production of fatty acids by biocatalysts (7–10), 
inhibition of fatty acid has been reported as a limiting factor of the bio-production.  
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Researchers have found that fatty acids are toxic to the microbes at concentration below 
the desired yield and titer (1, 11, 12), the same occurs with other desired biofuels and 
biorenewable chemicals (13–15). Toxicity is a major obstacle for boosting the yield and titer of 
fatty acids (1). The mechanism of the toxicity of fatty acid to Escherichia coli has been studied. 
It was reported that fatty acids can reduce the cell viability by damaging the cell membrane and 
decreasing intracellular pH (7, 11, 12). Several groups have tried to overcome this by different 
approaches. One strategy was to restore the cell membrane to improve cell viability by 
expressing one gene fabR and two different acyl-ACP thioesterase genes in E. coli. However, the 
engineered E. coli did not show improved fatty acid productivity (11, 16). Another one was to 
delete the acyl-ACP synthase (aas) gene in E. coli, which resulted a decreased percentage of 
medium-chain fatty acids in the membrane, increased tolerance to medium-chain fatty acids, and 
a slightly improved yield of fatty acids (17). Our group currently focuses on increasing the 
tolerance of E. coli to short-chain fatty acids (SCFAs) via adaptive laboratory evolution. The 
evolved strain has increased SCFAs tolerance and improved fatty acid production titer (7).  
Reverse engineering aims to identify the crucial mutations that enable evolved strains to 
obtain the evolved phenotype and to understand why these mutations are beneficial. It is a 
powerful tool to elucidate the mechanisms behind the evolution experiments, these mechanisms 
can be used as design strategies for improving tolerance and production of biocatalyst. 
Identifying and understanding the key mutations that support the evolved phenotype requires 
knowledge of what mutations occurred during the evolutionary engineering. Whole-genome 
sequencing is very important for finding the critical mutations (18), and transcriptome analysis 
and metabolic flux analysis have been proven quite useful for revealing the underlying 
mechanisms of the mutations (19, 20). Once the important mutations are found, the next steps are 
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to explore which mutations promote fitness, and understand the mechanisms of inhibition and the 
functions of poorly-characterized enzymes and pathways. For instance, in an isobutanol 
tolerance study, five mutations were identified primarily responsible for the increased isobutanol 
tolerance, and glucosamine-6-phesphate was identified as an important metabolite for isobutanol 
tolerance in E. coli (21). Increasing furfural tolerance was achieved by silencing the NADPH-
dependent oxidoreductase genes (yqhD and dkgA) in E. coli (20). The new glucose uptake 
system and mechanism of increased ATP level in the evolved strain has been well studied and 
were found to be essential for improving succinate production in E. coli (22). 
In this work, we investigated the evolved E. coli strains by employing reverse 
engineering to understand the mechanisms of the increased short-chain fatty acid tolerance and 
production. Four mutations were verified in evolved strains. We further studied each mutation 
contribution on short-chain fatty acid tolerance, fatty acid production, and cell membrane 
properties. All mutations were found to be important and they all somewhat contribute to the 
changed phenotypic of evolved strains.    
Materials and Methods 
Strains, plasmids and bacterial cultivation   
 All strains and plasmids used in this study are listed in Table 1 and Table 2. E. coli 
DH5α strain was used as a cloning strain, while the parent strain ML115 and the evolved strain 
LAR1 were used for genome modification. Overnight seeds cultures were grown in 250 mL 
flasks with 25 mL of MOPS minimal media with 2 wt% dextrose at pH 7±0.05, 37 ºC, and 250 
rpm. The overnight cultures were diluted to an optical density at 550 nm (OD550) of 0.05 for the 
octanoic acid tolerance test, or diluted to an OD550 of 0.1 for testing membrane leakage, 
membrane fluidity, cell hydrophobicity, and cell membrane composition. E. coli transformants 
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were grown in media at 37 ºC, or 30 ºC. Chloramphenicol (35 mg/L), ampicillin (100 mg/L), 
kanamycin (50 mg/L), or spectinomycin (50 mg/L) was added as needed.   
Whole-genome sequencing & verification of mutant genes 
The genomic DNA of ML1155, LAR1 and LAR2 was purified using the Qiagen Blood 
and Tissue kit. The Illumina Genome Analyzer II platform for high throughput sequencing was 
used for whole genome sequencing with 77 bp (base pair) paired-end reads as described (18). 
The softwares and algorithms used for genome assembly and obtaining the set of predicted 
mutations were previously described (18). Breseq version 0.26.1, a pipeline for finding mutations 
in microbial genomes, was used to analyze the short read data (23). Breseq aligns reads to a 
reference genome, in our case wild-type E. coli K-12 MG1655 U00096.2 (24), using the Bowtie2 
alignment algorithm (25). Genomes of the evolved and parent strains were aligned to the wild-
type genome and variations in the evolved strain that were not present in the parental were 
selected as mutations of interest to be verified with PCR and Sanger sequencing. 
The whole potential mutated gene sequence with additional 500 base pairs (bp) upstream 
and downstream sequences were verified in order to verify mutations with more confidence. All 
primers were designed by primer3 online software and synthesized by Integrated DNA 
Technologies (IDT). The size of PCR products was first checked on a 1% TAE agarose gel with 
1Kb plus DNA ladder (Invitrogen Life Science). Then PCR products were purified by QIAquick 
PCR purification kits (Qiagen) and submitted to Iowa State University DNA facility for DNA 
sequencing analysis. The sequencing result were compared with the MG1655 genome using the 
online Standard Nucleotide BLAST software. Verified mutations were double checked by 
repeating all steps above using the genome of evolved strain and parent strain separately as 
templates.  
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PCR-Restriction Fragment Length Polymorphism (PCR-RFLP) 
PCR-FRLP was employed to determine the chronological order of mutations during 
adaptive evolution. Cells cultures saved before every transfer during adaptive evolution were 
used as template DNA for PCR. For the rpoc (A1256C) mutation, the 660 bp DNA fragment 
which includes the mutant point was amplified by PCR with the primers rpoCCF, rpoCCR and 
DreamTaq Green PCR master mix 2X (Thermo Fisher Scientific). The PCR products were 
purified by DNA Clean & Concentration kit (Zymo). Approximately 10 µl of purified PCR 
products were digested with restriction enzyme BsaJI (New England Biolabs) according to the 
manufacturer’s instruction. The restriction fragments were separated on a 1% TAE agarose gel 
with 1Kb plus DNA ladder. The pair of primers basRCF and basRCR, and restriction enzyme 
SfcI were used for digesting basR PCR product and identify basR mutation. The basSCF and 
basSCR primers, and restriction enzyme FatI were used for identifying basS mutation. For the 
waaG mutation, waaGCF and waaGCR primers were needed.    
Genomic manipulations  
All genomic manipulations were carried out using either lambda red recombinase system 
(26) or CRISP-cas9 system (27). For the lambda red recombinase system, E. coli strains were 
first transformed by electroporation to harvest the pKD46 plasmid, and then the lambda red 
recombinases could be induced by adding L-arabinose (2 mM). The kanamycin resistance 
cassette was amplified from plasmid pKD4 by PCR using primers with flanking homologous 
regions for the target gene. The rpoC(1256A)+kan, and rpoC(1256C)+kan cassettes were 
synthesized by GenScript company. The purified PCR products were transformed into the 
electro-competent E. coli cells harboring pKD46, and the lambda red recombinase system was 
induced. The resulting kanamycin resistant colonies were screened for the successful gene 
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replacement by the PCR amplification, restriction enzyme digestion, and DNA sequencing. The 
scarless CRISPR-Cas9 approach was also applied to perform gene editing (27). 
Octanoic acid tolerance test 
Octanoic acid (C8) tolerance was determined by measuring OD550 every hour starring 
from two hours after inoculating, until growth get into stationary phase, twenty-four hours OD550 
was recorded as a metric of C8 tolerance test. Overnight seed cultures were inoculated into 250 
mL baffled flasks with 25 mL MOPS with 2.0 wt% dextrose with 10 mM octanoic acid (1.44 
g/L), at pH 7±0.05, 37 ºC, and 200 rpm. The control groups were growing in the same culture 
without exogenous octanoic acid.    
Fermentation for fatty acid production 
The strains transformed with the pJMY-EEI82564 plasmid were grown on LB plates with 
100 mg/L ampicillin and incubated at 30 ºC overnight. Individual colonies were cultured in 250 
mL flasks with 10 mL LB media and 100 mg/L ampicillin, at 30 ºC on a rotary shaker at 250 rpm 
overnight. Seed cultures were inoculated into 250 mL baffled flasks containing 50 mL of LB 
media with 1.5 wt% dextrose, 100 mg/L ampicillin, and 1.0 mM isopropyl-β-D-
thiogalactopyranoside (IPTG). The initial OD550 was approximately 0.1. The flasks were 
incubated in a rotary shaker at 250 rpm and 30 ˚C. At 6 h, 12 h, 24 h, 48 h, and 72 h, culture 
samples were saved for testing fatty acid titer. 
Determination of fatty acid titers 
Fatty acid production was quantified by fatty acid extraction and further derivatization 
from samples containing both media and cells. The FAMEs measured via an Agilent 6890 gas 
chromatograph coupled to an Agilent 5973 mass spectroscope (GC-MS) at the ISU W.M. Keck 
Metabolomics Research Laboratory, as previously described (28). Briefly, 1 mL culture was 
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transferred into a 2 mL microcentrifuge tube, 125 µL 10% NaCl (w/v), 125 µL acetic acid, 20 µL 
internal standard (1 µg/ µL C7, C11, C15 in ethanol), 500 µL ethyl acetate was added 
sequentially. The mixture was vortexed 30 s and centrifuged at 16,000×g for 10min. Then, 250 
µL of the top layer (contain free fatty acid) was transferred into a glass tube. For the fatty acid 
derivatization part, 2.25 mL 30:1 EtOH: 37% HCl (v/v) was added into the glass tube from fatty 
acid extraction part, incubated at 55 ºC for 1 hour, then cooled to room temperature. After this, 
1.25 mL ddH2O and 1.25 ml hexane were added, followed by vortexing and centrifugation at 
2,000×g for 2 min. The top hexane layer was then analyzed by GC-MS using the following 
programs: the initial temperature was set at 50 °C, holding for 1 min, with the following 
temperature ramp: 20 ºC/min to 140 ºC, 4 ºC/min to 220 ºC, and 5 ºC/min to 280 ºC with 1 
ml/min helium carrier gas. The relative retention factor of C7/C11/C15 was used to adjust the 
relative amounts of the individual fatty acids analyzed. The Enhanced Data Analysis (Agilent 
Technologies) and NIST 17 Mass Spectral Library software were used for peak identification. 
Extracellular polymeric substance (EPS) extraction and quantification 
The total extracellular protein and polysaccharide was determined by an extraction 
method (29). Briefly, E. coli cells were incubated on LB agar plates overnight at 37 ºC to obtain 
the total amount cell within the range of 2×1011 to 4×1011 cells. Then, cells were suspended in 30 
mL 0.85 wt% NaCl solution. Cell concentration was measured by the flow cytometry with 
CountBright absolute counting beads (ThermoFisher Scientific), at ISU Flow Cytometry Facility. 
The cell suspension was centrifuged at 16,300×g, at 4 ºC for 30 min, the supernatant was filtered 
through a 0.45 µm filter and 90 mL of ice-cold 100% ethanol were added. The mixture was 
incubated at -20 ºC for 24 h. Then, the EPS pellet was harvested by centrifuging at 16,300×g for 
30 min at 4 ºC and air-dried in a fume hood. The EPS pellet was resuspended in 20 mL DI water 
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and ready for the protein and sugar analysis. The Lowry method (30) was used to measure EPS 
protein, which is a spectrometric method based on measurement at a wavelength of 500 nm by 
using bovine serum albumin (Sigma-Aldrich, St. Louis, MO, USA) as the standard. The phenol-
sulfuric acid method was used to analyze EPS sugar, which is based on measurement at a 
wavelength of 488 nm using xanthan gum as the standard (31).  
Membrane characterization 
Membrane permeability: The seed culture was inoculated into 250 mL baffled flasks with 
25 mL MOPS media with 2 wt% dextrose, at 250 rpm and 37˚C. The cells were harvested at 
mid-log phase (OD550~1) followed by centrifugation at 4,500×g and 22 ºC for 10 min. Then, 
cells were treated with PBS with 10 mM octanoic acid at pH 7.0, incubated at 37 ºC for 1 hour. 
The control group treated with PBS without exogenous C8. Subsequently, cells were centrifuged 
at 4,500×g at 22 ºC for 10 min, washed twice with PBS, and resuspended in PBS at a final 
OD550~1. Then, 100 µL resuspended cells were diluted with 900 µL PBS. Cells were stained 
with 1 µL of 5 mM SYTOX green in dimethyl sulfoxide (Invitrogen, Carlsbad, CA) (16). 
Finally, cells were analyzed by flow cytometric on the BD Biosciences FACSCanto II, at ISU 
Flow Cytometry. About 18,000 events were tested per sample, and each sample had three 
parallel groups. 
Membrane fluidity: Membrane polarization was measured using 1, 6-diphenyl-1, 3, 5-
hexatirene as previously described (12, 32). Briefly, cells were treated as described in membrane 
permeability part. Cell pellets were resuspended in PBS at a final OD550~1. Then, transferred 500 
µL resuspended cells into a 1.5 mL centrifuge tube containing 500 µL of 0.4 µM DPH in PBS. 
The mixture was vortexed, and incubated at 37 ºC in dark for 30 min. Then the treated cells were 
centrifuged (5,000×g, 5 min) and the cell pellets were resuspended in 500 µL PBS. One hundred 
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µL of this mixture was transferred into sterile black-bottom Nunclon delta surface 96-well plate 
with 4 replicates. The suspension of cells without DPH treatment was used as control. Membrane 
fluorescence polarization values were determined based on vertical and horizontal fluorescence 
readings, which was assessed by the BioTek Synergy 2 Multi-Mode microplate reader at ISU 
W.M. Keck Metabolomics Research Laboratory. 
Cell surface hydrophobicity: The method of measuring cell surface hydrophobicity was 
based on the previously described procedure (33, 34). The mid-log cells were harvested and 
treated with MOPS with 2 wt% dextrose with or without 10 mM octanoic acid, at pH 7.0 and 37 
˚C with rotary shaking at 250 rpm for 1 hour. Then, cells were washed twice with PBS, and 
resuspended in PBS at a final OD550 ~ 0.6. Four mL cell suspension were added to a glass tube, 
and the OD550 was measured as OD1. Then, 1.0 mL dodecane was added, and the mixture was 
vortexed using a multi-tube vortexer (Thermo Fisher Scientific Inc., Waltham, MA, USA) at 
2500 rpm for 10 minutes to homogenize the aqueous and organic phases. The mixture were left 
to stand for 15 min to allow phase separation. The OD550 of the aqueous phase (OD2) as 
measured. Partitioning of the bacteria suspension is calculated as:  
Percent partitioning= [(OD1-OD2)/OD1]*100 
Membrane lipid composition: The mid-log cells were harvested and treated with MOPS 
with 2 wt% dextrose with or without 30 mM octanoic acid at pH 7.0, and incubated for 3 hours 
at 37 ºC. Then, cells were washed twice with cold sterilized water, and then resuspended in 6 mL 
methanol, transferred of 1.4 mL cells suspension into glass tubes with three replicates (35). 
Twenty μL of 1 µg/ µL C7, C11, C15 in methanol was added as internal standards. The mixtures 
were sonicated for three 30 s bursts, incubated at 70 ºC for 15 min, and cooled to room 
temperature. The cells were centrifuged at 4000×g for 5 min. The supernatant was transferred 
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into a new glass tube with 1.4 mL nanopure water, and the mixture was vortexed. 750 µL of 
chloroform was added to the cell pellet, followed by vortexing and shaking in a horizontal shaker 
at 150 rpm, 37 ºC for 5 min. The diluted supernatant was transferred back to the chloroform-
treated pellet. The mixture was vortexed for 2 min, then centrifuged at 3,000×g for 5min. The 
bottom chloroform layer which contain free fatty acid was transferred to a new glass tube. All 
solvent removed with an N-Evap nitrogen tree evaporator. For the fatty acid derivatization part, 2 
mL of 1N HCl in methanol was added to the dried samples, heated at 80 ºC for 30 min, then 
cooled to room temperature. Then, 2.0 mL 0.9 wt% NaCl and 1.0 mL hexane was added 
followed by vortexing for 2 min and centrifugation at 2,000×g for 2 min. The upper layer 
containing the hexane with FAMEs was transferred into a GC vial for analysis, using the method 
described above. The weight-average lipid length were calculated as previously described (12).  
Results and Discussion 
Verified mutations in evolved strains 
To identify mutations in evolved strains LAR1 and LAR2, the genomic DNA of ML115, 
LAR1, and LAR2 was sequenced by using the Illumina platform. We used the short-readers 
aligner, Bowtie and Velvet, to mapping the short-sequenced reads to the reference genome, 
MG1655. Potential mutations including single nucleotide polymorphisms (SNPs), deletions, 
insertions, and duplications could be identified by mapping short-sequenced reads of evolved 
strains, parent strain to the reference genome. Each potential mutation was verified by PCR and 
Sanger Sequencing. In summary, three insertions, respectively, in waaG gene, yeaJ gene, and 
yebB gene were verified in the genome of parent strain ML115. LAR1 was verified to contain 
two single amino acid changes, one was H419P in RpoC, another was D28Y in BasR gene, and 
the insertion in waaG gene was removed during adaptive evolution (Table 3). LAR2 was verified 
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to contain the same single amino acid change in RpoC (H419P), a 9-amino acids deletion in 
BasS, and the insertion in waaG gene was also removed (Table 3).  
The RpoC (H419P) mutation was identified in both evolved strains, which encodes the β' 
subunit of the RNA polymerase sigma 70 factor. The RNA polymerase sigma 70 factor interacts 
with sigma 70 promoter which controls expression of about 1000 genes in E. coli K-12 (36). 
Thus, this mutation in rpoC gene might widely affect the genes expression in the evolved strains. 
Different mutations in rpoC gene were found in other evolutionary studies of acid tolerance, and 
the mutated RpoC (V507L) contributed to increased acid-tolerant phenotype (37). It is highly 
possible the RpoC (H419P) mutation contributed to the increased C8 tolerance of the evolved 
strain. We also confirmed mutation in BasR (D28Y) in LAR1, which encodes the transcriptional 
regulator component of BasS/BasR system. The BasS-BasR two-component system is one of the 
two component signal transduction systems in E. coli which sense and respond to changes in 
environmental conditions (38). In an evolutionary study of n-butanol tolerance, overexpression 
of the basS gene increased n-butanol tolerance (14). Interestingly, nine amino acids deletion in 
BasS was verified in LAR2, which encodes sensory histidine kinase of the BasS/BasR system. 
The 768 base-pair insertions (InsB-5, InsA-5, and InsAB-5) in waaG gene in parent strain 
ML115 could stop the expression of WaaG and likely change the expression level of WaaP, 
WaaS, WaaS, WaaO, WaaJ, OmpR, and LrhA (Fig. 1). The WaaG is a lipopolysaccharide (LPS) 
glucosyltransferase I and adds the first glucose of the outer core of LPS (39). The deletion of 
waaG gene results in a truncated LPS core, loss of flagella pili (40), enhanced cell surface 
hydrophobicity, increased outer membrane permeability, and decreased ability of biofilm 
formation (41). The deletion of waaGPBI leads to a mucoid colony morphology (40), which is 
consistent with the morphological character of ML115 on LB plate (Fig. 2A). The TEM image of 
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ML115 showed cells have no flagella and pili (Fig. 2C). All verified mutations are of interest for 
further investigation of cell membrane properties.  
Identification of the chronological order of mutations  
Knowing the chronological order of mutations could provide a clear strategy to 
investigate each mutation and the synergistic interaction of these. The waaG gene has a 768 bp 
insertion sequence in the parent strain ML115, the waaG gene with insertion (1714 bp) and the 
restored waaG gene (946 bp) were identified. From Figure 3A, the fragment length of ML115 in 
lane 2 is 1714 bp, the fragment length of LAR1 in lane 17 is 946 bp. The cell population before 
the third transfer during adaptive evolution all had the restored waaG gene (Fig. 3A).  
The rpoC mutation A1256C could not be identified by fragment length like waaG 
mutation. However, combining PCR and digestion reaction with the restriction enzyme BsaJI, 
the rpoC mutation could be identified (Fig. 4A). The size of PCR produces of wild-type and 
mutant rpoC were both 660 bp. The restriction enzyme BsaJI was able to digest the wild-type 
rpoC fragment into two pieces 427 bp and 233 bp. The mutant rpoC fragment was digested into 
three pieces 208 bp, 219 bp, and 233bp. The PCR-RFLP results showed the parent strain ML115 
in lane 2 has two bands 427 bp and 233 bp, the evolved strain LAR1 in lane 17 has only one 
band around 200 bp. The cell population all had the mutant rpoC, before 13th transfer during 
adaptive evolution (Fig. 3B).  
The similar PCR and digestion reactions were able to design for basS and basR mutations 
(Fig. 4BC). However, according to the PCR-RFLP results, basS and basR mutations were not 
able to found in the cell population during adaptive evolution (Fig. 3CD). We hypothesize that 
basS and basR mutations showed up in the end of adaptive evolution, and the cells containing 
either basS mutation or basR mutation only were a small population. During adaptive evolution, 
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the chronological order of mutations occurred as follows: waaG mutation, rpoC mutation, and 
then basS or basR mutations. 
Investigation of the contribution of mutations on C8 tolerance  
Evolved strain LAR1 had significantly increased short-chain fatty acid tolerance 
phenotype relative to parent strain ML115 (7). In order to study the contribution of each 
mutation on C8 tolerance, we systematically constructed 12 strains, including strains with single 
mutation, double mutations, or triple mutations into the genome of parental strain ML115 (Table 
1). Firstly, we followed the chronological order of mutations to study their contributions on C8 
tolerance. The parent strain ML115 barely grew in MOPS with 2 wt% dextrose with 10 mM C8 
(Fig. 5A). With the restored waaG gene, the ML115+waaGInD strain showed clearly increased 
C8 tolerance (Fig. 5B). However, with exogenous 10 mM C8 challenging, the specific growth 
rate of ML115+waaGInD strain was only 0.39 h-1 (Table 3), which was lower than the specific 
growth rate of the evolved strain LAR1 (0.56 h-1). Then, the ML115+waaGInD+rpoC* strain 
showed further increased C8 tolerance relative to ML115+waaGInD (Fig. 5C). The specific 
growth rate of ML115+waaGInD+rpoC* strain was able to achieve 0.55h-1, with exogenous 10 
mM C8 challenging (Table 3). The reconstructed strain with restored waaG gene and mutant 
rpoC gene had the same level of increased C8 tolerance with the evolved strain LAR1 (Fig. 5 C-
E). In contrast, the reconstructed strain ML115+waaGInD+rpoC*+basR* showed no further 
increased C8 tolerance relative to the ML115+waaGInD+rpoC* (Fig. 5D). These results 
determine that the restored waaG gene and mutant rpoC gene are the two mutations mainly 
contributed on increased C8 tolerance of evolved strain LAR1.  
Then, we looked into other reconstructed strains to deepen the understanding of the 
contribution of mutations on C8 tolerance. The reconstructed strains YC002, YC003, YC004, 
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YC008, YC009 with disturbed waaG gene were not able to grow in MOPS media with 2 wt% 
dextrose with 10 mM C8 (Table 3). The reconstructed strains YC006, YC007, YC011 with wild-
type rpoC gene had specific growth rate lower than 0.4, with exogenous 10 mM C8 challenge. 
These results demonstrated that the chronological order of mutations was very important for 
reverse engineering the evolved strain. Following the order to investigate mutations could save 
more time when constructing strains and allowed us to have a better understanding of the 
evolved strains and the synergistic interactions of their mutations.      
The effect of identified mutations on fatty acid titer     
Since the reconstructed stains ML115+waaGInD and ML115+waaGInD+rpoC* 
demonstrated increased C8 tolerance when challenged with 10 mM C8, we tested their 
contribution to the increased short chain fatty acid production in the LAR1 strain. All strains 
contain plasmid pJMY-EEI82564 encoding the A. tetradius thioesterase (TE10), which primarily 
produces octanoic acid (42). The parent strain ML115 only produced about 80 mg/L fatty acid 
after 72 hours (Fig. 6A). The fatty acid titer of ML115+waaGInD was approximately 188 mg/L 
(Fig. 6A). The ML115+waaGInD+rpoC* strain was able to produce 782 mg/L fatty acid, as 
much as the evolved strain, which had a 9-fold increase in fatty acid production relative to parent 
strain (Fig. 6A). The OD550 value for the ML115+waaGInD+rpoC* and LAR1 had more than 
4.4-fold increase relative to the parent strain over the 72 hours fermentation (Fig. 6B). Thus, the 
9-fold increase in fatty acid production cannot solely be attributed to increased biocatalyst 
abundance. 
Parental strain ML115 had dramatic high content of EPS polysaccharides      
The waaG gene encodes to the lipopolysaccharide (LPS) glucosyltransferase I, which 
adds the first glucose of the outer core of LPS (39). We did extraction and quantification of the 
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two major components of the extracellular polymeric substance (EPS); polysaccharides and 
proteins, to determine if the disturbed waaG gene had an effect on the content of EPS. The cells 
of parent strain ML115 with disturbed waaG gene had dramatic high content of polysaccharides, 
about 2.8 µg/ (108 cells), which was at least 12-fold higher than the strains with restored waaG 
gene (Fig. 7). The parent strain ML115 with disturbed waaG gene should only have the inner 
core of LPS while the strains with restored waaG gene should have the complete LPS. These 
results indicate that the cells of parent strain ML115 have a large increase amount of LPS with 
only inner core part relative to strains with restored waaG gene. We have hypothesized that the 
strain with disturbed waaG gene has only inner core of LPS and this might lead to these mutant 
cells to overexpress all additional genes related to LPS synthesis as a defense mechanism to 
overcome the lack of inner core.  
Identified mutations had an effect on the cell membrane properties       
      It is known that cell membrane characterization is very important in the study of 
increasing microbial tolerance and production of biorenewable fuels and chemicals (8, 10, 16, 
42–44). From previous studies, the cell membrane damage is the main mechanism of short-chain 
fatty acid toxicity (7, 11, 12). The evolved strain LAR1 had improved membrane integrity 
relative to parent strain ML115 is reported in literature (7). Here, we did cell membrane 
characterization of ML115+waaGInD, ML115+rpoC*, ML115+basS* and ML115+basR* 
strains, to understand how each mutation was able to alter the cell membrane properties. In order 
to study the synergistic interaction of mutations on cell membrane, we also did the same cell 
membrane studies to ML115+waaGInD, ML115+waaGInD+rpoC* and 
ML115+waaGInD+rpoC*+basR* strains.  
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We used SYTOX Green to assess membrane permeability, where permeability to this 
compound indicates a damaged membrane. Then SYTOX-permeable and SYTOX-impermeable 
cells population could be separated and quantified by flow cytometry. This analysis showed 88% 
of the parent strain ML115 population became SYTOX-permeable in the 0 mM C8 control 
condition and 10 mM C8 treatment condition (Fig. 8). In accordance to our tolerance results, the 
ML115+waaGInD, ML115+waaGInD+rpoC*, ML115+waaGInD+rpoC*+basR* and LAR1 
strains with restored waaG gene, had less than 20% of SYTOX-permeable population, (Fig. 8A). 
These results determined parent strain ML115 has a serious membrane leakage problem and that 
by restoring the waaG gene this particular condition could be solved. This is consistent with 
previous reports demonstrating that deletion of waaG gene in E. coli increased outer membrane 
permeability (41). We also noticed that with only the rpoC mutation, the strain still had high 
percentage of SYTOX-permeable population (Fig. 8B). Interestingly, the SYTOX-permeable 
populations of ML115+basS* and ML115+basR* strains were lower than 65.4 %, only when the 
cells were challenged with exogenous 10 mM C8. These results indicated that strains with either 
basS or basR mutations had increased ability to adjust the 10 mM C8 challenge condition by 
preventing cell membrane leakage problem.    
The evolved strain LAR1 had significantly higher membrane polarization than the parent 
strain in the temperature range from 30-45 ºC (7), which corresponds to lower membrane fluidity 
and higher membrane rigidity. Here, we tested cell membrane polarization of the strains with and 
without 10 mM C8 exogenous challenge. In accordance to previous reports, the evolved strain 
LAR1 had significantly higher membrane polarization relative to parent strain ML115 in both 
conditions (Fig. 9A). This increased membrane polarization was likely mainly caused by the 
synergistic interaction of the three identified mutations under the control condition (Fig. 9A). In 
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contrast, none of the constructed strains with single mutations was able to recreate the same level 
of increased membrane polarization exhibited by the evolved strain LAR1 (Fig. 9B).  
In order to have a better understanding of the changes in cell membrane, we quantified 
the cell membrane lipid composition of the reconstructed strains, cells were treated with or 
without 30 mM C8 challenge. The evolved strain had significantly increased weight-average 
lipid length relative to parent strain (Fig. 10A), which is consistent with our previous report (7). 
Interestingly, the ML115+rpoC* strain had the same weight-average lipid length as LAR1 in 
both conditions (Fig. 10B). We also noticed that the parental strain with restored waaG gene had 
significantly increased weight-average lipid length relative to parent strain (Fig. 10B). The basS 
and basR mutations had no consistent effect on weight-average lipid length in both conditions.  
Increasing weight-average lipid length could be a strategy for potentially enhancing membrane 
integrity.       
From previous report, the deletion of waaG gene resulted in enhanced cell surface 
hydrophobicity (41). Thus, we measured the surface hydrophobicity of the reconstructed strains 
to study whether these mutations lead to changes in cell surface hydrophobicity. In both control 
and 10 mM C8 conditions, the parent strain ML115 had very low cell surface hydrophobicity 
(1%) (Fig. 11A). The cell surface hydrophobicity of evolved strain was significant higher than 
ML115 in control condition and 10 mM C8 condition (Fig. 11A). This large increase in cell 
surface hydrophobicity of evolved strain LAR1 was likely caused by the synergistic interaction 
of the identified three mutations (Fig. 11A). Especially, in the 10 mM C8 condition, none of the 
parent stains with single mutations had that large increase in cell surface hydrophobicity (Fig. 
11B). 
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The evolved strain had significant differences compared to the parent strain in all cell 
membrane characterization parameters we studied. We were pleased to see all mutations 
contributed to at least one cell membrane property. Cell membrane leakage could be prevented 
by restoring the waaG gene and this was the most helpful mutation for membrane integrity. We 
also noticed that the basS and basR mutations can partially mitigate the membrane leakage 
problem in the 10 mM C8 condition. The increased membrane polarization and cell surface 
hydrophobicity were caused by the synergistic interaction of waaG, rpoC and basR mutations. 
The restored waaG gene and mutant rpoC gene had effect on increasing the weight-average lipid 
length. The characterization of the cell membrane properties in the reconstructed strains provided 
new strategies for altering significantly the cell membrane polarization (fluidity), cell membrane 
lipid composition, and the cell surface hydrophobicity.     
Conclusions 
In this genome-level reverse engineering study, we have described the four mutations we 
verified in the evolved strains and the chronological order of mutations during adaptive 
evolution. We were able to recreate the changed phenotypic of the evolved strain by replacing 
mutations into the genome of the parent strain. We revealed how much each mutation and their 
synergistic interaction contributed on increased short-chain fatty acid tolerance, 9-fold increase 
in fatty acid titer, big change of EPS polysaccharides, and altering cell membrane 
characterizations. We noticed that the mutant rpoC gene plays a very important role for 
increasing tolerance and production, and for changing cell membrane properties. The RNA 
polymerase β’ subunit (rpoC) could impact the expression level of more than 1000 genes E. coli. 
It is very interesting to us to further investigate the rpoC mutation by transcriptome analysis, 
which will be discussed in forthcoming publications.      
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Table 1. Strains used in this study 
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Table 2. Plasmids used in this study 
 
Table 3. Identified mutations in evolved strains 
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Table 4. Contribution of mutations to increased C8 tolerance phenotype 
“*” indicates that gene in the specific strain is the mutant-type gene.  
aLog phase: recorded the hour when cell growth get into log phase, and the hour of  last time point in the log phase. 
bInflection OD: recorded the value of OD550 and the hour of first time point in the stationary phase. 
c24 h OD: recorded the value of OD550 at 24 hours. 
ND: Not Detected. 
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Figures 
 
 
 
 
Figure 1. Parent strain ML115 has a 768 bp insertion sequence in the waaG gene (45).  
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Figure 2. The colony morphology and TEM images of the parent strain ML115 and evolved 
strain LAR1.  
(A) the colony morphology of ML115; (B) the colony morphology of LAR1; (C) The TEM 
image of ML115; (D) the TEM image of LAR1.    
 
 
Colony morphology of LAR1 
(B) Functional WaaG  
(C) Non-functional WaaG  
TEM image of ML115 
(D) Functional WaaG  
TEM image of LAR1 
(A) Non-functional WaaG  
Colony morphology of ML115 
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(B) Representative RFLP genotypes of the rpoC gene fragment 
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(C) Representative RFLP genotypes of the basS gene fragment 
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(D) Representative RFLP genotypes of the basR gene fragment 
107 
 
 
Figure 3. PCR-Restriction Fragment Length Polymorphism uses to determine the order of 
mutations in evolved strains. Representative RFLP genotypes of the waaG, rpoC, basS, and basR 
genes fragment analysis using 1% agarose gel electrophoresis.  
Lanes 1 and 18 refer to the 1 Kb Plus DNA Ladder (Invitrogen); lane 2 refers to the genotype of 
parent strain ML115; from lanes 3 to lanes 16 refers to the genotypes of cell populations which 
from the culture we saved before each serial transfer during adaptive evolution; lane 17 refers to 
the genotype of evolved strain LAR1. (A) The waaG mutation; (B) The rpoC mutation; (C) The 
basS mutation; (D) The basR mutation. 
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Figure 4. Design strategy for applying PCR-Restriction Fragment Length Polymorphism to 
determine the order of mutations in evolved strains.  
(A) The rpoC mutation; (B) The basS mutation; (C) The basR mutation. Each mutation has a 
specific restriction enzyme, which can be used to determine if the gene is mutant or not. The 
primers for PCR are highlighted in purple; blue fonts are the sequences which can be cleaved by 
the specific restriction enzyme; bold fonts are the mutant positions. 
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Figure 5. Exogenous 10 mM C8 tolerance test of (A) ML115; (B) ML115+waaGInD; (C) 
ML115+waaGInD+rpoC*; (D) ML115+waaGInD+rpoC*+basR*; E) LAR1.  
Growth curve of all strains were measured in MOPS with 2.0 wt% dextrose with or without 
exogenously 10 mM C8 at pH 7.0, 200 rpm, and 37 ºC. 
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Figure 6. The restored waaG gene and mutant rpoC gene contribute to the increased fatty acid 
titer of the evolved strain LAR1.  
Four strains contain plasmid pJMY-EEI82564 encoding the A. tetradius thioesterase (TE10). 
Strains were grown for 72 h in LB with 1.5 wt% dextrose at 30 ºC, 250 rpm with 100 mg/L 
ampicillin and 1.0 mM IPTG. (A) Fatty acid titer after 72 hours. (B) Strain growth during 72 
hours. Values are the average of three biological replicates, with error bars indicating one 
standard deviation. 
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Figure 7. The extracellular polymeric substances (EPS) analysis of ML115, ML115+waaGInD, 
ML115+waaGInD+rpoC*, ML115+waaGInD+rpoC*+basR*, and LAR1.  
The parent strain ML115 with disturbed waaG gene had more than 10-fold extracellular 
polymeric polysaccharides relative to the strains with restored waaG gene.* Indicates a 
significant difference (p ≤ 0.05) between LAR1 with other strains. 
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Figure 8. The cell membrane leakage of (A) ML115, ML115+waaGInD, 
ML115+waaGInD+rpoC*, ML115+waaGInD+rpoC*+basR*, and LAR1; (B) ML115, the 
constructed strains with each single mutant gene, and LAR1.  
The cell membrane leakage problem was solved by repairing the non-funational WaaG; the 
mutant basS* and basR* partially contributes on solving the membrane leakage problem when 
treating cells with exogenous 10 mM C8 challenge. * Indicates a significant difference (p ≤ 0.05) 
between LAR1 with other strains. 
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Figure 9. The cell membrane polarization of (A) ML115, ML115+waaGInD, 
ML115+waaGInD+rpoC*, ML115+waaGInD+rpoC*+basR*, and LAR1; (B) ML115, the 
constructed strains with each single mutant gene, and LAR1.  
The difference of cell membrane polarization between ML115 and LAR1 was contributed by the 
synergistic interaction among the 3 mutations. * Indicates a significant difference (p ≤ 0.05) 
between LAR1 with other strains. 
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Figure 10. The weight-average lipid length of (A) ML115, ML115+waaGInD, 
ML115+waaGInD+rpoC*, ML115+waaGInD+rpoC*+basR*, and LAR1; (B) ML115, the 
constructed strains with each single mutant gene, and LAR1.  
The restored waaG gene and mutant rpoC gene both contributes to increased weight-average 
lipid length of evolved strain LAR1. * Indicates a significant difference (p ≤ 0.05) between 
LAR1 with other strains 
 
 
 
116 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. The cell surface hydrophobicity of (A) ML115, ML115+waaGInD, 
ML115+waaGInD+rpoC*, ML115+waaGInD+rpoC*+basR*, and LAR1; (B) ML115, the 
constructed strains with each single mutant gene, and LAR1. 
The difference of cell surface hydrophobicity between ML115 and LAR1 was contributed by the 
synergistic interaction of the 3 mutations. 
* Indicates a significant difference (p ≤ 0.05) between LAR1 with other strains. 
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Introduction 
Engineering microbial biocatalyst for producing biorenewable fuels and chemicals is an 
increasingly important area of research. Progress in biorenewable fuel and chemical research can 
contribute to a decreased reliance on petroleum derived compounds. Fatty acids are a valuable 
biorenewable chemical in industrial application as multifunctional precursors, which be 
converted to alkanes (1, 2), α-olefins (3, 4), and fatty acid methyl or ethyl esters (5). Short-chain 
fatty acids (SCFAs) are also directly used as food-preservatives (6, 7) and dietary supplements 
(8). As a food-preservative, SCFAs are toxic to microbes, which could inhibit cell growth and 
the fermentation performance (9–14). Many efforts have been made to address E. coli inhibition 
by SCFAs (9–12, 15). Our group focused on improving the SCFAs tolerance and production in 
E. coli by adaptive laboratory evolution (10) and understanding the mechanisms of inhibition and 
increased tolerance by reverse engineering.         
After the adaptive laboratory evolution, we obtained an evolved strain LAR1, which had 
a significant increase in SCFAs (C6-C10) tolerance and could produce at least 5-fold fatty acids 
relative to the parent strain ML115 (10). In order to understand the mechanisms of the beneficial 
phenotypes of the evolved strain, we applied the genome-level reverse engineering for further 
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investigation. We identified three mutations in LAR1 strain and studied the contributions of each 
mutations or their synergistic interaction. We found that the RpoC (H419) mutation contributed 
to the increased C8 tolerance and the increased fatty acid titer. The BasR (D28Y) mutation was 
able to partially mitigate the membrane leakage problem of cells in 10 mM C8 and the BasR 
(D28Y) mutation also increased the cell surface hydrophobicity. However, the two mutations 
encode transcriptional regulators, which cloud results in altering expression level of many genes 
in LAR1 (16–19).Transcriptome analysis is a powerful tool that has been used in the 
investigation of evolved strains, especially the evolved strains with mutations related to 
regulators (20–23).Thus, we decided to utilize transcriptome analysis for further investigation of 
the evolved strain LAR1. In this work, we aimed to reveal how the rpoC and basR mutations 
lead to phenotypic changes in short-chain fatty acid-tolerance.     
Materials and Methods 
Strains, plasmids and bacterial cultivation   
 All bacterial strains and plasmids used in this study are listed in Table 1 and Table2. All 
E. coli strains were grown overnight in 10 mL of MOPS minimal media with 2% glucose in 250 
mL flasks, at 37 ºC with 250 rpm. The overnight culture was diluted to OD550 of 0.05 for the 
octanoic acid (C8) tolerance test, or diluted to OD550 of 0.1 for testing membrane leakage, 
membrane fluidity, cell hydrophobicity, and cell membrane composition. E. coli transformants 
were grown in media at 37 ºC or 30 ºC, with chloramphenicol (35 mg/L), ampicillin (100 mg/L), 
kanamycin (50 mg/L), or spectinomycin (50 mg/L) as needed.   
Genomic manipulations 
The scarless CRISPR-Cas9 approach was applied to knock out the genes in LAR1 and 
ML115+waaGInD strains (24).  
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Octanoic acid tolerance test 
Octanoic acid tolerance was determined follow the same procedures in Chapter 4. 
Fermentation for fatty acid production 
The fatty acid production strains harboring the pJMY-EEI82564 plasmid (10) by 
electroporation were grown on LB plates with ampicillin (100 mg/L) and incubated at 30 ºC 
overnight. Individual colonies were inoculated into 10 mL LB media with ampicillin (100 mg/L) 
in 250 mL flasks at 30 ºC and 250 rpm for overnight. Seed cultures were then inoculated into 500 
mL flasks containing 100 mL of LB media with 1.5% dextrose, ampicillin (100 mg/L), and 
isopropyl-β-D-thiogalactopyranoside (IPTG) (1.0 mM) at an initial OD550 of 0.1. The flasks were 
incubated in a rotary shaker at 200 rpm and 30 ºC for 72 hours.  
Two mL of culture samples at 6 h, 12 h, 24 h, 36 h, 48 h, and 72 h were saved in -20 ºC 
refrigerator for testing fatty acid titer and glucose consumption. OD550 and pH of media was 
tested at each time point. Simultaneously, saved cell pellets (OD550=1.5) were first frozen in 
liquid nitrogen and then stored in -80˚C for total RNA isolation. 
Determination of fatty acid titers 
Fatty acid extraction and derivatization follow the same procedures in Chapter 4, as well 
as the GC-MS analysis (25). 
Determination of glucose consumption 
One mL saved culture samples were first centrifuged at 1450×g for 3 min, and the 
supernatant were filtered (0.45 µm pore size) followed by HPLC analysis. The HPLC system 
equipped with Aminex HPX-87H column and RID detector (Waters, Milford, MA). The 
program was as follows: 5 mM sulfuric acid was used as mobile phase; flow rate was 0.3 
mL/min; sample size was 10 µL; column temperature at 30 ºC; and running time was 30 
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min/sample. RID peak area were compared to a glucose standard curve to determine the 
concentration of glucose. 
RNA isolation  
Total RNA was isolated from saved cell pellets sampled at 6 h, 12 h and 24 h using 
RNeasy mini kit (Qiagen, Valencia, CA). Then genomic DNA contamination was removed by 
Turbo DNA-free kit (Life Technologies, Carlsbad, CA) followed by the verification of total 
RNA using Agilent 2100 Bioanalyzer, and RNA 600 Nano total RNA kit (Agilent, Santa Clara, 
CA). Ribosomal RNA (rRNA) was removed by Ribo-Zero (Bacteria) Magnetic kit (Illumina, 
San Diego, CA), and then massage RNA (mRNA) was purified and concentrated by the Rneasy 
MinElute Cleanup kit (Qiagen, Valencia, CA). Again, Agilent 2100 Bioanalyzer and RNA 6000 
Pico mRNA kit (Agilent, Santa Clara, CA) were used to verify the mRNA sample, which should 
not contain rRNA. All procedures were followed the manufacturers’ user guide.  
Analysis of RNA-seq data 
Single-end, directional RNA-Seq was performed by the Iowa State University DNA 
facility using the Illumina HiSeq 3000 platform with reads 100 base pairs (bp) in length. 
Reference-based assembly was performed using Rockhopper2 (version 2.0.3), which is designed 
specifically for bacterial systems (26). We created a reference transcriptome was corresponding 
to pJMY-EEI82564 that contained sequences of genes on the plasmid. Both de novo assembly 
and alignment to E. coli K-12 MG1655 (version U00096.3) (27, 28) reference transcriptome and 
pJMY-EEI82564 transcriptome were performed, which represented a combined 4,321 
transcripts. Assembled RNA transcripts were used to further validate previously predicted 
genomic mutations. 
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Raw read counts from the Rockhopper2 assembly were analyzed with DESeq2 version 
1.20.0 (29), a statistical package for differential expression analysis in R version 3.5.0.1. DESeq2 
was used to normalize raw count data and to test for differential expression between conditions 
and calculate pairwise log2 fold change (LFC). Differential expression analysis was performed in 
a pair-wise manner for strain contrasts at each time point and with each plasmid treatment. 
Differentially expressed genes were those with False Discovery Rate (FDR) adjusted p-value < 
0.05. 
Annotations from EcoCyc (30) and RegulonDB (31) were used to identify genes with 
promoters associated with sigma factor 70 or belonging to the BasS-BasR regulon. Gene 
Ontology (GO) enrichment was performed to identify trends in gene function and localization 
annotations (Gene Ontology Consortium validation date 12/21/2015). Gene lists were analyzed 
for overrepresented GO terms in the biological process, cellular component, and molecular 
function ontologies using BiNGO and a significance level of FDR corrected p-value < 0.05. 
E. coli Variant Analysis (EVA) software was used to generate a gene regulatory and 
metabolic network that reflected mutated features and downstream biological elements. Onto the 
network, we applied fold change data for strain contrasts to visualize altered transcript 
abundance for genes in the BasR regulon. We additionally modified EVA for use with candidate 
gene lists. Given a list of genes as input, we generated a gene regulatory and metabolic network 
to find potential interactions among perturbed genes. 
Membrane characterization 
Membrane permeability (32), membrane fluidity (9, 33), cell surface hydrophobicity (34, 
35) and membrane fatty acid lipid composition (36) were assessed by following the same 
producers in Chapter 4.   
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Results and Discussion 
Phenotypes of strains during fatty acid fermentation  
We first compared the cell growth during short-chain fatty acid production of parent 
strain ML115 and evolved strain LAR1 with pJMY-EEI82564 or pJMY-Empty (Figure 1A). 
LAR1 with pJMY-EEI82564 had the highest OD550 after 24 hours, which was 3.2, then 
decreased to 2.9 after 72 hours. ML115 with pJMY-EEI82564 reached the highest OD550 after 12 
hours, which was 1.4, then decreased to 1.3 after 72 hours. LAR1 and ML115 with pJMY-Empty 
reached stationary phase after 12 hours with an OD550 of 1.8 and 2.1, then slightly increased to a 
final OD550 of 2.2 and 2.5. The LAR1 with pJMY-EEI82546 had the fastest growth and highest 
OD550 relative to other strains, even comparing with the LAR1with pJMY-Empty, which 
indicated the LAR1 grew even better when the cells producing toxic short-chain fatty acid.  
LAR1 strain with pJMY-EEI82564 could achieve the highest fatty acid titer 420 mg/L, 
which was 3-fold higher than that of ML115 with pJMY+EEI82564 (Figure 1B.) The fatty acid 
titer of LAR1 and ML115 with pJMY-Empty was about 35 mg/L. The strains with pJMY-
EEI82564 mostly produced the free fatty acids C4, C6, C8:0, C8:1, C10:0, C10:1, C12:1, C12:0, 
C14:1, C14:0, C16:1, C16:0, C18:1, and C18:0, with the C8 and C16 as the primary components 
(Figure 1E). The strains with pJMY-Empty mostly produced free fatty acids C14:0, C16:1, 
C16:0, C18:1, and C18:0, with the C16:0 and C18:0 as the primary components (Figure 1E).  
LAR1 and ML115 strains with pJMY-EEI82564 consumed glucose mainly between 6 to 
24 hours, and the glucose consumption rate was 0.35 g/L/h and 0.14 g/L/h, respectively (Figure 
1C). Contrastingly, LAR1 and ML115 strains with pJMY-Empty consumed the most glucose 
during the lag and log phases (0 - 24 hours), the glucose consumption rate is 0.107 g/L/h and 
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0.165 g/L/h, respectively. After 24 hours, the glucose consumption was stopped for all the four 
strains.  
We also tested the pH of the fermentation media at different time points for all the strains 
(Figure 6D). Surprisingly, LAR1 with pJMY-EEI82564 was able to maintain the pH above 5.4, 
which had the highest short-chain fatty acid titer. The pH of the fermentation media of LAR1 
with pJMY-Empty, LAR1 and ML115 with pJMY-EEI82564 were below 4.85 after 72 hours. 
For the transcriptomic analysis, samples from the 6 hours, 12 hours, and 24 hours were 
selected. The three time points were selected to include one sample from each of the three main 
phases of growth: the lag phase, the log phase, and the stationary phase. After 24 hours, the 
OD550 value, the fatty acid titer, and the glucose concentration of the four strains were stable.  
Identifying the potential impacts of rpoC mutation  
Differentially expressed genes were identified for relation to the rpoC mutation by 
examining if they are known to be associated with sigma factor 70. Firstly, we identified genes 
that have a statistically significant and either consistently positive or negative fold change across 
at three time points between LAR1+pJMY-Empty and ML115+pJMY-Empty, and also between 
LAR1+pJMY-EEI82564 and ML115+pJMY-EEI82564. Fifty-eight genes had lower transcript 
abundance and forty-three genes had higher transcript abundance in LAR1 versus ML115. These 
sets of genes were filtered based on if they had a promoter that is associated with sigma factor 
70, resulting in thirteen downregulated and sixteen upregulated genes (Table 3). 
We decided to investigate the genes with either minimal fold changer (MFC) smaller than 
0.5, or MFC larger than 1.9 (Table 3), by knocking out individual genes or the whole operons in 
the genome of ML115+waaGInD strain (Table 1). Surprisingly, the waaG gene had fold changer 
0.44, which indicates the expression level of waaG gene is higher in the parent strain ML115 
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relative to the evolved strain LAR1. However, from the previous study, we identified an 
insertion sequence in the waaG gene in the genome of ML115. Further investigation of the waaG 
gene has been done and reported in Chapter 4. Thus, the waaG gene was excluded from the gene 
list for further investigation.    
We considered that genes with sigma 70 promoters could also be influenced by other 
mutations in LAR1. We analyzed the gene regulatory network generated by EVA for the basR 
mutations and included the next three levels of gene regulation, which included 130 genes. When 
cross-referencing the list of genes downstream of these mutations with the differentially 
expressed genes mentioned above, we identified osmY and fliR genes as being indirectly 
regulated by the BasR transcription factor. In the case of osmY, BasR is a transcriptional 
activator for csgD (18). CsgD represses transcription of fliZ (37), and FliZ represses transcription 
of csgD and osmY. For fliR(38, 39), BasR activates transcription of qseB (40), QseB is believed 
to activate transcription of flhC and flhD (41), and FlhDC is a transcriptional activator for fliR 
(42). In both cases, it is possible that the differences in transcript abundance between strains are 
indirectly affected by the basR mutation. 
GO enrichment highlighted the relationship between fdnH and fdnI as components of the 
formate dehydrogenase complex but did not give insight into larger trends among the genes. 
Because these genes are in the same operon and co-transcribed, it is not surprising that they 
appeared in the same list. Other operons that appeared in our analysis include yfiRNB, fadAB, 
and hofBC. The hofBC genes have sequence similarity to protein secretion and fimbrial assembly 
genes (43) and yfiRNB genes is involved in exopolysaccharide biosynthesis in Pseudomonas 
aeruginosa. Thus, we decided to knock out the fdnGHI, yfiRNB, fadAB, and hofBC operons in 
130 
 
the genome of ML115+waaGInD strain, instead of knocking out each gene for further 
investigation (Table 1). 
Identifying the potential impacts of basR mutation 
Differentially expressed genes were compared with genes in the BasS-R regulon and up 
to three downstream levels of transcriptional regulation. In order to investigate genes in the BasR 
regulon, we used EVA to construct a gene regulatory and metabolic network that represented 
genes downstream of the transcription factor and included additional transcriptional regulation 
activities. Genes with consistent and statistically significant fold changes at three time points 
between LAR1+pJMY-EEI82564 and ML115+pJMY-EEI82564 were listed in Table 3. We 
decided to investigate the genes with either MFC smaller than 0.5, or MFC larger than 2.0 (Table 
4), by knocking out individual genes or the whole operons in the genome of LAR1 strain (Table 
1). From previous a report, overexpression of arnB gene in strain BW25113 significantly 
increased n-butanol tolerance (19). In our study, the analysis results showed some of the genes in 
arn operon had significant fold changes (p≤0.05) at 12 hours and /or 24 hours. We decided to 
knock out the arnABCDTEF operon in the genome of LAR1 strain for further investigation 
(Table 1). 
Impact of ∆bssS on C8 tolerance   
The reconstructed strain ML115+waaGInD+∆bssS had higher specific growth rate in 
MOPS with 2 wt% glucose without C8 challenging relative to ML115+waaGInD and 
ML115+waaGInD+rpoC* (Figure 2A). The ML115+waaGInD+∆bssS and 
ML115+waaGInD+rpoC* strains had similar OD550 at 24 hour. The specific growth rate of 
ML115+waaGInD+∆bssS in MOPS with 2 wt% glucose with 10mM C8 is 0.44 h-1, which is 
higher than ML115+waaGInD, but still lower than ML115+waaGInD+rpoC* (Figure 2B). The 
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OD550 of ML115+waaGInD+∆bssS and ML115+waaGInD at 24 hours was approximately 1.5, 
which was significantly lower than the OD550 of ML115+waaGInD+rpoC* at the same time. 
When challenged with 10 mM C8, the bssS knockout mutant only had increased specific growth 
rate but did not have higher OD550 compared to the ML115+waaGInD strain. It was still strong 
evidence that knocking out the bssS gene in ML115+waaGInD is able to increase the C8 
tolerance which could be caused by the rpoC mutation.      
Conclusion and Further Plan 
In this present work, in order to have a better understanding of the RpoC (H419) and 
BasR (D28Y) mutations, we further investigated the evolved strain LAR1 by transcriptome 
analysis during fatty acid production. Twenty-nine genes were identified that could be influenced 
by rpoC mutation, which had consistent and statistically significant fold changes between 
LAR1+pJMY-EEI82564 and ML115+pJMY-EEI82564, and between LAR1+pJMY-Empty and 
ML115+pJMY-Empty, at 6 hours, 12 hours, and 24 hours. We decided to start with studying the 
genes with MFC smaller than 0.50 or MFC larger than 1.90, by knocking out the genes or the 
operons in the genome of ML115+waaGInD strain. Nine genes were targeted that could be 
impacted by the basR mutation, which had consistent and statistically significant fold changes 
between LAR1+pJMY-EEI82564 and ML115+pJMY-EEI82564, at 6 hours, 12 hours, and 24 
hours. The genes with MFC smaller than 0.50 or MFC larger than 2.0 were selected for further 
investigation. We decided to knock out the genes or the operons in the genome of the LAR1 
strain.  
Firstly, we will test C8 tolerance of all reconstructed strains to identify the genes impact 
on C8 tolerance. Then we will identify the genes which not only impact C8 tolerance but also 
influence on the fatty acid production, by testing the fatty acid production of the screen out 
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strains from tolerance study. Finally, we will further study the genes which contribute to both 
increased C8 tolerance and improved fatty acid production to understand the mechanisms of 
rpoC mutation and basR mutation.  
With this study, we can identify the genes which could increase short-chain fatty acid 
titer and improve fatty acid production by altering the expression level. Thus, we are able to 
understand the mechanisms of the beneficial phenotypes of evolved strain LAR1. There are a 
few genes of unknown function in the interesting gene list. We may able to characterize the 
protein function of these genes.       
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Tables 
Table 1. Strains used in this study 
 
 
 
134 
 
 
Table 2. Plasmids used in this study 
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Table 3. Genes with consistent and statistically significant fold changes at three time points 
between LAR1+pJMY-Empty and ML115+pJMY-Empty, and between LAR1+pJMY-EEI82564 
and ML115+pJMY-EEI82564, which could be affected by the mutant rpoC gene. 
MFC: The minimal fold change is the smallest fold change in three time points. 
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Table 4. Genes with consistent and statistically significant fold changes at three time point 
between LAR1+pJMY-EEI82564 and ML115+pJMY-EEI82564, which could be affected by the 
mutant basR gene. 
MFC: The minimal fold change is the smallest fold change in three time points. 
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Figure 1. Strains characteristics during fatty acid production. Strains containing plasmid pJMY-EEI82564 or pJMY-Empty were 
grown for 72 hours. (A) Growth; (B) Total fatty acid titer (mg/L); (C) Glucose concentration in medium (g/L); (D) pH of the medium; 
(E) Relative distribution, by weight. 
Values are the average of four biological replicates, with error bars indicating one standard deviation. 
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Figure 2. Knock out the bssS gene in ML115+waaGInD strain did effect on the growth in MOPS 
media with 2% glucose with 0 mM or 10 mM octanoic acid at 37 ºC. (A) Control group medium 
without C8; (B) Challenging group with 10 mM C8. 
Values are the average of three biological replicates, with error bars indicating one standard 
deviation. The line of fit when estimating the specific growth rate had an R2 value ≥0.9. 
 
Specific Growth rate (h-1) 
ML115+waaGInD: 0.53 
ML115+waaGInD+∆bssS: 0.61 
ML115+waaGInD+rpoC*: 0.57 
Specific Growth rate (h-1) 
ML115+waaGInD: 0.39 
ML115+waaGInD+∆bssS: 0.44 
ML115+waaGInD+rpoC*: 0.55 
140 
 
Reference 
1.  Lopez-Ruiz J.A., Davis R.J. 2014. Decarbonylation of heptanoic acid over carbon-
supported platinum nanoparticles. Green Chem 16:683–694. 
2.  Korstanje T.J., Vlugt J.I., Elsevier C.J., Bruin B. 2015. Hydrogenation of carboxylic 
acids with a homogeneous cobalt catalyst. Science (80- ) 350. 
3.  Chatterjee A., Jensen V.R. 2017. A heterogeneous catalyst for the transformation of fatty 
acids to α-olefins. ACS Catal 7. 
4.  Tee T.W., Chowdhury A., Maranas C.D., Shanks J.V. 2014. Systems metabolic 
engineering design: Fatty acid production as an emerging case study. Biotechnol Bioeng 
111:849–857. 
5.  Steen E.J., Kang Y.S., Bokinsky G., Hu Z.H., Schirmer A., McClure A., Cardayre S.B., 
Keasling J.D. 2010. Microbial production of fatty-acid-derived fuels and chemicals from 
plant biomass. Nature 463. 
6.  Black B.A., Zannini E., Curtis J.M., Gänzle M.G. 2013. Antifungal hydroxy fatty acids 
produced during sourdough fermentation: microbial and enzymatic pathways, and 
antifungal activity in bread. Appl Environ Microbiol 79:1866–73. 
7.  Desbois A.P., Smith V.J. 2010. Antibacterial free fatty acids: activities, mechanisms of 
action and biotechnological potential. Appl Microbiol Biotechnol 85. 
8.  Clegg M.E. 2010. Medium-chain triglycerides are advantageous in promoting weight loss 
although not beneficial to exercise performance. Int J Food Sci Nutr 61:653–679. 
9.  Royce L.A., Liu P., Stebbins M.J., Hanson B.C., Jarboe L.R. 2013. The damaging effects 
of short chain fatty acids on Escherichia coli membranes. Appl Microbiol Biotechnol 97. 
10.  Royce L.A., Yoon J.M., Chen Y., Rickenbach E., Shanks J.V., Jarboe L.R. 2015. 
Evolution for exogenous octanoic acid tolerance improves carboxylic acid production and 
membrane integrity. Metab Eng 29. 
11.  Tan Z., Yoon J.M., Chowdhury A., Burdick K., Jarboe L.R., Maranas C.D., Shanks J.V. 
2018. Engineering of E. coli inherent fatty acid biosynthesis capacity to increase octanoic 
acid production. Biotechnol Biofuels 11:87. 
141 
 
12.  Tan Z., Yoon J.M., Nielsen D.R., Shanks J.V., Jarboe L.R. 2016. Membrane engineering 
via trans unsaturated fatty acids production improves Escherichia coli robustness and 
production of biorenewables. Metab Eng 35:105–113. 
13.  Liu P., Chernyshov A., Najdi T., Fu Y., Dickerson J., Sandmeyer S., Jarboe L. 2013. 
Membrane stress caused by octanoic acid in Saccharomyces cerevisiae. Appl Microbiol 
Biotechnol 97:3239–3251. 
14.  Gajewski J., Pavlovic R., Fischer M., Boles E., Grininger M. 2017. Engineering fungal de 
novo fatty acid synthesis for short chain fatty acid production. Nat Commun 8. 
15.  Zhang C., Yang H., Yang F., Ma Y. 2009. Current Progress on Butyric Acid Production 
by Fermentation. Curr Microbiol 59:656–663. 
16.  Huerta A.M., Collado-Vides J. 2003. Sigma70 Promoters in Escherichia coli: Specific 
Transcription in Dense Regions of Overlapping Promoter-like Signals. J Mol Biol 
333:261–278. 
17.  Harden M.M., He A., Creamer K., Clark M.W., Hamdallah I., Martinez K.A., Kresslein 
R.L., Bush S.P., Slonczewski J.L. 2015. Acid-adapted strains of Escherichia coli K-12 
obtained by experimental evolution. Appl Environ Microbiol 81:1932–41. 
18.  Ogasawara H., Shinohara S., Yamamoto K., Ishihama A. 2012. Novel regulation targets 
of the metal-response BasS-BasR two-component system of Escherichia coli. 
Microbiology 158:1482–1492. 
19.  Reyes L.H., Almario M.P., Winkler J., Orozco M.M., Kao K.C. 2012. Visualizing 
evolution in real time to determine the molecular mechanisms of n-butanol tolerance in 
Escherichia coli. Metab Eng 14:579–590. 
20.  Yang S., Land M.L., Klingeman D.M., Pelletier D.A., Lu T-Y.S., Martin S.L., Guo H-B., 
Smith J.C., Brown S.D. 2010. Paradigm for industrial strain improvement identifies 
sodium acetate tolerance loci in Zymomonas mobilis and Saccharomyces cerevisiae. Proc 
Natl Acad Sci U S A 107:10395–400. 
21.  Brynildsen M.P., Liao J.C. 2009. An integrated network approach identifies the 
isobutanol response network of Escherichia coli. Mol Syst Biol 5. 
142 
 
22.  Xiao M., Zhu X., Xu H., Tang J., Liu R., Bi C., Fan F., Zhang X. 2017. A novel point 
mutation in RpoB improves osmotolerance and succinic acid production in Escherichia 
coli. BMC Biotechnol 17:10. 
23.  Horinouchi T., Tamaoka K., Furusawa C., Ono N., Suzuki S., Hirasawa T., Yomo T., 
Shimizu H. 2010. Transcriptome analysis of parallel-evolved Escherichia coli strains 
under ethanol stress. BMC Genomics 11:579. 
24.  Jiang Y., Chen B., Duan C., Sun B., Yang J., Yang S. 2015. Multigene editing in the 
Escherichia coli genome via the CRISPR-Cas9 system. Appl Environ Microbiol 
81:2506–14. 
25.  Torella J.P., Ford T.J., Kim S.N., Chen A.M., Way J.C., Silver P.A. 2013. Tailored fatty 
acid synthesis via dynamic control of fatty acid elongation. Proc Natl Acad Sci U S A 
110:11290–5. 
26.  McClure R., Balasubramanian D., Sun Y., Bobrovskyy M., Sumby P., Genco C.A., 
Vanderpool C.K., Tjaden B. 2013. Computational analysis of bacterial RNA-Seq data. 
Nucleic Acids Res 41:1–16. 
27.  Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S., Ohtsubo E., Baba 
T., Wanner B.L., Mori H., Horiuchi T. 2006. Highly accurate genome sequences of 
Escherichia coli K‐12 strains MG1655 and W3110. Mol Syst Biol 2. 
28.  Blattner F.R., Plunkett G., Bloch C.A., Perna N.T., Burland V., Riley M., Collado-Vides 
J., Glasner J.D., Rode C.K., Mayhew G.F., Gregor J., Davis N.W., Kirkpatrick H.A., 
Goeden M.A., Rose D.J., Mau B., Shao Y. 1997. The Complete Genome Sequence of 
Escherichia coli K-12. Science (80- ) 277:1453–1462. 
29.  Love M.I., Huber W., Anders S. 2014. Moderated estimation of fold change and 
dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. 
30.  Keseler I.M., Mackie A., Santos-Zavaleta A., Billington R., Bonavides-Martínez C., 
Caspi R., Fulcher C., Gama-Castro S., Kothari A., Krummenacker M., Latendresse M., 
Muñiz-Rascado L., Ong Q., Paley S., Peralta-Gil M., Subhraveti P., Velázquez-Ramírez 
D.A., Weaver D., Collado-Vides J., Paulsen I., Karp P.D. 2017. The EcoCyc database: 
reflecting new knowledge about Escherichia coli K-12. Nucleic Acids Res 45:D543–
D550. 
143 
 
31.  Gama-Castro S., Salgado H., Santos-Zavaleta A., Ledezma-Tejeida D., Muñiz-Rascado 
L., García-Sotelo J.S., Alquicira-Hernández K., Martínez-Flores I., Pannier L., Castro-
Mondragón J.A., Medina-Rivera A., Solano-Lira H., Bonavides-Martínez C., Pérez-
Rueda E., Alquicira-Hernández S., Porrón-Sotelo L., López-Fuentes A., Hernández-
Koutoucheva A., Moral-Chávez V. Del, Rinaldi F., Collado-Vides J. 2016. RegulonDB 
version 9.0: high-level integration of gene regulation, coexpression, motif clustering and 
beyond. Nucleic Acids Res 44:D133–D143. 
32.  Lennen R.M., Pfleger B.F. 2013. Modulating membrane composition alters free fatty acid 
tolerance in Escherichia coli. PLoS One 8. 
33.  Mykytczuk N.C.S., Trevors J.T., Leduc L.G., Ferroni G.D. 2007. Fluorescence 
polarization in studies of bacterial cytoplasmic membrane fluidity under environmental 
stress. Prog Biophys Mol Biol 95:60–82. 
34.  Pembrey R.S., Marshall K.C., Schneider R.P. 1999. Cell surface analysis techniques: 
What do cell preparation protocols do to cell surface properties? Appl Environ Microbiol 
65:2877–94. 
35.  Rosenberg M., Gutnick D., Rosenberg E. 1980. Adherence of bacteria to hydrocarbons: 
A simple method for measuring cell‐surface hydrophobicity. FEMS Microbiol Lett 9:29–
33. 
36.  Bligh E.G., Dyer W.J. 1959. A RAPID METHOD OF TOTAL LIPID EXTRACTION 
AND PURIFICATION. Can J Biochem Physiol 37:911–917. 
37.  Dudin O., Geiselmann J., Ogasawara H., Ishihama A., Lacour S. 2014. Repression of 
flagellar genes in exponential phase by CsgD and CpxR, two crucial modulators of 
Escherichia coli biofilm formation. J Bacteriol 196:707–15. 
38.  Pesavento C., Hengge R. 2012. The global repressor FliZ antagonizes gene expression by 
σ S -containing RNA polymerase due to overlapping DNA binding specificity . Nucleic 
Acids Res 40:4783–4793. 
39.  Pesavento C., Becker G., Sommerfeldt N., Possling A., Tschowri N., Mehlis A., Hengge 
R. 2008. Inverse regulatory coordination of motility and curli-mediated adhesion in 
Escherichia coli. Genes Dev 22:2434–2446. 
144 
 
40.  Guckes K.R., Kostakioti M., Breland E.J., Gu A.P., Shaffer C.L., Martinez C.R., 
Hultgren S.J., Hadjifrangiskou M. 2013. Strong cross-system interactions drive the 
activation of the QseB response regulator in the absence of its cognate sensor. Proc Natl 
Acad Sci U S A 110:16592–7. 
41.  Sperandio V., Torres A.G., Kaper J.B. 2002. Quorum sensing Escherichia coli regulators 
B and C (QseBC): a novel two‐component regulatory system involved in the regulation 
of flagella and motility by quorum sensing in E. coli. Mol Microbiol 43:809–821. 
42.  Brandi A., Giangrossi M., Giuliodori A.M., Falconi M. 2016. An Interplay among FIS, 
H-NS, and Guanosine Tetraphosphate Modulates Transcription of the Escherichia coli 
cspA Gene under Physiological Growth Conditions. Front Mol Biosci 3:19. 
43.  Whitchurch C.B., Mattick J.S. 1994. Escherichia coli contains a set of genes homologous 
to those involved in protein secretion, DNA uptake and the assembly of type-4 fimbriae 
in other bacteria. Gene 150:9–15. 
 
 
 
 
 
 
 
 
 
 
 
 
 
145 
 
 
CHAPTER 6. LESSONS IN MEMBRANE ENGINEERING FOR OCTANOIC ACID 
PRODUCTION FROM ENVIRONMRNTAL ESCHERICHIA COLI ISOLATES 
Manuscript submitted to Applied Environmental Microbiology 
Yingxi Chen1, Michael Reinhardt2,3, Natalia Neris3,4, Lucas Kerns1, Thomas J. Mansell1, Laura 
R. Jarboe1 
1Department of Chemical and Biological Engineering, Iowa State University, Ames, IA 50011 
2Department of Chemical Engineering, University at Buffalo, Buffalo, NY, 14260 
3NSF Center for Biorenewable Chemicals Engineering Research Center REU program, Ames, 
IA, 50011 
4Department of Biochemistry, Mount Saint Mary’s University, Los Angeles, CA, 90047 
Abstract  
Fermentative production of many attractive biorenewable fuels and chemicals is limited 
by product toxicity in the form of damage to the microbial cell membrane. Metabolic 
engineering of the production organism can help to mitigate this problem, but there is need for 
identification and prioritization of the most effective engineering targets. Here, we use a set of 
previously-characterized environmental E. coli isolates with high tolerance and production of 
octanoic acid, a model membrane-damaging biorenewable product, as a case study for 
identifying and prioritizing membrane engineering strategies. This characterization identified 
differences in the membrane lipid composition, fluidity, integrity and cell surface hydrophobicity 
relative to the lab strain MG1655. Consistent with previous publications, decreased membrane 
fluidity was associated with increased fatty acid production ability. Maintenance of high 
membrane integrity or longer membrane lipids seemed to be of less importance than fluidity. 
Cell surface hydrophobicity was also directly associated with fatty acid production titers, with 
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the strength of this association demonstrated by expression tuning of the multiple stress 
resistance outer membrane protein BhsA. Expression tuning of bhsA was effective in altering 
hydrophobicity, but the direction and magnitude of the change differed between strains. Thus, 
additional strategies are needed to reliably engineer cell surface hydrophobicity. This work 
demonstrates the ability of environmental microbiological studies to impact the metabolic 
engineering design, build, test, learn cycle and possibly increase the economic viability of 
fermentative bioprocesses. 
Importance  
Production of bulk fuels and chemicals in a bio-based fermentation process requires high 
product titers. This is often difficult to achieve, because many of the target molecules damage the 
membrane of the microbial cell factory. Engineering the composition of the membrane in order 
to decrease its vulnerability to this damage has proven to be an effective strategy for improving 
bio-production, but additional strategies and engineering targets are needed. Here, we study a 
small set of environmental Escherichia coli isolates that have higher production titers of octanoic 
acid, a model biorenewable chemical, relative to the lab strain MG1655. We found that 
membrane fluidity and cell surface hydrophobicity are strongly associated with improved 
octanoic acid production. Fewer genetic modification strategies have been demonstrated for 
tuning hydrophobicity relative to fluidity, leading to the conclusion that there is a need for 
expanding hydrophobicity engineering strategies in E. coli. 
Introduction 
Throughout the vast majority of human history, transportation energy and commodity 
goods have been obtained from woody biomass, crops, and animals (1–3). However, in the past 
century, petroleum has become the predominant source of carbon and energy for the production 
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fuels and chemicals, with a variety of undesirable outcomes (4–6). The fermentative production 
of bulk fuels and chemicals, such as ethanol, lactic acid and the ABE process, for example, were 
commercially viable prior to establishment of the petrochemical industry (7, 8). However, the 
economically viable production of bio-based fuels and chemicals that could displace petroleum-
derived molecules still remains challenging (6).  
One of the limitations of fermentative production of bulk fuels and chemicals is toxicity, 
both in terms of the product molecules and the biomass-derived carbon streams (9, 10). This 
toxicity can be addressed through in-situ product removal (11–14) and/or increasing the 
robustness of the microbial biocatalyst (15–18). Design strategies for robust biocatalysts can be 
based on known mechanisms of inhibition and tolerance (19–21). Implementation of the “learn” 
step of the design, build, test, learn cycle (22, 23) can provide inspiration for such rational design 
strategies. This learning can come from characterization of evolved strains (21) or wild 
populations (24). 
Fatty acids have a large and increasing industrial demand due to their wide range of 
applications. Short-chain fatty acids are directly used as a food preservative (25, 26) and dietary 
supplement (27). Fatty acids also can be used as precursors for a variety of industrial chemicals, 
such as alkanes (28, 29), α-olefins (30, 31), and fatty acid methyl or ethyl esters (32). Extensive 
work has been done to improve the fermentative production of fatty acids (5, 33–36). However, 
as with many other desirable biorenewable products (37, 38), fatty acid toxicity to microbes (9, 
10, 19, 39) limits the product titers, and thus negatively impacts the economic viability of bio-
based fatty acid production. Substantial progress has been made in addressing cytotoxicity of 
fatty acids in E. coli (9, 18, 33), with a variety of studies concluding that membrane damage is 
the major mechanism of fatty acid toxicity (9, 10, 18, 19, 39). This membrane damage 
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corresponds to a decrease in membrane integrity (9) and perturbation of membrane fluidity (9, 
18). Engineering the cell membrane composition (e.g. lipid distribution) to mitigate the damage 
imposed by fatty acids (33, 40), enabling the production of trans unsaturated fatty acids (16), and 
altering of the phospholipid head distribution (41), have proven effective for increasing fatty acid 
tolerance and/or production. Despite this progress, further increases in fatty acid titer are 
desirable - particularly in terms of short-chain fatty acids, such as octanoic acid (C8).   
A previously-described collection of environmental E. coli isolates was found to have 
wide variation in membrane properties such as the hydrophobicity and the zeta potential (42). 
Here, we characterized these strains for their ability to tolerate and produce octanoic acid. This 
characterization identified membrane properties that are promising additions to the arsenal of 
strategies for improving microbial robustness for increasing production of biorenewable fuels 
and chemicals. 
Materials and Methods 
Strains, plasmids and bacterial cultivation   
 All bacterial strains and plasmids used in this study are listed in Table 1. E. coli strains 
were grown overnight in 250 mL flasks with 10 mL of MOPS media with 2.0 wt% dextrose at 
pH 7.00±0.05, at 37 ºC and 250 rpm. For octanoic acid tolerance tests, the overnight seed culture 
was diluted to an optical density at 550 nm (OD550) of 0.05. For fatty acid fermentation, 
measurement of membrane leakage, membrane fluidity, cell hydrophobicity, and cell membrane 
composition, the overnight seed culture was diluted to an OD550 of 0.1. Ampicillin (100 mg/L), 
and kanamycin (50 mg/L), were added as needed. All growth media and phosphate buffered 
saline solutions had an initial pH of 7±0.05.    
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Octanoic acid tolerance test 
Tolerance to octanoic acid was assessed in 250 mL baffled flasks with 25 mL MOPS 
medium with 2.0 wt% dextrose with or without exogenous 10 mM C8, at 37 ºC and 200 rpm. 
Octanoic acid was provided via a stock solution containing 4.0 M C8 in ethanol. The pH of the 
media was adjusted using 2.0 M KOH. 
Fatty acid production 
Strains were transformed with the pJMY-EEI82564 plasmid (18) by electroporation and 
grown on LB plates with ampicillin 30 ºC overnight. Individual colonies were inoculated in 10 
mL MOPS media with 2.0 wt% dextrose and ampicillin in 250 mL flasks at 30 ºC on a rotary 
shaker at 250 rpm overnight. These seed cultures were subsequently inoculated into 250 mL 
flasks containing 50 mL of MOPS media with 2.0 wt% dextrose, ampicillin and 1.0 mM 
isopropyl-β-D-thiogalactopyranoside (IPTG) at an initial OD550 of 0.1. The flasks were incubated 
in a rotary shaker at 200 rpm and 30 ºC. 
Determination of fatty acid titers 
Fatty acid production was quantified by fatty acid extraction from samples containing 
both media and cells. The extracted fatty acids were derivatized and measured at the ISU W.M. 
Keck Metabolomics Research Laboratory via an Agilent 6890 gas chromatograph coupled to an 
Agilent 5973 mass spectroscope (GC-MS), as previously described (63). Briefly, 1 mL culture 
was transferred into a 2 mL microcentrifuge tube and 125 µL 10% NaCl (w/v), 125 µL acetic 
acid, 20 µL internal standard (1 µg/ µL C7, C11, C15 in EtOH), and 500 µL ethyl acetate were 
added sequentially. The mixture was vortexed for 30s and centrifuged at 16,000×g at room 
temperature for 10 min. 250 µL of the top layer was transferred into a glass tube and 2.25 mL 
30:1 EtOH: 37% HCl (v/v) was added. This mixture was then incubated at 55 ºC for 1 hour, then 
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cooled to room temperature. Then, 1.25 mL each of ddH2O and hexane were added, followed by 
vortexing and centrifugation at 2,000×g for 2 min. The top hexane layer was then analyzed by 
GC-MS using the following program: the initial temperature was 50 ºC, hold for 1 min, with the 
following temperature ramp: 20 ºC/min to 140 ºC, 4 ºC/min to 220 ºC, and 5 ºC/min to 280 ºC 
with 1 ml/min helium carrier gas.  
The Enhanced Data Analysis (Agilent Technologies) and NIST 17 Mass Spectral Library 
software were used for peak identification. The relative retention factors of C7, C11, and C15 
were used to calculate the relative amounts of the individual fatty acids analyzed.  
Membrane lipid composition  
Seed cultures were inoculated into 250 mL baffled flasks with 50 mL MOPS medium 
with 2.0 wt% dextrose, at 30 ºC and 250 rpm. For analysis of C8 challenge, E. coli cells were 
harvested at mid-log (OD~0.8), resuspended in 25 mL media with 0 mM or 30 mM C8 at pH 7.0, 
and incubated for 3 hours at 30 ºC. For analysis of C8 production, cells were harvested at 24 and 
48 hours. 
Harvested cells were washed twice in cold sterile water, resuspended into 6 mL 
methanol, and sonicated for three 30 s bursts. Then, 1.4 mL of this sonicated solution was 
transferred into each of three glass tubes, to be processed in parallel (64). Twenty μL of a 
solution containing 1 µg/µL each of C7, C11, and C15 in methanol was added. These mixtures 
were incubated at 70 ºC for 15 min and cooled to room temperature. The cells were centrifuged 
at 4,000×g for 5 min, and the resulting supernatant and pellet were treated separately. The 
supernatant was transferred into a new glass tube with 1.4 mL nanopure water and vortexed. 750 
µL of chloroform was added to the pellet, followed by vortexing and shaking in a horizontal 
shaker at 150 rpm, 37 ºC for 5 min. The diluted supernatant was added back to the chloroform-
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treated pellet. This mixture was vortexed for 2 min, then centrifuged at 3,000×g for 5min. The 
bottom layer was transferred to a new glass tube and all solvent removed with an N-Evap 
nitrogen tree evaporator. Two mL of 1.0N HCl in methanol was added to the dried samples, 
heated at 80 ºC for 30 min, then cooled to room temperature. Two mL 0.9 wt% aqueous NaCl 
and 1.0 mL hexane was added, followed by vortexing for 2 min and centrifugation at 2,000×g for 
2 min. The upper layer was analyzed by GC, using the method described above.  
The weight-average lipid length was calculated as previously described (9). The percent 
abundance of unsaturated fatty acids was calculated as the sum of the percent abundance of 
C12:1, C14:1, C16:1, and C18:1. 
Membrane permeability  
Cells were harvested at 24 h and 48 h. Following centrifugation at 4,500×g and 4 ºC for 
10 min, cell pellets were washed twice with PBS, and resuspended in PBS at a final OD550 ~ 1. 
Then, 100 µL of resuspended cells were diluted with 900 µL PBS. Cells were stained with 1 µL 
of 5 mM SYTOX Green in dimethyl sulfoxide (Invitrogen, Carlsbad, CA), for a final 
concentration of 5 mM. Cells were then analyzed by flow cytometry at the ISU Flow Cytometry 
Facility on a BD Biosciences FACSCanto II (18). About 18,000 events were tested per sample, 
and each sample had three parallel groups.  
Membrane fluidity 
Membrane polarization was measured using 1,6-diphenyl-1,3,5-hexatirene (DPH) as 
previously described (9, 47). Harvested cells were prepared as described above for assessment of 
membrane permeability. Five hundred µL of cells in PBS at an OD550 of ~ 1 were transferred to a 
1.5 mL centrifuge tube containing 500 µL of 0.4 µM DPH in PBS. The mixture was vortexed 
and incubated at 37 ºC in the dark for 30 min. The samples were then centrifuged (5,000×g, 5 
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min) and the cell pellets were resuspended in 500 µL PBS. One hundred µL of this mixture was 
transferred into sterile black-bottom Nunclon delta surface 96-well plates with 4 replicates. A 
suspension of cells with no DPH was used as a control. Membrane fluorescence polarization 
values were determined based on vertical and horizontal fluorescence readings, which were 
assessed by via the BioTek Synergy 2 Multi-Mode microplate reader at the ISU W.M. Keck 
Metabolomics Research Laboratory. 
Cell surface hydrophobicity  
The method for measuring cell surface hydrophobicity was based on the previously 
described procedure (42, 65, 66). The seed culture was inoculated into 25 mL MOPS media with 
2 wt% dextrose with or without exogenous 10 mM C8, at 30 ºC with rotary shaking at 250 rpm. 
Cells were harvested at mid-log phase (OD550~0.8) followed by centrifugation at 4,500×g and 
room temperature for 10 min. Cell pellets were then washed twice with PBS buffer, and 
resuspended in PBS at a final of OD550~0.6. Four mL of cell suspension was added to a glass 
tube, and the OD550 was measured (OD1). Then, 1.0 mL of dodecane was added, and the mixture 
was mixed using a multi-tube vortexer (Thermo Fisher Scientific Inc., Waltham, MA, USA) at 
2500 rpm for 10 minutes. The mixtures were left to settle for 15 min at room temperature and the 
OD550 of the aqueous phase (OD2) was measured. Partitioning of the bacteria suspension was 
calculated using the following equation: 
Percent partitioning = [(OD1-OD2)/OD1]*100 
Results 
Environmental isolates show increased fatty acid tolerance and production  
It has previously been demonstrated that short chain fatty acids are inhibitory to E. coli, 
having a detrimental impact on both growth and on fatty acid production (9, 18, 43). Several E. 
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coli strains were previously isolated from Squaw Creek in Ames, IA, and characterized in terms 
of various cell surface properties and phylotype (42). Given that these environmental isolates 
have previously demonstrated an ability to survive and propagate in harsh environmental 
conditions, we proposed that these environmental isolates may be able to provide insight into 
design strategies for developing robust microbial cell factories for short-chain fatty acid 
production.    
Fifteen of these previously-characterized environmental isolates were compared to the 
standard K-12 lab strain MG1655 in terms of short-chain fatty acid sensitivity and production 
(Table 2). Specifically, strains were grown in MOPS media with 2.0 wt% glucose at 37 ºC with 
and without 10 mM C8 at pH 7.0. Nearly all of the strains showed less than 20% inhibition 
relative to growth in the absence of C8. Note that environmental isolate #6 showed a very high 
C8 sensitivity, with approximately 90% inhibition. All of the environmental isolates, except for 
strains #48 and #236, showed significantly (p < 0.05) less inhibition by 10 mM C8 relative to 
MG1655 (Table 2).  
Given these promising results regarding fatty acid tolerance, we then characterized short-
chain fatty acid production for a smaller set of these environmental isolates via expression of the 
A. tetradius thioesterase. This set was selected so that there was at least one isolate from each 
each of the phylogroups. Fatty acid production was characterized for seven of these 
environmental isolates and MG1655 in MOPS media with 2.0 wt% glucose at 30 ºC (Table 2). 
All of the environmental isolates had significantly higher fatty acid titers than MG1655. 
Specifically, MG1655 produced 56.4±0.8 mg/L while all of the isolates produced at least 145 
mg/L. All of the environmental isolates also showed an approximately 5-fold increase in biomass 
production during fatty acid production relative to MG1655. These results provide further 
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motivation for characterizing these isolates in order to identify design strategies for increasing 
fatty acid production in industrial strains. 
We selected three environmental isolates for further characterization. Isolate #18 had the 
lowest fatty acid titer (148±3 mg/L) while isolates #83 and #292 had the highest fatty acid titers 
(251 mg/L). Isolate #292 also had the smallest OD550 relative to the other environmental isolates.  
Measurement of the free fatty acid chain length distribution indicates that the wild-type 
lab strain MG1655 shows slightly improved specificity for C8:0 fatty acids relative to the 
environmental isolates (Figure 1). Specifically, the pool of free fatty acids produced by MG1655 
contained more than 75 wt% C8. The free fatty acid pools produced by the environmental 
isolates contained between 50 and 60 wt% C8 with a shifting of the distribution towards chain 
lengths of 14 or more carbons. 
Identification of design strategies from the membrane lipid distribution 
Damage to the microbial membrane is a key component of fatty acid toxicity (9, 19, 39) 
and changes to the membrane composition have been associated with increased fatty acid 
tolerance and production (16, 18, 33, 40, 41). Characterization of the membrane of each of our 
selected focal E. coli strains during fatty acid challenge and during fatty acid production supports 
the contribution of the lipid tail distribution to differences in strain robustness (Table 3). 
A few differences in membrane lipid tail distribution were observed between the 
environmental isolates and MG1655 regardless of the presence or production of octanoic acid 
(Table 3). Specifically, in all conditions strain #83 had above-average abundance of C12:0, while 
MG1655 had below-average abundance. Also, each of the environmental isolates showed 
increased abundance of C12:1 during fatty acid production relative to the non-production 
condition. This trend was not observed for MG1655. 
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It has previously been demonstrated that increasing the average fatty acid chain length in 
the membrane can improve fatty acid production (40). Each of the environmental isolates 
characterized here showed a decrease in average lipid length during fatty acid production relative 
to the non-production condition (Table 3). While MG1655 showed a similar decrease, the 
magnitude was smaller.   
The relative degree of unsaturation is also known to be a key metric of membrane fatty 
acid composition (9, 18, 33). Previous reports have described an increase in the relative 
abundance of unsaturated C16 and C18 lipids in the membrane during fatty acid production by a 
K-12 E. coli strain (33). However, the characterization reported here observed a significant 
decrease in the relative abundance of unsaturated fatty acids in the membrane of MG1655 during 
fatty acid production (Table 3). The environmental isolates also showed, in general, a decrease in 
the abundance of unsaturated lipids during fatty acid production. However, in MG1655 the 
abundance of unsaturated membrane lipids was much smaller during fatty acid production than 
for the environmental isolates.  
The opposite trend was observed for the relative abundance of cyclic fatty acids: their 
abundance generally increased in all strains during fatty acid production. A broad interpretation 
of these trends is that changes in the MG1655 membrane during fatty acid production mainly 
consisted of changes in the abundance of unsaturated fatty acids. However, during fatty acid 
production the membranes of the environmental isolates changed in terms of length, not 
unsaturation. 
In addition to the membrane composition metrics described above, the C16:1/C16:0 ratio 
also seems to be useful for comparing these strains (Figure 2). The MG1655 membrane showed a 
significant decrease in this ratio during challenge with 30 mM C8 relative to the untreated 
156 
 
control, decreasing from 0.32 to 0.23. In contrast, each of the environmental isolates showed an 
increase in this ratio. For example, for strain #18 this ratio increased from 0.46 to 0.63 (p < 
0.0006). During fatty acid production, the three environmental isolates all had a significantly 
higher C16:1/C16:0 ratio than the MG1655 strain (p < 0.0006). At 24 hours, this ratio was 0.07 
for MG1655, but was 0.20 for strain #18 and 0.37 for strain #292.  
Previous membrane engineering efforts have aimed to engineer the membrane 
composition in terms of average lipid length and abundance of unsaturated lipids. Our results 
suggest that it may also be useful to target the C16:1/C16:0 ratio.  
Decreased membrane fluidity is associated with increased fatty acid production 
Membrane damage is generally considered a key mechanism of E. coli inhibition during 
challenge with or production of short chain fatty acids, along with many other biorenewable 
fuels and chemicals (9, 16, 18). The membrane composition can be quantified by metrics such as 
the lipid tail distribution, as described above. However, the membrane also consists of many 
proteins, sugars, and phospholipid head groups. Metrics such as membrane fluidity and integrity 
reflect the overall function and state of the membrane.  
Maintenance of appropriate membrane fluidity is vital to membrane function. In general, 
membrane fluidity trends with the relative abundance of unsaturated lipids (44), though other 
membrane components can also contribute to this property (16, 45, 46). Membrane fluidity was 
measured via cell membrane polarization, where increased membrane polarization corresponds 
to decreased membrane fluidity (9, 47). Our previous studies have shown that the membrane 
polarization of MG1655 decreased substantially during challenge with exogenous C8 without 
prior adaptation (9). However, cells that had 3 hours of prior exposure to 30 mM C8 were able to 
maintain a membrane polarization of approximately 0.3 during exogenous C8 challenge. These 
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prior results demonstrate that free fatty acids could change membrane polarization, but changes 
in the membrane composition could make the cell membrane more resistant to this effect.  
Membrane polarization was assessed for the fatty acid producing strains at 24 and 48 
hours (Figure 3A). At 24 hours, isolates #18 and #292 had significantly (p<0.05) increased 
polarization relative to MG1655. At 48 hours, all three isolates had significantly increased 
polarization relative to MG1655. The increased polarization during fatty acid production for the 
environmental isolates relative to MG1655, indicates that the isolates have a lower fluidity than 
MG1655.  
Previous studies of an evolved E. coli strain and an E. coli strain engineered to produce a 
novel membrane lipid tail also reported that increased membrane polarization was associated 
with increased fatty acid production (9, 16). The isolate characterization described here provides 
further evidence that decreasing membrane fluidity is a promising strategy for improving short 
chain fatty acid tolerance and production. Surprisingly, the isolates all had a higher abundance of 
unsaturated lipids relative to MG1655, leading to the expectation of a higher fluidity. Thus, 
differences in fluidity cannot be solely attributed to the relative abundance of unsaturated fatty 
acids in the membrane. 
The isolates also differ from MG1655 in that their polarization value significantly (p < 
0.05) increased from 24 hours to 48 hours (Figure 3A). These results indicate that the 
environmental isolates are able to further modulate their membrane fluidity. For isolates #83 and 
292, this further increase in polarization is surprising, given the observed significant (p < 0.05) 
increase in the percentage of unsaturated fatty acids (Table 3) and the C16:1/C16:0 ratio (Figure 
2). This provides further demonstration that fluidity is not solely a function of unsaturated fatty 
acid content. Isolate #18 did not have a significant increase in the percentage of unsaturated fatty 
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acids or C16:1/C16:0 ratio. Instead, isolate #18 showed a significant (p=0.041) increase in the 
average lipid length. Thus, the environmental isolates might be using distinct strategies to control 
membrane fluidity during fatty acid production.  
Investigation of membrane integrity during fatty acid production 
Decreased membrane integrity is a widespread problem during microbial production of 
fuels and chemicals (15, 16, 18, 39, 41). Membrane integrity can be quantified via the 
permeability of cells to the SYTOX nucleic acid dye (33). At both time points during fatty acid 
production, MG1655 had dramatically decreased SYTOX permeability relative to the 
environmental isolates (Figure 3B). This could be due to the very low fatty acid titer of MG1655 
(Table 2). A large percentage of cells from the three environmental isolates were SYTOX-
permeable. Specifically, all of the strains were more than 99% permeable at 48 hours. These 
results show that the environmental isolates have decreased cell membrane integrity relative to 
MG1655 during fermentation, which indicates that the lower fatty acid titer achieved by 
MG1655 cannot be attributed to a loss of membrane integrity. 
Higher cell surface hydrophobicity leads to higher fatty acid production  
The measurements of membrane polarization and integrity described above reflect the 
physical state of the phospholipid bilayer. Contrastingly, measurement of the cell surface 
hydrophobicity reflects the abundance and type of proteins and sugars on the cell surface (ref). 
The environmental isolates used in this study are part of a larger set that was previously 
characterized in terms of various cell surface properties, including hydrophobicity (42). 
Hydrophobicity was found to range from 1 to 90 % adhesion to hydrocarbons (42). Thus, we also 
characterized the cell surface hydrophobicity during fatty acid challenge in the current work. 
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The three focal environmental isolates all had increased hydrophobicity relative to 
MG1655, with and without exogenous C8 challenge in MOPS minimal media at 30 ºC (Figure 
4). Also, each of the environmental isolates showed a decrease in hydrophobicity during C8 
challenge relative to the control condition. Thus, the environmental isolates differ from MG1655 
in both the value of the hydrophobicity and its modulation in response to C8. 
A positive correlation between the cell surface hydrophobicity and fatty acid production 
was observed (Figure 4). Specifically, fatty acid titers increased as cell hydrophobicity increased. 
These results suggest that increasing the cell surface hydrophobicity might be a strategy for 
improving fatty acid production. It has been previously demonstrated in yeast that increasing the 
cell surface hydrophobicity increased tolerance of nonane (48) and increased production of 
ethanol in the presence of inhibitors such as carboxylic acids, furfural and biomass hydrolysate 
(49).  
Expression tuning of outer membrane protein BhsA in E. coli was previously 
demonstrated to change the cell surface hydrophobicity (50). Here, we altered the cell surface 
hydrophobicity of the four focal strains by expressing bhsA via the pACYC184 plasmid with the 
MG1655 bhsA promoter (15). For strain MG1655 and isolate 18, the cell surface hydrophobicity 
significantly (p < 0.05) increased when bhsA expression was increased in either the absence or 
the presence of C8 (Figure 5). Expression of bhsA had no impact on the hydrophobicity of strain 
#83 in the absence of C8, but decreased the hydrophobicity in the presence of C8. In contrast, for 
isolate #292, bhsA expression decreased hydrophobicity only in the absence of C8. Thus, in 
accordance with previous reports, expression tuning of bhsA can alter the cell surface 
hydrophobicity of E. coli strains. However, the trends were not consistent across strains and 
conditions. 
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This perturbation of the hydrophobicity was performed in order to investigate the 
relationship between cell surface hydrophobicity and fatty acid production. Consistent with the 
increase in hydrophobicity for MG1655+bhsA and #18+bhsA, fatty acid titers also significantly 
increased (Figure 5B). The association of hydrophobicity and fatty acid production was 
conserved for the isolates #83 and 292. Specifically, these strains each showed a decrease in cell 
surface hydrophobicity, either in the presence or absence of C8, and they each showed a 
significant decrease in fatty acid titer. Thus, tuning of cell surface hydrophobicity is a promising 
method of improving fatty acid production, but additional genetic targets for altering 
hydrophobicity in E. coli are needed. 
Discussion 
Many physical and genetic factors determine microbial tolerance to and production of 
inhibitory chemicals. Implementation of the design, build, test, learn cycle (22) in the 
construction of improved fermentation organisms, particularly in regards to membrane 
engineering, can benefit from the characterization of evolved or non-model organisms (18, 20, 
51–53). The microbial cell membrane is an increasingly important engineering target for the 
design of high-performing microbial biocatalysts (54, 55). In this case, we found that several 
aspects of the E. coli membrane, such as composition and physical properties, were associated 
with increased tolerance to and production of octanoic acid, a representative fatty acid.  
The ability to modulate the relative abundance of unsaturated lipids and the resulting 
impact on tolerance phenotypes has been previously reported in E. coli and S. cerevisiae (33, 44, 
56). Here, we saw that the high-producing environmental isolates did have an altered abundance 
of unsaturated lipids relative to MG1655 (Table 3). Additionally, our results suggest that the 
C16:1/C16:0 ratio may be a useful metric distinct from the standard consideration of total pools 
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of saturated and unsaturated lipids. However, the observed differences in membrane fluidity did 
not appear to be solely attributable to the relative abundance of unsaturated lipids (Figure 3A).  
Engineering of the average lipid length has also been previously reported as strategy for 
increasing fatty acid tolerance and production in E. coli (40), and an evolved E. coli strain with 
increased fatty acid tolerance and production also showed an increase in average lipid length 
(18). Each of environmental isolates characterized here showed a decrease in the average lipid 
length during fatty acid production relative to the control condition (Table 3). Thus, an increase 
in average lipid length is not required for attainment of the high fatty acid titers achieved by 
these isolates, possibly due to other differences in membrane composition.  
The isolates characterized here show intriguing changes in the relative abundance of 
these cyclopropane fatty acids (Table 3). The relative abundance of these molecules has been 
previously reported as impacting E. coli tolerance of various stressors, such as heat, pressure and 
acid stress (57, 58). However, previous attempts to increase the abundance of these fatty acids in 
order to increase tolerance of fatty acids have not been successful (9, 10).  
The overall membrane composition, not just in terms of the fatty acid tails, but other 
components such as proteins, phospholipid head groups and polysaccharides, contribute to the 
bulk membrane properties, such as fluidity, integrity, rigidity, curvature, and thickness (59–62). 
Our characterization of environmental isolates with increased fatty acid production titers 
supports the idea that membrane fluidity is a critical determinant of fatty acid production 
capability (Figure 3A), consistent with previous reports that decreased fluidity is associated with 
increased production (16, 18). However, the substantial loss of membrane integrity during the 
course of fatty acid production by the environmental isolates (Figure 3B) does not appear to be 
detrimental to their ability to achieve high fatty acid titers. This suggests that focusing on 
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engineering of membrane fluidity may be more impactful than trying to combat the decrease of 
membrane integrity often observed during bio-production. 
Beyond modulation of the physical properties of the membrane lipid bilayer, the lipids, 
proteins and sugars associated with the membrane contribute to cell surface properties such as 
hydrophobicity and charge (42, 61, 62). Our characterization of these environmental isolates 
indicates that cell surface hydrophobicity is strongly associated with the ability to produce fatty 
acids at a high titer (Figure 4). Thus, engineering strategies that enable tuning of cell surface 
hydrophobicity may be useful for improving bio-production. Consistent with previous reports 
(50), expression tuning of BhsA was shown to impact cell surface hydrophobicity (Figure 5A). 
These changes in cell surface hydrophobicity were consistent with changes in fatty acid titers 
(Figure 5B). However, the impact of BhsA expression tuning on cell surface hydrophobicity 
varied according to the strain background, and in some cases the change was relatively small. 
Thus, additional strategies for predictably and substantially changing cell surface hydrophobicity 
could be useful for the strain design toolkit. 
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Tables 
Table 1. Strains and Plasmids used in this study 
 
Strains Genotype or description Phylogroup Reference 
MG1655 F- lambda- ilvG- rfb-50 rph-1 A Wild-type 
#9, 18, 284 
Environmental E. coli isolate 
from Squaw Creek, Ames, IA 
A/C 
(42) 
#8, 13, 28, 48, 
57, 236, 248 B1 
#6, 32, 44, 83 D/E 
#292 Unknown 
Plasmids Genotype or description  
pJMYEEI825
64 
pTrc-EEI82564 thioesterase (TE10) from 
Anaerococcus tetradius, AmpR (18) 
PACYC184-
Kan-ycfR pACYC184-Kan harboring ycfR, Kan
R This work 
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Table 2. Environmental isolates have decreased fatty acid sensitivity and increased fatty acid 
production relative to MG1655. Strains were grown in MOPS minimal medium with 2.0 wt% 
glucose, with or without 10 mM C8 at pH 7.00±0.05. For fatty acid production, strains expressed 
the TE10 thioesterase from Anaerococcus tetradius via the pJMYEEI82564 plasmid induced 
with 1.0 mM IPTG. Growth was assessed at 37 ºC and production was assessed at 30 ºC. 
+indicates environmental isolates whose C8 sensitivity was not significantly different (p˃0.05) 
from MG1655. 
* indicates significantly (p ≤ 0.0001) different fatty acid titer or OD550 relative to MG1655 
Strain OD550 at 8 h, 37 ºC % 
decrease 
in OD550 
Fatty acid titer 
(mg/L) 
OD550 during fatty acid 
production 
 0 mM C8 10 mM C8 24 h 48 h 24 h 48 h 
MG1655 2.0±0.1 1.69±0.01 15.5±0.8 52.7±0.8 56.4±0.8 0.59±0.01 0.58±0.01 
#6 1.7±0.1 0.145±0.03 90±20     
#8 1.94±0.01 1.70±0.02 12.4±0.2 235±7* 213±5* 3.7±0.2* 3.92±0.05* 
#9 1.8±0.0 1.69±0.02 6.1±0.1     
#13 1.8±0.1 1.7±0.0 5.6±0.3     
#18 1.84±0.02 1.67±0.02 9.2±0.2 144±2* 148±3* 3.00±0.02* 3.64±0.06* 
#28 1.80±0.04 1.69±0.01 6.1±0.1     
#32 1.86±0.07 1.640±0.002 11.8±0.5     
#44 1.83±0.05 1.61±0.04 12.0±0.4 101±1* 200±10* 3.8±0.1* 4.0±0.1* 
#48 2.07±0.02 1.77±0.01 14.5±0.2+ 200±20* 228±9* 3.6±0.1* 4.01±0.02* 
#57 1.68±0.05 1.56±0.01 7.1±0.2     
#83 1.86±0.05 1.62±0.06 12.9±0.6 245±5* 251±3* 3.6±0.1* 3.98±0.01* 
#236 2.04±0.01 1.72±0.01 15.7±0.1+ 220±10* 216±6* 3.7±0.1* 3.8±0.1* 
#248 1.92±0.06 1.75±0.05 8.9±0.4     
#284 1.90±0.06 1.71±0.02 10.0±0.3     
#292 1.96±0.03 1.73±0.07 11.7±0.5 245±5* 251±2* 2.98±0.03* 2.84±0.04* 
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Table 3. Membrane fatty acid tail composition (mol%) differs among MG1655 and the environmental isolates during C8 challenge 
and fatty acid production. Strains were assessed in MOPS+2.0 wt% dextrose at 30 ºC in shake flasks at 200 rpm. Cells assessed for the 
control and +30 mM conditions do not encode the thioesterase. All cultures had an initial pH of 7.0. For the control and +30 mM 
experiments, cells were harvested at mid log, corresponding to an OD550 of approximately 1.0.  
Numerical values are the average of three biological replicates, with the number of significant digits shown being selected based on 
the value of the standard deviation. Shading indicates the value relative to the median for each row according to the 95% confidence 
intervals. Values shaded in red are smaller than the median, values shaded in green are larger than the median. 
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Figures 
 
 
Figure 1. The focal environmental E. coli isolates have decreased chain-length specificity among 
the free fatty acid pool relative to MG1655. All strains contain the pJMYEEI82564 plasmid 
encoding the A. tetradius thioesterase.  
Strains were grown for 48 hours in MOPS mineral salts medium with 2.0% (w/v) dextrose at 
30 °C, initial pH 7.0, 200 rpm with 1.0 mM IPTG. Values are the average of three biological 
replicates with error bars indicating one standard deviation. 
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Figure 2. Increased growth during C8 challenge and increased C8 production by environmental 
isolates #83 and #292 are associated with an increase in C16:1 relative to C16:0 in the presence 
of C8. All strains were grown in MOPS minimal medium containing 2.0 wt% dextrose at 30 ºC 
with an initial pH 7.0. Values are the average of three biological replicates with error bars 
indicating one standard deviation. 
Values are the average of three biological replicates with error bars indicating one standard 
deviation. 
* indicates a significant difference (p ≤ 0.0006), selected using the Bonferroni correction 
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Figure 3. Membrane fluidity and integrity change during fatty acid production and differ for the 
environmental isolates relative to MG1655. All values are the average of three biological 
replicates with error bars indicating one standard deviation.  
(A) Membrane polarization, which is inversely proportional to membrane fluidity, significantly 
increased in the environmental isolates during the course of C8 production. 
(B) Membrane integrity, which is inversely proportional to SYTOX permeability, significantly 
increased during the course of fatty acid production in environmental isolates #18 and #292.  
* indicates a significant difference (p ≤ 0.05) between 24 hours and 48 hours for a single strain 
† indicates a significant difference (p ≤ 0.05) in the membrane polarization between MG1655 
and environmental isolates, at 24 hours or 48 hours 
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Figure 4. Increased fatty acid production is associated with higher cell surface hydrophobicity. 
Cell surface hydrophobicity was measured for mid-log cells growing in minimal medium with 0 
mM or 10 mM C8 at 37 ºC, fatty acid titers are reported in Table 2. All values are the average of 
three biological replicates with error bars indicating one standard deviation. 
All values are the average of three biological replicates with error bars indicating one standard 
deviation. 
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Figure 5. Expression tuning of bhsA alters cell surface hydrophobicity and fatty acid production. 
Values are the average of three biological replicates with error bars indicating one standard 
deviation. 
(A) Cell surface hydrophobicity with and without exogenously provided C8. Cells were grown in 
MOPS minimal media at 37 ºC with and without 10 mM C8, with an initial pH of 7.0. 
(B) Fatty acid production via expression of the A. tetradius thioesterase in MOPS minimal media 
at 30 ºC with an initial pH of 7.0.  
† indicates a significant difference (p ≤ 0.05) in the cell surface hydrophobicity between the two 
indicated conditions for the same strain  
* indicates a significant difference (p ≤ 0.05) in the cell surface hydrophobicity between wild 
type strain and the +bhsA strain for the same condition 
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CHAPTER 7. SUMMARY AND FUTURE WORK 
Summary 
This work has focused on the identification of mechanisms that increase short-chain fatty 
acids (SCFAs) tolerance and production in E. coli with the goal of providing rational engineering 
strategies for improving robustness of microbial biocatalyst and increasing production of value-
added biorenewable chemicals and fuels. 
Although extensive studies have been done for improving fatty acid production of 
microbial biocatalysts, the SCFAs titers and yields still need further increase for achieving 
economic viability and compete with fossil fuels. One of the biggest challenge is SCFAs toxicity 
to microbes, which limits the cell growth and fermentation performance. It is known that 
membrane damage is one of the main mechanisms of the SCFAs toxicity to E. coli strains. In this 
study, we investigated the short-chain fatty acid-tolerant evolved strains and characterized a 
small set of environmental E. coli isolates with high short chain fatty acid production. All the 
efforts made were intended to understand the mechanisms of increased SCFAs tolerance and 
improved SCFAs production, which could be used as design strategies for rational engineering of 
microbial biocatalyst. 
We applied genome-level reverse engineering to investigate the short-chain fatty acid-
tolerance of the evolved strains. We identified four mutations and their chronological order of 
occurrence during adaptive evolution. Knowing the chronological order of the mutations in this 
study was very important, which helped us to have a better understanding about the evolved 
strains and provided a clear strategy to study each mutation and the synergistic interaction of 
them. Then we constructed 12 strains for further investigating how mutations contribute to the 
phenotypic changes of the evolved strain. In summary, the increased C8 tolerance phenotype was 
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observed after restoring the waaG and placing the mutant rpoC in the genome of parent strain. 
The mutant rpoC gene was the key mutation for improving fatty acid titer. The insertion 
sequence in the waaG gene present in the parent strain had a dramatic effect on the amount of 
extracellular polysaccharides. Likewise, by restoring the waaG gene the membrane leakage 
problem was solved. Interestingly, the basS and basR mutations were able to partially solve the 
membrane leakage problem when treating cells with 10 mM C8. The decreased membrane 
fluidity and increased cell surface hydrophobicity of evolved strain was recreated by the 
reconstructed strain which has the restored waaG gene, rpoC and basR mutations. The restored 
waaG gene and mutant rpoC gene both contributed to increased weight-average lipid length of 
the evolved strain. Thus, all mutations are important, especially the mutant rpoC resulted in 
increased C8 tolerance and high fatty acid titer. However, the rpoC and basR encode 
transcriptional regulators, which could influence on the expression level of many genes in E. 
coli. If we want to understand the mechanisms of rpoC and basR mutations, we have to utilize 
transcriptome analysis for further investigation. 
In order to discover how the rpoC and basR mutations lead to phenotypic changes during 
fatty acid production, we did transcriptome analysis to identify differentially expressed genes 
between the evolved strain LAR1 and the parent strain ML115. Nineteen genes with differential 
transcript abundance likely caused by the rpoC mutation were selected, similarly twenty-one 
genes with differential transcript abundance likely caused by the basR mutation were chosen. 
Therefore, we constructed eighteen strains by knocking-out interesting genes or whole operons. 
Characterization of these reconstructed strains is in progress to further investigate the evolved 
strain.  
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We also characterized a small group of environmental E. coli isolates which had 
significant higher short-chain fatty acid production in minimal medium relative to the MG1655. 
In this study, we aimed to identify and prioritize membrane engineering strategies for improving 
fatty acid production in E. coli. We found differences in the cell membrane lipid composition, 
membrane fluidity, membrane integrity, and cell surface hydrophobicity between environmental 
isolates and MG1655. Consistent with the genome-level reverse engineering and previous 
publications, a decreased membrane fluidity was associated with an increased in fatty acid 
production. Surprisingly, cell surface hydrophobicity was also directly associated with fatty acid 
titer. For the cell membrane lipid composition, the C16:1/C16:0 ratio (mol/mol) was brought to 
our attention, since three environmental isolates all had a significantly higher ratio than the 
MG1655 strain during fatty acid production. Thus, we provided a new strategy for improving 
fatty acid production by rational altering the cell surface hydrophobicity. We also suggested that 
C16:1/C16:0 ratio could be a useful target for engineering the cell membrane composition.  
To sum up, the first part of this work was to systematic investigate the evolved strain by 
genome-level reverse engineering and transcriptome analysis. Additionally, in order to deepen 
the understanding of cell membrane properties for improving short-chain fatty production, we 
investigated environmental E. coli isolates with high short-chain fatty acid titer. The findings 
obtained from this work could be used as rational engineering strategies for improving short-
chain fatty acid tolerance and production of microbial biocatalyst.  
Future Work 
From the genome-level reverse engineering study, we noticed that the mutant rpoC gene 
resulted in an increased short-chain fatty acid tolerance and production. The evolved strain 
LAR1 had significant increased butanol tolerance relative to the parent strain ML115, as 
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previous studies reported. It would be interesting to know whether the rpoC mutation could also 
impact tolerance of other inhibitory compounds and environmental stressors, such us styrene, 
butanol, furfural, high temperature and low pH. Additionally, to find out whether the rpoC 
mutation could improve production of other desired toxic products, such as styrene, butanol and 
succinate might be an impactful strategy. The rpoC mutation may also contribute to increase 
tolerance and production of other inhibitory compounds in E. coli. 
In the transcriptome analysis study, we focused on discover how the rpoC and basR 
mutations lead to the phenotypic changes of evolved strain LAR1. So, we selected the genes with 
differential transcript abundance between LAR1 and ML115 which were directly associated with 
the rpoC and basR genes. The transcriptome analysis results could provide more information for 
further investigation. 
In the environmental isolates study, we altered the cell surface hydrophobicity by 
expressing the bhsA gene, in order to prove the directly association between cell surface 
hydrophobicity and fatty acid production titer. However, the direction and magnitude of the 
changes of cell surface hydrophobicity differed between strains. Thus, more reliable and stable 
strategies for altering cell surface hydrophobicity are needed for rational cell membrane 
engineering. 
 
